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Abstract: 
 
 
During the anaesthesia of dangerous zoo animals, additional anaesthetic risks to 
patients arise from precautions required to assure human safety. Evaluating the safety 
of anaesthetic approaches for these animals is not straightforward, with challenges 
associated with identifying disturbances to physiological homeostasis, attributing these 
disturbances to particular interventions and relating them to morbidity endpoints. In 
zoo animal anaesthesia, more reliance is necessarily placed on observational studies to 
quantify risks related to immobilisation regimens and to refine and improve the ways 
anaesthesia is subsequently delivered. 
 
This study applied an opportunistic approach, using readily accessible monitoring 
methods to investigate general changes to physiological homeostasis occurring under 
zoo anaesthesia in twenty-six individuals. This included comparative analysis of nine 
large mammal species, of diverse phylogeny and dietary ecology. In eleven large felids 
representing three different Felidae species included in the study, assessment was then 
undertaken of changes in metabolic acid-base status, the contribution of anions that are 
not normally measured to these changes and their possible association with mean 
arterial blood pressure preceding blood sampling episodes.  
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Strong evidence was found for time effects during anaesthesia on a variety of the 
measures of homeostasis that were monitored. Within the broad species ranges that 
were apparent in the homeostatic parameters measured, many unexpected findings 
were manifest in the way that different species and/or different conspecific individuals 
responded to anaesthesia. Within a species, differences were sometimes apparent in 
spite of relatively minor variations in the immobilisation protocols used, as was evident 
within the Panthera genus. Clinically significant alterations noted included blood 
pressure changes, changes to ventilation, possible ventilation-perfusion mismatches, 
alterations in acid-base status and occasional but concerning instances of acidaemia, 
hypoglycaemia, hypoxaemia and hyperkalaemia. All animals survived anaesthesia and 
did not show any apparent morbidity, limiting our ability to determine the pathological 
effects, if any, of the changes seen. Based on extrapolations from other mammals, some 
disturbances may have caused pathology or mortality if they had become more 
sustained or progressive.  
 
Extracellular (blood) base deficits exceeding -7mmol/L were common in the 
anaesthetised large felids, suggesting that these animals commonly displayed a state of 
metabolic acidosis under anaesthesia based on proposed definitions from domestic 
felids. However, there were marked species differences in acid-base status under 
anaesthesia, and further analysis showed that the drivers of the changes also varied 
between species. Although strong cautionary caveats are associated with the low power 
of the analysis, the findings suggest that inter-species extrapolations of acid-base 
physiology will be flawed, indicating a strong need for readily accessible species-specific 
reference ranges.  
 
There was no evidence for an association between strong ion gap and mean arterial 
pressure, but blood pressure was actively managed in most of the anaesthetics which 
may have confounded these results. Further study of tissue perfusion states than those 
provided by mean arterial blood pressure will be required to evaluate if a relationship 
exists between strong ion gap levels and corresponding states of blood flow in zoo 
animal anaesthesia. Nevertheless, this study has demonstrated that strategic point of 
care clinical pathology tests and blood gas analysis provide practical opportunities to 
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minimise and even prevent many physiological changes, with the potential to diminish 
risk to patients without placing human safety at additional risk. 
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1.1 Introduction: 
 
Zoo animal veterinary care involves particular challenges with the provision of 
anaesthesia to dangerous wildlife. Such challenges include inabilities to carry out  full 
pre-anaesthetic health assessments, a dearth of scientific information supporting 
particular anaesthetic practices, precautionary use of high doses of potent immobilising 
drugs without ability to titrate them, unpredictable drug uptake associated with remote 
drug delivery, dispositions of wild animals placing them at greater risk of self-injury, 
inabilities to approach patients during high risk periods of anaesthesia and the physio-
anatomical challenges associated with anaesthetic monitoring and support for animals 
of extremes of body size and aspect.  
 
The goal of anaesthetic management in a zoological setting is to improve patient 
anaesthetic safety without compromising human safety and although discoveries of new 
neuro-modulatory agents have revolutionised the safety of veterinary anaesthesia 
(Taylor 2014), there are still significant risks to zoo patients associated with delivering 
and maintaining anaesthesia using existing therapies (Lamont and Grimm 2014, Ozeki 
and Caulkett 2014). A clear understanding of the determinants of anaesthetic safety 
permits anaesthetic risk to be better mitigated using technologies available, which is 
important as technological breakthroughs in the delivery of anaesthesia are not 
frequent (Pronovost et al 2004, Lamont and Grimm 2014). A framework for developing 
this understanding is to identify the changes to homeostasis that occur during zoo 
mammal anaesthesia and to examine the risk factors associated with them, as a basis 
for gaining further insight into how and why they develop. 
 
1.2 Definition of Anaesthesia:  
 
Anaesthesia is traditionally defined as ‘a drug-induced absence of sensation’ (Heavner 
2001). Better mechanistic understanding has since broadened this definition (Eger and 
Sonner 2006) to encompass the various attributes of an anaesthetic state and the 
synergism of different drugs used to achieve this (Tonner 2005), as enshrined in the 
concept of ‘balanced anaesthesia’ (Lundy 1942). Key components of balanced 
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anaesthesia include loss of consciousness, muscle relaxation, analgesia and the 
suppression of stress responses (Hubbell and Muir 2009). In this thesis, the term 
‘anaesthesia’ is used to embrace the combined neuro-modulatory effects of drugs used 
to provide balanced anaesthesia in zoo animals. Its use therefore applies to agents used 
for anxiolysis, chemical restraint, and analgesia as well as the general and dissociative 
anaesthetics. This inclusive definition is applied because the combined effects of these 
neuro-modulatory agents are integral to determining associated outcomes (Hubbell and 
Muir 2009, Hernandez 2014).  
 
In zoo animal anaesthesia, these outcomes may include the loss and subsequent return 
to consciousness and mobility in a time frame that allows human safety, with minimal 
detrimental effects on the anaesthetised animal. These effects include short term but 
acutely hazardous changes in homeostasis, such as hypothermia, hypoxia or 
hypercapnia, and long term effects on health such as muscle damage, gastrointestinal 
ulceration or decreased renal function.  
 
1.3 Overview of Homeostatic Disturbances and Risks Associated with Anaesthesia: 
 
General anaesthesia involves controlled, reversible, drug induced intoxication of the 
central nervous system, hereinafter ‘CNS’ (Trim, Clarke and Hall 2014, Taylor 2014). 
Depending on pre-anaesthetic clinical states and on peri-anaesthetic management, 
induction and maintenance of anaesthesia may constitute a threat to the life of a patient 
(Hall and Clarke 1991, Trim, Clarke and Hall 2014, Taylor 2014).  Most of the effects of 
neuro-modulatory agents on organ function are mediated through their depression or 
alteration of neurological and neuro-endocrine control of such organs, involving 
alteration of synaptic activity and membrane conduction in brain centres and associated 
neurological and neuro-endocrine pathways (Hall and Clarke 1991). Every organ system 
may be affected in this way (Hall and Clarke 1991) and lethal anaesthetic overdose 
results from cessation of such controls rather than direct induction of brain death 
(Musizza and Ribarac 2010).  
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The CNS control of functions altered by neuro-modulatory agents is complex (Trim, 
Clarke and Hall 2014) and mechanism of actions and processes by which the molecular 
and cellular actions of these drugs translate into neuro-modulation is still poorly 
understood (Urban 2008, Musizza and Ribarac 2010). Anaesthesia itself is a particularly 
complex state: anaesthetics produce separate sub-states, probably at different areas of 
the CNS (Musizza and Ribarac 2010), each in a manner specific to particular agent types 
(Perouansky et al 2012).  
 
Potential impacts on homeostasis arise not just from general depression of neurological 
function; those occurring following the abolition of CNS inhibition or impaired 
coordination may be similarly profound. Examples from the veterinary zoological 
domain include excitatory responses to potent or high opioid dosage in felids and horses 
(KuKanich and Weise 2015) and excitatory and ataxic phases associated with lighter 
planes of anaesthesia (Meyer 2015), risking patient self-injury and hyperthermia. 
Complex interactions between the sympathetic nervous system, the endocrine system 
and muscular activity may also contribute towards the development of the different 
syndromes of capture myopathy (Hernandez 2014, Breed et al 2019).  
 
Wide dose-dependence, varying routes of administration, individual idiosyncrasies 
(Trim, Clarke and Hall 2014), drug interactions (Hall and Clarke 1991) and pre-
anaesthetic clinical and behavioural states (Lamont and Grimm 2014) all influence the 
pharmacokinetics and pharmacodynamics of each of the various neuro-modulatory 
agents. Furthermore, marked variations in the way that different species tend to 
respond to these agents and marked variations in the way that each species tend to 
process them (Forsyth 1992, Ozeki and Caulkett 2014) adds yet another layer of 
complexity to the range of expected responses arising from their use within the domain 
of veterinary anaesthesia. 
 
The most common conditions affecting the course of veterinary anaesthesia involve the 
cardiovascular and respiratory systems (Trim, Clarke and Hall 2014). Almost all drugs 
that elicit anaesthesia, particularly inhalational anaesthetics (such as isoflurane, 
sevoflurane and halothane) and to a lesser extent injectable anaesthetics (such as 
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barbiturates, propofol and steroid anaesthetics) affect cardiovascular function by 
inducing dose-dependent myocardial depression, mediated through a range of 
mechanisms including negative chronotropy, inotropy and possible conduction 
disturbances (Lees 1991). They also alter vascular reactivity directly or via reduced 
autonomic activity (Hall and Clarke 1991), causing spasmolytic vasodilation and affecting 
compensatory auto-regulatory blood flow responses. These effects may lead to 
hypotension and redistribution of blood flow, with potential for hypoxic injury (Noel-
Morgan and Muir 2018).  
 
Some agents have stimulatory effects on certain cardiovascular functions, potentially 
inducing hypertension. Examples in a veterinary zoological context are potent narcotics 
(Swan 1993, Burroughs et al 2014), cyclohexamines (Cerveny and Sleeman 2014), high 
doses of alpha-2 agonists (Ozeki and Caulkett 2014) and different combinations thereof 
as, for example, documented in canids (Larsen and Kreeger 2014), ursids (Caulkett and 
Fahlman 2014) and ungulates (Ball and Hofmeyr 2014). When chronic or extreme or 
sustained, hypertension may predispose to cerebral and pulmonary oedema and 
haemorrhage, retinopathy, choroidopathy and renal injury (Brown et al 2007, Haskins 
2015). Select agents, such as alpha-2 agonists, may have biphasic stimulatory and 
depressive cardiovascular effects (Scheinin et al 1989, Grimm et al 2001, Saleh et al 
2005, Trim, Clarke and Hall 2014), with changing haemodynamic impacts. 
 
Most anaesthetic agents (including cyclohexamines) and many sedative, opioid 
analgesic and hypnotic agents (including dexmedetomidine, midazolam, fentanyl and 
remifentanil) have varying dose-dependent depressive effects on ventilation and 
respiratory performance (Goudra and Farid 2013), often secondary to their influences 
on neurogenic and myogenic activity. Bradypnoea may occur with excessive anaesthetic 
depth, apnoea is common following induction of anaesthesia and some irregular 
breathing patterns observed during anaesthesia directly reflect medullary depression 
(Trim, Clarke and Hall 2014, Haskins 2015). All anaesthetics tend to depress 
chemoreceptor responses to carbon dioxide (Lamont and Grimm 2014) and loss of the 
intercostal component of breathing with deepening anaesthesia exacerbates poor 
chemoreceptor responses to carbon dioxide elevations (Hall and Clarke 1991), leading 
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to carbon dioxide accumulation without assistance to ventilation. The hypoxic drive to 
breathing is also abolished by certain anaesthetics such as halothane, in some species 
(Hall and Clarke 1991). Through various mechanisms, particularly following anaesthetic-
induced reductions in functional residual lung capacity (Hall and Clarke 1991), 
ventilation-perfusion mismatches may develop and most inhalant agents may interfere 
with hypoxic pulmonary vasoconstriction, exacerbating such mismatching (Lamont and 
Grimm 2014). Furthermore, cardiovascular and respiratory depressive effects may be 
interconnected through arrays of mechanisms, for example through the effects of 
positive end pressure ventilation on reducing venous return and resultant cardiac 
output (Hall and Clarke 1991).  
 
One of the effects which may contribute in particular to a multitude of other 
homeostatic derangements is the multifaceted impact of chemical restraint and 
anaesthesia on thermoregulation (Haskins 2015). The risk of such derangements depend 
on pre-existing morbidities and the extent of thermal dysregulation. Hypotension, 
myocardial ischemia and arrhythmias may be potentiated by hypothermia (Ko and 
Krimins 2014) and its occurrence is also associated with elevated risks of anaesthetic 
overdose, prolonged anaesthetic recovery and possibly impaired coagulation and 
predisposition to post-operative wound infection (Grimm 2015).  Severe hyperthermia 
may cause multiple organ dysfunction and organ failure (Haskins 2015). 
Homeostatic alterations induced by anaesthesia are almost invariably the aggregate 
result of multiple pathophysiological processes because of the dependence of higher 
metazoan cellular health on the integrated function of different organs. Since normally 
self-regulating physiological components are either suspended or radically altered by 
neuro-modulatory agents (Ludders and McMillan 2017), body systems under 
anaesthesia have been described as ‘tightly coupled’ (Gaba et al 1987) because changes 
in one component very rapidly affect others, with cascading domino-like effects. For 
their ability to induce profound cascading effects most immediately threatening to life, 
the neurological, cardiovascular, respiratory and thermoregulatory systems are 
prioritised in anaesthetic monitoring (Hall and Clarke 1991, Hubbell and Muir 2009). 
Metabolic disorders may well reflect the aggregate effects of multiple system 
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dysfunctions and acid-base disorders, electrolyte imbalances and alterations in 
glycaemic states provide salient examples of such potentially life-threatening 
homeostatic disturbances that also warrant close monitoring, particularly in at-risk 
patients (Trim, Clarke and Hall 2014).  
 
Anaesthetic agents have multiple and varied effects on the gastrointestinal tract, some 
of which may be particularly significant to patient prognosis. Most reduce 
gastrointestinal motility and may be associated with emesis, regurgitation and 
gastroesophageal reflux (Adams et al 2015). Ruminants are particularly prone to 
anaesthesia induced regurgitation and ileus (McDonell and Kerr 2015) and the 
cardiopulmonary consequences of gastric tympany may rapidly become life threatening.  
Regurgitation is also the most prevalent documented peri-anaesthetic gastrointestinal 
complication in small animal veterinary practice (Brodbelt et al 2015). Various 
significantly adverse morbidities may be associated with this passive process, including 
aspiration pneumonia and ulcerative oesophagitis and stricture (Wilson and Shih 2015). 
The risk of mucosal injury from gastroesophageal reflux may be greater than evident 
from times where reflux is observed (Brodbelt et al 2015, Wilson and Shih 2015). 
Contributing causes are many and given the lack of overt clinical signs at occurrence 
(Wilson and Shih 2015), these conditions are not well characterised in zoological 
medicine.  
A rapid transition through the intermediate stages of anaesthesia is vital to reduce 
aspiration risk from reflex emesis. In humans (Dutton 2013), non-human hominids 
(Murphy 2015) and other monogastrics such as felids, canids and ursids (Caulkett and 
Fahlman 2014) as well as ruminants such as caprines (Tranquili and Grimm 2015), 
antelopines (Ball and Hofmeyr 2014) and giraffids (Citino and Bush 2014), emesis or 
regurgitation is associated with laryngeal or pharyngeal stimulation under light planes 
of anaesthesia during induction. Chemo-emesis is also a common side effect of opioids 
and alpha-2 agonists in certain taxa such as canids and felids (Swan 1993, Kreeger and 
Arnemo 2012, Lamont and Grimm 2014) and while usually occurring prior to the 
abolition of swallowing reflexes, residual ingesta that remains in proximity to the glottis 
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may still pose a risk for aspiration. 
Often considered of less importance in the immediate term than the cardiovascular and 
respiratory systems, other organ systems are nevertheless critically important to 
general cellular health and function in the peri-anaesthetic period. Hepatic and renal 
function in particular may be variably impacted by anaesthesia, directly or via 
haemodynamic disturbances and alterations in their neuro-endocrine control (Papper 
1953, Gelman 1987, Mercatello 1990, Motayagheni et al 2017). Their functional 
capabilities are more the focus of pre-anaesthetic consideration where possible 
(Hubbell and Muir 2009) and are usually inferred during anaesthesia from amalgamated 
measures used to monitor more immediately vital organ systems (Hall and Clarke 1991). 
Nevertheless, the pharmacokinetic effects of altered renal or hepatic function (together 
with other important biotransformation organs such as lungs) may profoundly alter the 
course of anaesthesia through affecting the actions and eliminations of neuro-
modulatory drugs (Sear 1987, Hiraoka et al 2005). 
 
Procedural errors and equipment malfunctions during provision of anaesthesia may also 
have far-reaching impacts on homeostasis. The most prevalent complications in a large 
Australian study of human anaesthetic morbidity involved airway injury and aspiration 
pneumonia, arising respectively from difficult intubations and inadequate airway 
securement, with occurrences and sequels most manifest during intubation and after 
removal of the endotracheal tube (McNicol and Mackay 2010). Another particularly 
important procedural source of risk is error in clinical reasoning and anaesthetic decision 
making (Ludders and McMillan 2017), whereby anaesthetists’ errors in their responses 
to information from anaesthetic monitoring may further complicate the anaesthesia 
rather than resolve the disturbance to homeostasis. Often there may be more than one 
possible explanation for particular clinical abnormalities identified during anaesthesia, 
with the likelihood of each being influenced by complex interactions between the 
effects of the anaesthetic agent, the patient’s pre-anaesthetic health status and 
conditions that may develop during anaesthesia. The clinical discipline of anaesthesia is 
therefore both a learned practical art and a science (Taylor 2014, Trim, Clarke and Hall 
2014), drawing on both experience and on research to improve safety. 
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1.4 Particular Challenges Associated with Zoo Animal and Wildlife Anaesthesia:  
 
The practicalities of anaesthetising captive wildlife often involve enhanced risks to the 
patient relative to human and domestic animal anaesthesia and also to the staff involved 
in the procedure. These risks may be further accentuated in free-ranging wildlife. 
 
1.4.1 Disposition of Wildlife:  
 
The often dangerous disposition of wildlife demands application of precautionary 
principles for human safety. Associated risks of anaesthesia to the animal patient may 
be enhanced by such emphasis on human safety, through accentuation of dose-
dependent homeostatic impairments (Hatt and Jurado 2012) and associated prolonged 
recoveries (Hernandez 2014). Although there is no published data pertaining to the 
prevalence or incidence of human morbidity or mortality associated specifically with zoo 
animal and free-ranging wildlife restraint and anaesthesia, occupation-related fatalities 
have been reported to occur (Langley and Hunter 2001) and in one survey, albeit now 
somewhat dated, 61% of zoo veterinarians reported themselves to have been victims of 
major animal-induced trauma at some point during their career (Hill et al 1998). 
Furthermore, injuries to staff sustained by dangerous animals which have 
spontaneously awoken from anaesthesia have occurred (M Kock pers comm, D Cooper 
pers comm). Nevertheless, occupational safety has become a particularly important 
focus in the provision of zoo animal veterinary care, including for anaesthesia. This is 
evidenced by the development and implementation of comprehensive protocols and 
measures for dangerous animal crisis management (Murphy 2012), widespread legal 
emphases on responsibility towards safety and in developments in health and safety 
planning and program implementation (Hammond 2019).  
 
To allow human operators safe interactions with captive and free-ranging wildlife, 
Forsyth et al (1999) noted at the time that relatively high dosages of immobilising agents 
may be administered to animals such as tigers (in comparison with sedation of domestic 
species of shared taxa, especially when doses are allometrically adjusted) and this 
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observation is still largely valid for dosages often applied in current zoo practice 
involving large felids and other dangerous animals. Besides the precautionary principle 
(Hatt and Jurado 2012), part of the reason for these high doses may relate to the need 
to overcome the patient’s psychogenic response to restraint (Carregaro et al 2016). 
There is rarely proper opportunity to titrate such drugs to effect in zoo medicine (Ozeki 
and Caulkett 2014, Lamont and Grimm 2014), yet potent or concentrated formulations 
are often administered (Ozeki and Caulkett 2014, Caulkett and Arnemo 2015). Particular 
uncertainties may surround drug bioavailability, especially with remote drug application 
depending on full intramuscular delivery (Caulkett and Arnemo 2015, Hernandez 2014) 
and with the use of oral premedication; supplementation in the face of uncertainty may 
risk overdoses.  
 
Sudden awakening from anaesthesia with few premonitory signs is a documented risk 
in various species, particularly involving the use of alpha-2 agonists (for examples, see 
Burroughs et al 2014, Lamberski 2015 and Murphy 2015) and actual occurrences have 
been reported in less recent literature, involving medetomidine-ketamine combinations 
commonly used at the time in large felids (Jalanka and Roeken 1990, Miller et al 2003). 
As a result, such concerns may incline zoo veterinarians to err towards caution in the 
anaesthetic ‘plane’ maintained in species considered as particularly dangerous by 
zoological institutions (Hatt and Jurado 2012). The risk incurred as a result is that CNS 
functions may be depressed beyond what is necessary for anaesthesia. 
 
The nervous, flighty disposition of wild animals places them at significant risk of self-
injury prior to full immobilisation, necessitating fast-acting (and therefore often potent) 
drugs be delivered at the higher end of the dose range in an endeavour to induce 
anaesthesia rapidly (Ozeki and Caulkett 2014). Overdosing is even considered by some 
authors to be relatively less unsafe to many patients than under-dosing (particularly in 
free-ranging wildlife), because extended induction times may significantly increase 
stress and associated complications (Haigh 1990, Arnemo et al 2014). Prey species 
housed in zoological collections may be more at risk of self-injury and capture myopathy, 
particularly with added confinement, human approach, physical restraint and 
associated unnatural fear and stresses (Chalmers and Barrett 1982, Paterson 2014).  
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Significant advancements have, however, been made in relation to the reduction of pre-
anaesthetic stress responses (leading to pre-anaesthetic states more conducive to safer 
anaesthesia), particularly with the application of patient training techniques based on 
positive reinforcement (see, for example, Reichard 2008 and Whittaker and Laule 2012), 
the strategic use of neuroleptic or psychotropic drugs such as sedatives and tranquilisers 
(see, for example, Kaandorp 2005 and Tynes 2014) and the general application of holistic 
approaches towards animal care which better address the social and psychological 
aspects of patient wellbeing (Kagan et al 2015, Mellor 2016). 
 
1.4.2 Challenges Associated with Anaesthesia of Megafauna:  
 
In general, the larger the animal, the greater the anaesthetic risks likely to be involved 
(Trim, Clarke and Hall 2014). In equine practice, for example, a wider range and higher 
prevalence of perioperative and postoperative complications are evident compared 
with small animals (Brodbelt et al 2015), with many of these discrepancies being 
associated with anaesthesia. Equids are particularly susceptible to anaesthesia-related 
cardiovascular collapse (Muir and Hubbell 2009), myopathies, neuropathies (Duke et al 
2006, Trim, Clarke and Hall 2014) and significant ventilation-perfusion mismatches (Hall 
and Clarke 1991). Gravitational influences, in which the weight of the animal bears on 
organs and results in restricted breathing or compression of vasculature, are important 
in the pathogenesis of many of these conditions (Lamont and Grimm 2014, Trim, Clarke 
and Hall 2014). Anaesthesia of the megafauna encountered in zoo animal practice may 
face even greater gravitational challenges than domestic equids and these are combined 
with challenges posed by the peculiar physiological and anatomical considerations 
associated with greater extremes of body size and body aspect.  
 
The varied nature of these challenges are well documented for many large terrestrial, 
semi-aquatic and aquatic mammals.  Texts advising on restraint and anaesthesia of 
Giraffidae, Rhinoceridae, Elephantidae, Hippopotamidae, Tapiridae and Bovidae 
highlight the importance of taking steps to mitigate risks of local weight-focused 
myopathies and neuropathies (Stegmann et al 2014, Miller and Buss 2014, Miller et al 
2014, Wolfe 2015, Zimmerman and Hernandez 2015). These pathologies are 
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nevertheless avoidable even under prolonged anaesthesia in high risk animals such as 
black rhinoceros and elephant (Burroughs et al 2014, Horne and Loomis 2014, Radcliffe 
and Morkel 2014) and they occur as a result of general or local inadequacies in providing 
for tissue oxygenation requirements (Meltzer and Kock 2014). In terms of blood flow, 
giraffes are thought to show particular myocardial susceptibility to the effects of hypoxia 
due to significantly reduced cardiac output under anaesthesia (Citino and Bush 2014, 
Masterton 2020), especially because their inability to auto-regulate cranial blood 
pressure under anaesthesia may induce profound reflex bradycardia and resultant 
hypotension (Geiser et al 1992, Citino and Bush 2014, Masterton 2020). Furthermore, 
giraffe kidneys maintain extremely high renal interstitial hydrostatic pressures as a likely 
adaptation to protect against the high arterial driving pressures that are physiologically 
normal for this taxon, with physiologically low effective renal plasma flow as a result (Bie 
et al 2012). As such, it may be hypothesised that renal blood flow in giraffes may become 
particularly compromised by major reductions in arterial blood pressures. 
 
In terms of the respiratory system, larger species may be at greater risk of developing 
both hypoxaemia and hypercapnia, due to difficulties associated with achieving 
adequate ventilation and due to greater tendencies towards ventilation-perfusion 
mismatching under anaesthesia (Muir and Hubbell 1991). Hypoxaemia and hypercapnia 
may become particularly manifest in species with poor lung compliance under 
anaesthesia due to thoracic muscle rigidity or due to the immense pressure of 
abdominal contents on the diaphragm and sternum (Elephantidae: Burroughs et al 2014, 
Rhinoceridae: Wenger et al 2007, Horne and Loomis 2014, Radcliffe and Morkel 2014). 
Particular challenges may be associated with the anaesthesia of species with a reduced 
ability to respond to hypercapnia because of their relatively limited residual lung 
volumes in relation to body size (Elephantidae: Burroughs et al 2014, Giraffidae: Mitchell 
and Skinner 2011, Delk et al 2019). In terms of amelioration of these conditions, there 
are challenges associated with minimising the negative cardiovascular effects arising 
from positive pressure ventilation in animals exceeding one hundred kilogrammes in 
bodyweight (Simpson 2007). Furthermore, given the propensity for high fractions of 
inspired oxygen to induce varying degrees of atelectasis under anaesthesia (Lumb 2007), 
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much work still needs to be performed to determine optimal inspired oxygen fractions 
in zoological species in different clinical situations. 
 
In terms of the challenges associated with extremes of body aspect, giraffes provide the 
most salient example in this regard, with their long neck and legs making them 
extremely prone to head and limb injuries sustained during anaesthetic induction and 
recovery (Burroughs et al 2014, Citino and Bush 2014). At a different part of the aspect 
spectrum, there is marked potential for hyperthermia in species with lower surface area 
to volume ratios (Elephantidae, Hippopotamidae: Miller et al 2014; Rhinoceridae: Miller 
and Buss 2015; Pinnipedia: van Bonn 2015). In cetaceans, in which bodyweight is 
normally supported by buoyancy forces exerted by the water column, their removal 
from water immediately induces significant and potentially life-threatening 
compromises to cardiopulmonary and thermoregulatory function and these 
compromises are further exacerbated by chemical restraint and anaesthesia (Dold and 
Ridgeway 2014). 
 
1.4.3 Constraints Facing Preparedness in Zoo Anaesthesia:  
 
Safe and effective anaesthesia is particularly reliant on thorough pre-anaesthetic patient 
assessment and preparation (Bednarski et al 2011) in order to identify and provide 
optimal anaesthetic management of pre-existing conditions. Such requirements are 
addressed well in human clinical anaesthesia (see, for example, Pollard and Kitchen 
2018) and reasonable provision for it is possible in domestic animal veterinary medicine.  
 
For safety reasons, rarely is there the opportunity to provide the same depth of 
evaluation in zoo animal medicine (Caulkett and Arnemo 2015, Hernandez 2014, Divers 
2014), although holistic approaches to veterinary care that draw on a multi-disciplinary 
approach to health (see, for example, EAZA 2014 and Meehan 2015), recognition of 
subtle clinical and behavioural changes by keepers (see, for example, AZA 2012 and AZA 
2017), application of various technologies (see, for example, Al-Naji et al 2019) and 
patient training based on positive reinforcement (see, for example, McNally 2017 and 
Murphy and Danforth 2019) have improved capacities for pre-anaesthetic health 
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assessment.  Nevertheless, Cerveny and Sleeman (2014) state that unknown diseases 
may easily go undetected and Ball and Hofmeyr (2014) note that wild animals may still 
mask significant disease, with both of these cautions likely having similar validity in 
current wildlife anaesthesia practice. Furthermore, there are often only a few pre-
anaesthetic baselines against which the range and extent of anaesthetic impacts may be 
assessed. 
 
Significant technological developments and knowledge advancements have been made 
in the art and science of exotic animal, zoo and wildlife anaesthesia over recent decades, 
particularly towards monitoring and understanding the pathophysiological effects of 
anaesthesia (see, for example, Fahlman 2008), the development of safer anaesthetic 
protocols even for particularly high risk species such as giraffe (see, for example, Bush 
et al 2002, Citino and Bush 2014, Burroughs et al 2014, Bertelsen 2015, Delk et al 2019 
and Masterton 2020) and the provision of anaesthetic support (see, for example, 
Comolli et al 2019). These advances have drawn upon progress made in human and 
domestic animal anaesthesia and from research and sharing of knowledge and 
experiences in the zoological veterinary arena.  
 
In many zoological species there is, however, often still a paucity of information to 
provide scientific support for anaesthetic techniques (Ozeki and Caulkett 2014, Caulkett 
and Arnemo 2015), with pharmacodynamics studies of different protocols tending to 
dominate the empirical evidence base. Of particular relevance in this regard, one of the 
core requirements for anticipating the effects of anaesthesia is knowledge of the 
pharmacology and side effects of drugs used for its induction and maintenance 
(Cracknell 2008, Hubbell and Muir 2009). Yet in zoo animal medicine, rarely have 
detailed pharmacokinetic studies been performed in the species involved (Hunter 2010, 
Hernandez 2014). In practical terms, the number of options available for achieving 
balanced anaesthesia may also be more limited in zoo animal medicine because 
particular drug combinations have to be given together to counter each drug’s side 
effects, leaving less facility for more controlled, sequential premedication and induction.  
Before the completion of procedures and the conscious decision to awake a dangerous 
animal, anaesthetists may also be cautious to administer antagonists to the reversible 
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components of these combinations (such as alpha-2 agonists), as unexpected patient 
awakening or loss of balanced anaesthesia may be elicited. As a result, there is the 
potential for prolonged exposure to the unwanted side effects of such drugs. A personal 
observation is that for human safety reasons, a cautious approach may also be taken 
towards trialling alternative or complementary anaesthetic maintenance approaches 
such as total or supplementary use of intravenous anaesthesia. 
 
1.5 Assessing Zoo Animal Anaesthesia: 
 
1.5.1 Practical Constraints Facing Anaesthetic Monitoring and Response in Zoo 
Anaesthesia Practice: 
 
Unlike in other domains of anaesthetic practice, particularly limited anaesthesia 
monitoring may be undertaken in zoo animal and free-ranging wildlife settings and there 
may also be limited scope for timely corrective interventions, especially during the high 
risks periods prior to induction and post endotracheal tube removal (Lamont and Grimm 
2014, Hernandez 2014).   
 
Ideally, anaesthetic monitoring should be undertaken continuously from the moment of 
safe approach (Ozeki and Caulkett 2014) until it is no longer safely feasible, ideally 
conforming in manner and extent to recommendations made by professional bodies (for 
examples, see ACVA 1995, ACVA 2009, Robertson et al 2018 and Grubb et al 2020). To 
limit the need to repeat anaesthesia, there may be a tendency in zoo veterinary practice 
to carry out several diagnostic activities or health assessments with each anaesthetic 
event, in order to make the most of opportunities provided by them. A personal 
observation is that besides the need for patient transport, the frequent patient re-
positioning associated with the pursuit of these activities may potentially interfere with 
anaesthetic vigilance, especially if the practicalities of placing and maintaining 
monitoring equipment and undertaking monitoring are deemed to unjustifiably protract 
procedure time and thus incur potential additional risk to the patient.  
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1.5.2 Detecting Homeostatic Disturbances: Technical and Interpretative Challenges:  
 
Clinical reasoning and decision-making are critical skills in anaesthesia, permitting rapid 
diagnosis and application of appropriate and timely therapy (Ludders and McMillan 
2017). To respond to anaesthetic changes appropriately, the anaesthetist must have a 
good understanding of the physiological and pathophysiological processes involved for 
each species. In zoological medicine, such foundations may be lacking.  For example, 
reference ranges for clinical pathology parameters are poorly established for many 
species (Stacy and Hollinger 2018). With the anatomical and physiological variation 
apparent in such a wide range of species (Hernandez 2014), clinical errors may arise 
from inter-species extrapolations (Caulkett and Arnemo 2015). Anaesthetic equipment 
and techniques designed for use in medical and domestic veterinary fields also require 
adjustment, with interpretation having to be extrapolated to the unique and diverse 
anatomy and physiology of different taxa (Divers 2014). Particular challenges arise, for 
example, when monitoring equipment is applied to very large or very small patients 
(Ozeki and Caulkett 2014). 
 
Many of the significant interpretative challenges facing zoo animal anaesthetists are 
universal to anaesthetic monitoring, but they may be more complicated in a zoo setting.  
One of the key objectives of anaesthetic monitoring is to permit accurate assessment of 
the adequacy of tissue perfusion (Ozeki and Caulkett 2014) and various advanced 
modalities have been developed to complement the clinical parameters used to assess 
its adequacy in human medicine.  Many of the associated haemodynamic monitoring 
methods are invasive and often not practical to use in routine clinical situations, 
particularly in zoological medicine where time of anaesthesia is often limited. Therefore, 
reliance is placed instead on indirect macro-circulatory measures as the basis for making 
approximations of cardiovascular function. These include basic measures of heart rate, 
blood pressure and pulse pressure, together with mucous membrane colour, capillary 
refill time and temperature gradients. By cross referencing between these measures, a 
judgement is made about the likelihood that vital organs are being adequately perfused 
and oxygenated (Ozeki and Caulkett 2014). The limitations that are associated with a 
reliance on these measures have important implications for the accuracy of clinical 
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judgements based upon them. Foremost of these is the reliance on blood pressure as a 
poor proxy both for cardiac output and tissue perfusion (Wagner 2005, Lawson and 
Hutton 2012). Furthermore, macro-circulatory measures may not reflect the adequacy 
of oxygen delivery to different organs (Lawson and Hutton 2012), particularly as blood 
flow afforded to them is likely to be differentially distributed to reflect bodily 
importance of function (Bonanno 2011).  
 
Many commonly employed clinical indicators of the perfusion of particular organs that 
may be of use in conscious states, such as measures of cognitive function and urine 
output, often bear limited or no relation to organ function during anaesthesia (Noel-
Morgan and Muir 2018). Other more general measures, such as the assessment of 
mucous membrane colour and capillary refill time and vigour, do retain utility as general 
measures of perfusion but they may not necessarily reflect the reality of critical organ 
blood flow (Haskins 2015). A discussion by Chawla and Wilson (2007) stated that a 
clinically robust intra-operative measure of renal function does not yet exist. As such, if 
this still holds true, less specific and more indirect measures will need to be applied to 
assess the likely health and functioning of organs and monitor the effectiveness of 
resuscitative efforts on organs such as the kidneys and gastrointestinal tract under 
anaesthesia.  
 
The control of anaesthetic depth is equally fundamental to safe anaesthesia (Hubbell 
and Muir 2009), with the judiciousness of the anaesthetist being one of the most 
important influences in determining patient anaesthetic outcomes. The accurate 
assessment of patient anaesthetic depth is not straightforward (Trim, Clarke and Hall 
2014) and particularly with the added complexities associated with multimodal methods 
used to achieve balanced anaesthesia, it is recognised as a current challenge in medicine 
(Musizzi and Ribarac 2010). Significant inter-individual and procedure related variations 
exist in responses to anaesthetic drugs (Musizzi and Ribarac 2010) and interspecies 
variations add further dimension to these challenges in the veterinary context (Hubbell 
and Muir 2009). Physical signs such as blood pressure, heart rate, heart rate variation 
and respiratory rates often provide inaccurate, non-specific or too variable measures of 
anaesthetic depth (Trim, Clarke and Hall 2014) and the classical signs of depth of 
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anaesthesia based on Geudel’s observations may vary with species and reflect only 
momentary measures under situations where depth may be changing rapidly (Trim, 
Clarke and Hall 2014, Raue et al 2019). These challenges make it a refined art to gauge 
and pitch depth to safely accord with anticipated levels of patient stimulation, incurring 
risk that anaesthesia may be conducted at levels deeper than is often necessary (Trim, 
Clarke and Hall 2014).  
Assessment of lung function is the third major foundation of anaesthetic monitoring. As 
lungs function as a cardio-respiratory unit, this demands the ability to assess how well 
lung perfusion and ventilation are matched.  Monitoring based on respiratory rates and 
tidal minute volumes may be useful for detecting trends and can signal changes in the 
underlying status of the patient but their value alone is limited because they do not 
provide information about physiologic dead space and functional alveolar ventilation 
(Haskins 2015). These more detailed parameters require assessment of alveolar or blood 
gas measures (Bourgoin et al 2017). Capnography, which is the graphic display or 
recording of expired carbon dioxide concentration versus time or expired volume during 
a respiratory cycle (Pypendop 2015), is a valuable monitoring tool to identify whether 
ventilation is adequate and whether cardiac output may be changing (Williamson et al 
1993), providing trending information to indicate the development of excessive alveolar 
dead space (Haskins 2015) and thus prompting the anaesthetist to search for underlying 
causes. However, as the clinical status of a patient changes, so too may dead space and 
the relationship between end tidal carbon dioxide and arterial partial pressure of carbon 
dioxide (PaCO2) may become less predictable. In this situation, periodic serial blood gas 
determination needs to be undertaken to calibrate the two, particularly when changes 
in pulmonary function are indicated by end-tidal carbon dioxide or capnography 
changes (McSwain et al 2010).  
Current best practice in human anaesthesia is that monitoring is carried out by 
combining these techniques with more sophisticated methods where necessary. These 
include monitoring of systemic and peripheral haemodynamics, microcirculation and 
tissue oxidation (Kipnis and Vallet 2016), use of electro-encephalographic sensors and 
mathematical algorithms for assisting with anaesthetic depth estimation (Musizza and 
Ribarac 2010) and the application of various means to serially assess gas exchange, 
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respiratory system mechanics and patients’ readiness for withdrawal from positive 
pressure ventilation (Kipnis et al 2012).   
 
In veterinary anaesthesia and, in particular, zoo animal anaesthesia, anaesthetic 
monitoring is often much more basic, increasing the risk of adverse effects and 
introducing more uncertainly about whether procedures are being conducted within 
acceptable margins of safety for the patient. In many cases, this also means that 
anaesthesia safety and success is assessed simply and crudely by the nature of recovery 
from anaesthesia and survival of the animal beyond the immediate procedure. Lack of 
knowledge about the disturbances to homeostasis which are occurring and lack of 
understanding of the reasons for them make it more difficult to make safety-enhancing 
refinements to anaesthetic procedures. 
 
1.6 Quantifying and Mitigating Risk in Zoo Anaesthesia: 
 
1.6.1 Overview of Methods Currently Used to Quantify Anaesthetic Risk: 
 
Being able to quantify anaesthetic safety and identify the risk factors most strongly 
associated with it are important steps in anaesthetic risk mitigation. These risk factors 
provide a basis for more informed anaesthetic decision making and for refining 
protocols or exploring novel approaches to enhancing anaesthetic safety. Their most 
effective contribution to risk mitigation arises from the better causal and mechanistic 
understanding they may provide about the homeostatic disturbances occurring under 
anaesthesia. 
In human medicine, the tenets of evidence-based medicine have been advanced to 
promote more robust comparative evaluation of different treatments (Sackett et al 
1996, Sackett et al 1997). Some critics consider these tenets to have limited application 
to the domain of anaesthesia (Horan 1997). Besides, there is neither the scope nor 
quantity of data, nor the rigorous and systematic approach demanded of its collection 
(as set out by Myles et al 1999) to permit such full critical appraisal of different 
approaches in zoo anaesthesia.  
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Nonetheless, it is still critical to scrutinise the strength of evidence to support the safe 
and effective application of different anaesthetic approaches (Masters et al 2007). This 
is particularly relevant to choices involving the various ways to achieve balanced 
anaesthesia, as published protocols are widely disseminated and may be widely applied 
without the full context of their evaluation. Any lack of safety substantiation may be 
particularly relevant to patients who are already physiologically compromised, for 
whom the homeostatic effects of pre-existing morbidities may be exacerbated by 
anaesthesia (Hall and Clarke 2014). 
Critical determinants of the strength of evidence for studies evaluating the safety of 
treatments are the outcomes measured (Guyatt et al 1995). Mortality measures provide 
the most definitive representation of anaesthetic procedural safety and records of 
fatality provide one of three key inputs for describing and quantifying the safety of zoo 
anaesthesia in the Species360® Zoo Information Management System (ZIMS). A wide 
body of information pertaining to peri-anaesthetic mortality is now available in ZIMS 
and in the veterinary zoological literature and historically, the extensive use of certain 
protocols with minimal or no associated mortality has been stated as an argument to 
support and promote their safe use (for example, see Jalanka and Roeken 1990). Even 
in less dated, peer-scrutinised literature, there is the acknowledgement that safety of 
wildlife capture and immobilisation methods are sometimes still evaluated on the basis 
of mortality rather than on physiological responses (Fahlman 2008). 
 
Two of the most important limitations of using mortality based outcomes to quantify 
and compare anaesthetic risk are the inherent difficulties of defining ‘anaesthetic 
mortality’ (Jones 2001, Brodbelt et al 2015, Haller et al 2009) and the variations in study 
designs applied to their derivation (Masters et al 2007), especially since associations 
between anaesthetic events and outcomes do not necessarily imply cause and effect 
(Dyson et al 1998). Nevertheless, information from published peri-anaesthetic studies 
do suggest a much greater risk of peri-anaesthetic mortality in many domestic animals 
relative to humans. In human anaesthesia, peri-anaesthetic mortality rate estimates 
range from 0.01% to 0.001% (Irwin and Kong 2014, cited by Dugdale and Taylor 2016). 
By comparison, estimates in dogs and cats vary between 0.2% and 0.6% (Brodbelt et al 
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2015) and those associated with equine anaesthesia range from 0.08% to 1.8% (Dugdale 
and Taylor 2016).  
 
There have been few systematic attempts to evaluate the relative safety of zoo 
anaesthetic procedures in a manner comparable to the studies undertaken in human 
and domestic veterinary anaesthesia. The only comprehensive study of peri-anaesthetic 
mortality under zoo conditions published to date is a retrospective review involving 
great apes undertaken by Masters et al (2007), in which the derived peri-anaesthetic 
mortality was 1.35%. Given this apparently high risk of mortality relative to humans, 
dogs and cats, if these estimates do provide a reflection of the safety of zoo anaesthesia 
more widely, there is obviously some cause for concern. The authors concluded that 
only prospective studies may permit the systematic analysis of each death incident 
required to judge its likely relation to anaesthesia. Furthermore, there was uncertainty 
whether the high reported rates of peri-anaesthetic complications documented by this 
study were associated with increased risk of mortality and the same uncertainty could 
equally apply to whether potentially significant subclinical or undetected injuries were 
occurring as well.  Such uncertainties emphasise the importance of seeking earlier, more 
sensitive and more specific outcomes than mortality for assessing anaesthetic safety. 
 
Measures of morbidity provide other means for assessing anaesthetic safety and risk, 
although their application to evidence-based anaesthesia has been questioned by some 
(Horan 1997). Extensive morbidity information is generated from comprehensive 
requirements for monitoring anaesthetic performance in human anaesthesia (McNicol 
and Mackay 2010) and strong efforts to standardise their definition make comparison 
between studies more meaningful (Myles et al 2016). In the veterinary literature, peri-
anaesthetic morbidities are far less comprehensively documented (Brodbelt et al 2015) 
and in a much less recent prospective study, monitoring limitations were cited as a 
major reason for difficulties of ensuring consistent detection of adverse events in the 
veterinary practice setting (Dyson et al 1998).  
 
The monitoring and documentation of morbidity also appears to be limiting in zoo 
animal practice. ZIMS, for example, provides only limited scope for capturing the nature 
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and quantifying the significance of morbidities encountered during zoo anaesthetic 
procedures, although facility exists for ranking their perceived gravity into one of three 
semi-quantitative and subjectively delineated categories. Database users are thus able 
to draw on only three broad outcome-based measures (mortality, gravity of 
complication and abnormalities of recovery) to make judgements about the safety of 
particular drug regimens and there is no facility within the database to enable 
discrimination of patient and anaesthetic factors contributing to the data. These 
limitations associated with the characterisation of morbidity emphasise the importance 
of monitoring homeostatic changes in relation to risk factors as another basis for 
generating insight about safety and its determinants in the zoo anaesthesia setting. 
 
1.6.2 Associating Homeostatic Disturbances with Anaesthetic Risk: Focus of the 
Zoological Anaesthesia Literature: 
 
The evidence base for substantiating the safety of zoo animal anaesthesia protocols 
documented in the scientific literature is largely predicated on the ability to assess and 
evaluate how these protocols may affect homeostatic processes most closely linked to 
the patient’s immediate survival. To this end, reproducible and reliable means of 
assessing anaesthetic depth are required for comparison of different anaesthetic 
regimens (Whelan and Flecknell 1992) and evaluations also depend on the ability to 
perform extensive assessments of cardiovascular and respiratory performance (Hubbell 
and Muir 2009) in order to provide some gauge of the adequacy of tissue perfusion and 
oxygenation. With advances in point of care blood testing (see, for example, Radcliffe et 
al 2015) and laboratory analytical techniques, opportunities have opened for more 
comprehensive assessments of a wider range of homeostatic alterations to complement 
the more routine monitoring using physiological variables in zoo anaesthesia.  
 
Much of the literature pertaining to the anaesthesia of wild and captive mammals has 
been devoted towards evaluation of different immobilisation regimens and (much more 
infrequently) to extended anaesthesia protocols. Of the sixty-nine non-review articles 
directly related to mammalian anaesthesia published in the Journal of Zoo and Wildlife 
Medicine between 2010 and October 2020, forty-one involved such evaluations. Over 
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half of these studies did broaden characterisation of cardiovascular and respiratory 
performance beyond routine physiological measures by using serial blood gas 
assessments (involving two or more repeated measures) as part of the evaluation and 
many of these involved arterial measures to improve understanding of pulmonary 
performance.  Of particular note, very few of these studies took full advantage of readily 
accessible testing technology to widen concurrent and serial assessment to include 
other parameters of homeostasis and provide further measures of the likely general 
states of the cellular environment.  For instance, only five of the regimen studies (Boesch 
et al 2011 - white-tailed deer; Fahlman et al 2011 - brown bears; Black et al 2020 – nyala; 
Eggers et al 2020 – black-footed cats; Hewlett et al 2020 – warthogs;) detailed serial 
characterisation of acid-base status and only two studies (Boesch et al 2011 – white-
tailed deer; Gerlach et al 2017 - impala) additionally measured serial creatinine or 
creatine kinase, respectively to track changes in azotaemia status and to quantify muscle 
cell injury.  
 
Of the remaining studies, nineteen involved targeted assessments of very specific 
homeostatic disturbances occurring under anaesthesia, their focus being specifically 
restricted to investigations of hyperkalaemia in large felids (McEntire et al 2020) or to 
investigations of echocardiographic performance or other very specific cardiovascular 
and cardiopulmonary alterations in various taxa, such as investigations into the effects 
of anaesthesia on renal blood flow in cheetahs (Stagegaard et al 2017). A further nine 
studies have either specifically evaluated the safety and effectiveness of particular 
anaesthetic monitoring techniques or have evaluated a very specific means (such as 
specialised ventilation) of providing additional patient support. 
 
1.6.3 The Evidence Base Used to Substantiate the Safety of Immobilisation-
Anaesthetic Protocols in Zoo Practice: Large Felids as a Case Illustration: 
 
A review of the anaesthetic management of select captive large felids provides a largely 
reflective illustration of the published approaches used and the strength of evidence 
they generate in the evaluation of safety of zoo anaesthetic regimens, with many of the 
findings relating similarly to other taxa. Of the published anaesthetic regimens involving 
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the management of large felids in captivity, most document procedures of short 
duration. They do, nevertheless, illustrate how integral the sedative protocol is in 
contribution to balanced anaesthesia, particularly as the immobilisation protocol may 
profoundly reduce general anaesthetic requirements for the first sixty to eighty minutes 
after being administered (Nam et al 2013, cited by Buck et al 2017).  
 
Of the ten non-review publications of studies involving the anaesthesia of captive tigers 
published between 1997 and October 2020, only two of these studies (Curro et al 2004, 
Clarke-Price et al 2015) were analytical, being very low power cohort studies comparing 
two different drug regimens. The remainder (Forsyth et al 1999, Miller et al 2003, Steeil 
et al 2013, Lewis et al 2014, Reilly et al 2014, Laricchiuta et al 2015, Larsson et al 2017, 
McEntire et al 2020) involved even lower power observational (case series) or 
retrospective studies, of which only half provided reasonably comprehensive serial 
assessment of a range of homeostatic parameters; the focus of the remainder had other 
specific objectives. Only a single study (Lewis et al 2014) investigated association 
between drug pharmacokinetics and measured outcomes. Using immediate survival and 
quality of recovery from anaesthesia as measures of post-emergence outcome, all but 
one study specified such outcomes by either describing or scoring them. Of the 144 
anaesthetic procedures involving tigers covered by these publications, five cases of 
anaesthetic mortality were documented and eight cases required cardiopulmonary 
resuscitative interventions to survive (Steeil et al 2013, Reilly et al 2014, McEntire et al 
2020), although some were multi-species studies where the species effected were 
sometimes not specified and some of the same mortality or resuscitation cases may 
have been repeatedly included in different publications. Furthermore, four post-
anaesthetic recoveries involved significant or protracted complications (Lewis et al 
2014, McEntire et al 2020), three of which involved profound post-anaesthesia lethargy 
in individuals treated for hyperkalaemia with intravenous insulin (McEntire et al 2020).  
 
Five of the publications provide important illustrations of how absence of mortality or 
demonstrated morbidity provide poor reflections of possibly significant risks facing 
patients or operators. Although somewhat dated, Forsyth et al (1999) documented the 
occurrence of profound cardiovascular and respiratory depression using medetomidine 
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dosages recommended at the time for tigers (0.03 mg/kg) and in one case, a tiger awoke 
from sedation and dissociative anaesthesia following patient stimulation when ‘mid-
range’ medetomidine (0.025 mg/kg) was combined with a lower dose (1.66mg/kg) of 
ketamine (Miller et al 2003).  More recently, three of the publications (with the 
acknowledgement, in some cases, of repeated inclusion of the same animals) described 
the occurrence of a number of electrocardiographic abnormalities during anaesthesia 
(although the timing of their development were not always specified), sometimes 
associated with but not necessarily resulting from hyperkalaemia (Steeil et al 2013, 
Reilly et al 2014, McEntire et al 2020). 
 
Only two of the ten studies provided for serial integrated assessment of cardiovascular 
status based on measurement of mean arterial pressure, heart rate and continuous 
electrocardiographic monitoring. Only one study included enough data for serial 
assessments of cardiovascular status based on these parameters combined with serial 
acid base, lactate and azotaemia marker measurements. Just two permitted serial 
estimates of anaesthetic depth (either by invasive blood pressure measurement or from 
frequently recorded Guedel-type staging of anaesthetic depth). Only one provided data 
to evaluate (to some extent) the serial relationship between cardiovascular status and 
anaesthetic depth. Finally, only one enabled reasonable assessment of ventilation and 
cardiopulmonary parameters using serial measurement of arterial blood gases, end tidal 
carbon dioxide and pulse oximetry.  The study by Curro et al (2004) is the only one 
providing enough scope for more integrated, serial evaluation of all these homeostatic 
parameters together. In common with half the studies, the investigation by Curro et al 
(2004) also involved only short procedures where anaesthetic maintenance agents were 
not used. As an example of the relative paucity of research on the use of intravenous 
anaesthetics as primary maintenance agents in the Panthera genus, no studies have yet 
evaluated the use of propofol in tigers. 
 
On the basis of the quality of recovery, the regimens which were applied appear to 
perform safely but given the limited scope of the studies to identify homeostatic 
derangements and associate them with risk factors, the evidence base to substantiate 
the safety of important procedural considerations such as the choice of dosage of 
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anaesthetic protocol in captive tigers has been furthered only to a limited extent since 
the study by Forsyth et al (1999). There is clearly still much to learn about the effects of 
various drugs used in anaesthesia on biochemical, cardiovascular and other clinical 
parameters in captive tigers.  Similar remarks apply to other large felids, for whom it is 
most evident that there is a particular paucity of research pertaining to detailed 
evaluation of approaches used to maintain anaesthesia (Buck et al 2017). Just as with 
tigers, almost all of the associated studies published between 1997 and October 2020 
involving captive cheetahs and lions were undertaken with procedures of short 
duration. In the only study comparing the use of propofol in lions with other induction 
protocols (Epstein et al 2002), the physiological parameters measured were too limited 
and the procedures too short to properly evaluate its safety as a maintenance agent.  
 
To date, the most robust study permitting safety comparisons of propofol and isoflurane 
maintenance protocols involved an investigation of their cardiopulmonary effects in 
cheetahs (Buck et al 2017). The authors of this study expressly recognise the difficulties 
associated with comparing these regimens (given possible lack of equi-potency between 
them). Furthermore, by undertaking serial arterial blood gas monitoring and relating the 
findings to macro-circulatory and acid-base measures, this study marks an important 
step forwards in providing better serial characterisation of the relative adequacy of 
ventilation and perfusion under the regimens which were compared, but there is still 
much scope for wider investigations into the homeostatic effects which may occur. 
There is also need for further research to better inform about the most judicious use of 
maintenance agents and their combination with other approaches to achieve and 
maintain balanced anaesthesia in large felids.  
 
1.7 Comprehensive Serial Monitoring to Improve Safety Evaluation of Zoo Animal 
Anaesthesia: 
 
The challenges associated with assessing risk and substantiating the safety of zoo 
anaesthesia practices do not detract from the importance of finding ways to minimise 
their impact on physiological homeostasis and to better match anaesthetic approaches 
to the particular demands of intended interventions.  There is no facility to perform 
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controlled trials in a zoo context and knowledge will need to come from observational 
studies to develop safety enhancing procedural refinements pertaining to both the 
regimens used and the subsequent delivery of anaesthesia.  
 
Because many safety-related evaluations have involved drug regimen evaluations based 
on a limited range of measured homeostatic parameters, there is often uncertainty 
about the wider range of homeostatic alterations which patients may be experiencing. 
The evidence from human anaesthesia suggests that the more information gathered on 
physiological functions during zoo animal anaesthesia, the better will be the ability to 
identify changes in homeostasis that affect morbidity, long term health or mortality. 
Most importantly, the broader the range of parameters which can be tracked together 
and cross referenced in accordance with physiological principles, the better the prospect 
of being able to explain the changes which occur. To date, the full range of analytes 
available with blood gas analysers have rarely been fully exploited to monitor changes 
with much serial intensity in zoo animal anaesthesia.  
 
Consideration of the risk factors associated with such changes is an equally important 
part of this explanatory process and the more considered the risk factors, the more 
informed will be the risk mitigation process.  While studies of different anaesthetic 
regimens provide critical contributions to the overall promotion and enhancement of 
anaesthetic safety, an equally important priority in risk mitigation is to better 
understand the factors most determinant of anaesthetic risk in practice. Few studies in 
the zoo medical literature have assessed how well or otherwise patients are supported 
in everyday zoo anaesthetic circumstances and investigation of the factors influencing 
such adequacy should extend beyond the regimens used to include other procedural 
aspects. The working hypothesis is that current protocols for zoo animal anaesthesia are 
causing physiologically important homeostatic disturbances that are not detected by 
routine anaesthetic monitoring used in zoo settings. Identifying and prioritising these 
changes in homeostasis under anaesthesia could be used to improve zoo animal 
anaesthesia.  
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To address these knowledge gaps, more systematic and comprehensive serial collection 
and monitoring of a wider range of readily measurable parameters reflecting 
homeostasis should be applied to evaluate the safety of zoo anaesthesia as it occurs in 
practice. By identifying which homeostatic parameters tend to change over the course 
of anaesthesia and assessing the factors that are reflected in the scope and extent of 
these changes, the process should lay the foundations for more targeted investigations 
aimed at better understanding the causes and pathogenesis of the homeostatic 
disturbances which are apparent. A better mechanistic understanding of these 
disturbances should then provide a stronger evidence base for recommending practical 
refinements to anaesthesia management which contribute to enhanced safety. 
 
1.8 Research Aims, Objectives and Applications: 
 
The aims of the research presented in this thesis were: 
- to identify disturbances to physiological homeostasis occurring in larger species 
of mammals under anaesthesia in zoo practice, in order to advance understanding about 
the safety of anaesthetic practices for zoo patients, and 
- to gain further insight into how and why such disturbances occur.  
The practical application of this research is that a better understanding of the causes 
and mechanisms associated with the disturbances identified should permit 
identification of more effective measures to mitigate them, generating 
recommendations of both a monitoring and procedure-related nature. 
These research aims were addressed in this thesis by pursuing the following objectives:  
1. To apply readily accessible techniques to serially monitor and describe the 
prevalence and extent of physiological disturbances occurring in large mammals 
during zoo anaesthesia practice; 
2. To initiate examination of risk factors associated with these disturbances; 
3. To describe and characterise serial alterations in metabolic acid-base and 
unmeasured ion status occurring in large felids during anaesthesia; 
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4. To assess whether unmeasured anion values are associated with mean arterial 
blood pressures in the anaesthetic period preceding blood sampling events; 
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2.1 Introduction:  
 
The anaesthesia of many zoo mammals is frequently complicated by their dangerous 
nature, which often results in limited pre-anaesthetic evaluation, remote delivery of 
anaesthetic agents and limited opportunities for intensive monitoring during the 
induction and recovery phases of anaesthesia. There is also a wide variety of species 
involved, often for which veterinary knowledge is relatively rudimentary. The end result 
is that zoo mammal anaesthesia is suspected to have higher rates of complications and 
mortality than for human or domestic animal procedures. Hence, better mitigation of 
risks that can be managed should be a priority for enhancing the safety of zoo animal 
anaesthesia. 
 
Evaluation of the safety of anaesthesia in the zoological literature is dominated by 
pharmacodynamics studies involving or comparing particular immobilisation regimens. 
Much less published attention has been given to critically evaluating the wider aspects 
of anaesthesia provision and to evaluating patient physiology under anaesthesia in 
everyday zoo veterinary practice.  To identify ways to enhance safety using existing 
drugs and technologies, both the regimens used and the risk factors associated with 
their application must be considered together if a better mechanistic understanding is 
to be developed of how and why disturbances to physiological homeostasis occur under 
anaesthesia. This assessment process is particularly relevant to compromised patients, 
for whom the effects of pre-existing morbidities may be greatly exacerbated by 
anaesthesia (Clarke and Trim 2014). 
 
Even with empirical contributions from extensive pharmacodynamics studies, major 
knowledge gaps still remain which limit informed choices in the immobilisation and 
anaesthesia practices used in zoological medicine (Ozeki and Caulkett 2014). For 
example, these studies are largely predicated on evaluation of the effect of different 
regimens on the cardiovascular and respiratory system but often a lack of more specific 
monitoring and a variety of interpretative issues influence how effective these measures 
are for evaluating fundamental processes such as tissue perfusion and lung function 
(Noori and Seri 2008, Hubbell and Muir 2009). It may also be particularly difficult to 
 50 
directly compare regimens, given the challenges associated with making valid 
comparisons about anaesthetic depth (Whelan and Flecknell 1992, Musizza and Ribarac 
2010, Clarke and Trim 2014). The restricted physiological focus of these studies also 
raises uncertainty about the range of other effects on the animals’ physiological 
homeostasis these regimens may be inducing, including the potential for subclinical 
injury of long-term health significance. Rarely, too, have pharmacodynamics studies in 
zoological species been undertaken concomitantly with pharmacokinetic studies 
(Hunter 2010, Hernandez 2014), making it difficult to refine protocols on the basis of 
abilities to relate physiological effects to the bio-distribution of drugs used in different 
approaches. 
 
With limited recourse to controlled clinical trials in a zoo context, more opportunistic 
means are required to assess safety pertaining both to the regimens used and the 
subsequent delivery of anaesthesia. Refinements of anaesthetic regimens may include 
fine dosage adjustments, trialling of alternate drug combinations for balanced 
anaesthesia and reduction of anaesthetic drug maintenance requirements (particularly 
the application of remifentanil constant rate infusions for their potential anaesthetic 
dose-sparing benefits), as well as exploration of total or supplementary intravenous 
anaesthesia (TIVA, SIVA) to reduce dependence on inhalational anaesthetics for 
maintenance. Refinements to the delivery of anaesthesia may include the critical 
evaluation of the anaesthetic depth at which patients are maintained, the optimal 
manner and timing of alpha-two adrenergic agonist reversal, the use of vasoactive drugs 
based on better understanding of their haemodynamic effects in different species 
(Mama 2019) and the optimisation of ventilation support and inspired oxygen fractions 
provided to different patients. 
To address these knowledge gaps, much more systematic and comprehensive serial 
monitoring of a range of readily measurable parameters reflecting homeostatic 
processes needs to be applied to evaluate the safety of zoo anaesthesia as it occurs in 
practice. To date, few studies have taken full advantage of point of care blood gas 
analysers to serially monitor patients, although some authors have exploited them to 
incorporate advanced cardiopulmonary and acid-base assessments into their regimen 
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evaluations (Zeiler et al 2015, Gerlach et al 2017, Zeiler and Meyer 2017a, 2017b, Buck 
et al 2017b). Concurrent use of an increasingly wide range of laboratory-based measures 
of physiological homeostasis is also becoming more accessible.   
As a preliminary basis for investigating how zoo animals fare under anaesthesia, the aim 
of this study was to combine these readily accessible techniques and apply them with 
routine monitoring to assess the range, frequency and extent of disturbances to 
physiological homeostasis that are occurring in zoo anaesthetic practice in a range of 
large mammal species. Measures which reflect cardiovascular status, ventilation, acid-
base balance, electrolyte status and cellular injury were chosen in this initial focus. The 
working hypothesis is that current protocols used for zoo animal anaesthesia are causing 
physiologically important homeostatic disturbances that are not detected by routine 
anaesthetic monitoring used in zoo settings. Identifying, understanding the causes of, 
and prioritising these changes in homeostasis under anaesthesia could be used to 
improve zoo animal anaesthesia and patient safety. 
2.2. Materials and Methods:  
 
2.2.1 Study Design, Inclusion Criteria, Patient Recruitment:  
 
Zoo anaesthetic procedures were monitored at two New Zealand zoos for the 
occurrence and course of significant alterations to physiological homeostasis 
identifiable using clinical techniques, accessible anaesthetic monitoring equipment and 
analysis of blood analytes using point of care and laboratory technologies. The study 
used a prospective cohort design per criteria of Vandenbroucke et al (2007) and Dekkers 
et al (2012). Inclusion was restricted to eutherians exceeding twenty kilogrammes in 
bodyweight and patient recruitment was opportunistic, governed by zoo veterinary staff 
decisions on which animals required anaesthetic interventions over a two-year 
timeframe.  The ancillary monitoring described in this study was undertaken as soon as 
practical following intramuscular immobilising drug delivery (defined as time =0), 
continuing until endotracheal tube removal or final sedative/opioid reversal. The extent 
of monitoring and its timing varied between animals, depending on safety and 
accessibility to the animals at the time. The research was undertaken under zoo practice 
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conditions, although many findings from ancillary monitoring for the research were 
immediately available to the attending anaesthetists. 
2.2.2 Physiological Variables: Equipment and Measurement:  
 
Anaesthetic monitors (Surgivet Advisor® Vital Signs Monitor, Smiths Medical, Dublin, OH 
43017, USA or Tafonius® Ventilator/Monitor, Vetronics, Abberkerswell, UK) were used 
in 35 procedures (n=27 and n=8 respectively) to measure rectal/oesophageal 
temperature (T°), non-invasive (NIBP) or invasive (IBP) mean arterial pressure (MAP), 
heart rate (HR), end-tidal carbon dioxide (ETCO2) and respiratory rate (RR). Blood-
pressure cuff widths accorded as close as possible to 40 per cent of patient appendage 
circumferences (per recommendations of Clarke and Trim 2014) but location of cuff 
placement varied. The measurements of this physiological data, included in the results 
below, corresponds to nearest times to blood sampling. 
2.2.3 Blood Sampling:   
 
Venous (n=104) or arterial (n=23) blood samples were collected opportunistically from 
saphenous, jugular, cephalic, coccygeal, auricular or dorsal pedal vessels. Samples were 
drawn into a 3ml non-heparinised syringe using 18G needles or via catheterised vessels, 
latterly discarding the first 1-3mls of blood drawn up. Venous samples were then placed 
into lithium heparin anticoagulant tubes (BD microtainers, BD Diagnostics, Franklin 
Lakes, NJ, USA) and plain serum tubes (BD microtainers, BD Diagnostics, Franklin Lakes, 
NJ, USA). Venous heparinised samples were analysed at earliest opportunity using point 
of care analysis (mean 17, median 4, range 0-390 minutes), samples being chilled at 2 °C 
if holding time exceeded 10 minutes. The samples in serum tubes were chilled to 2 °C, 
left to clot for 30 minutes and centrifuged at approximately 1000g for 10 minutes. The 
serum was extracted and stored at -80°C until further analysis. Arterial samples were 
drawn from catheterised dorsal pedal or auricular arteries. Discarding the first 1-3mls of 
blood drawn, a further 1-3mls of blood was then collected using a 3ml non-heparinised 
syringe and analysed immediately from the same unpressurised and capped non-
heparinised 3ml syringes, by point of care testing. Remaining arterial blood drawn up 
was managed as per venous blood.  
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2.2.4 Analytical Equipment Used and Analytes Measured: 
 
A point of care blood gas analyser (EPOC®, Siemens Healthineers, Erlangen, Germany, 
EPOC® BGEM cartridges, Epocal Inc, Ottowa, ON, Canada) was used for all procedures, 
save for one procedure using a different blood gas analyser (i-STAT Portable Clinical 
Analyzer, Heska Corporation, Waukesha, WI, USA with CG4+ and CG8+ cartridges). 
Measured and machine calculated parameters included blood acidity (pH), partial 
pressure of carbon dioxide (pCO2), concentration of total carbon dioxide (cTCO2), 
bicarbonate ion concentration (cHCO3), standard base excess (cBEecf); sodium (Na), 
potassium (K), calcium (Ca), chloride (Cl), lactate (lact), anion gap including potassium 
(cAGK), partial pressure of oxygen (pO2), percent saturation oxygen (sO2%), 
haematocrit (Hct), haemoglobin (cHgb), glucose (Gluc) and creatinine (EPOC Crea). 
Serum was analysed in two batches by wet biochemistry using at a commercial 
laboratory (IDEXX, School of Veterinary Science, Massey University, Palmerston North, 
New Zealand). Analytes included blood urea nitrogen (BUN), sulphyl-dimethyl-arginine 
(SDMA), creatinine (NZVP Crea), total protein (TP), albumin (Alb), globulin (Glob), 
albumin: globulin ratio (A:G), creatine kinase (CK) and phosphate (PO4-). These analytes 
were run on stored serum in batches to limit inter-assay variation and, hence, collection 
to analysis intervals varied (1-18 months). 
 2.2.5 Statistical Analysis:  
 
All statistical analysis was carried out using SPSS v25 (IBM, Armonk, NY, USA). A general 
linear model (GLM) was carried out to assess for differences between species using time 
from immobilisation as a covariate and patient identity as a random factor. Where there 
was evidence of an effect (Pillai’s trace p<0.05) of time from immobilisation or between 
species, posthoc analysis was performed using a K matrix. Given the restricted sample 
sizes, the analytes assessed were categorised as follows and analysed as separate GLMs: 
1. Physiological variables (T°, MAP, HR, ETCO2 and RR) 
2. Blood gas analysis (pH, pCO2, cTCO2, cHCO3, cBEecf, Na, K, Ca, Cl, Lact, cAGK, 
pO2, sO2%, Hct, cHgb, Gluc and EPOC Crea). 
3. Serum biochemistry (BUN, SDMA, NZVP Crea, TP, Alb and Glob, Alb: Glob ratio,  
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CK, PO4-).  
2.3 Results:  
 
The results include the analysis from twenty-six different zoo mammals who underwent 
anaesthetic procedures of varying duration (27-451 minutes) involving different 
induction/maintenance regimens (data sheet supplied in Appendix A1). The procedures 
occurred over an eighteen-month period, with representation of nine different species 
from three broad dietary groups, involving animals ranging in age from 1-39 years (Table 
2.1).  
Table 2.1: Anaesthetic events included in the study: Species inclusion, ranges in 
duration of anaesthesia, and ages of patients. 
 
Species Scientific Name 
Number of 
Anaesthetic 
Events 
Mean 
Anaesthetic 
Duration 
(Minutes) 
Anaesthetic 
Duration: 
Range 
(Minutes) 
Mean 
Age 
(Years) 
Age Range 
(Years) 
African Lion  Panthera leo 6 295 217 to 451 17 13 to 19 
Sumatran 
Tiger Panthera tigris sumatrae 2 221 221 to 222 9 8 to 10 
African 
Cheetah Acinonyx jubatus 3 159 140 to 189 4 2 to 8 
Malayan Sun 
Bear Helarctos malayanus 2 250 150 to 349 17 13 to 22 
Common 
Chimpanzee Pan troglodytes 5 102 58 to 212 27 7 to 39 
Hamadras 
Baboon Papio hamadryas 3 167 140 to 183 11 7 to 15 
Lowland 
Nyala Tragelaphus angasii 3 178 27 to 285 2 1 to 2 
Southern 
White Rhino Ceratotherium simum  1 117 117 17 17 
Plains Zebra Equus burchelli 1 117 117 26 26 
 
Every patient survived the anaesthetic procedures without apparent post-anaesthetic 
complications. However, aspiration of ingesta was narrowly avoided in one particular 
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patient and particularly prolonged recoveries were reported following four procedures 
(notably including all geriatric felids maintained under propofol anaesthesia). 
Furthermore, much inter- and intra-individual variation was apparent in the 
homeostatic parameters measured. A sufficient number of procedures were monitored 
to evaluate the influence of the species involved and the time since administration of 
immobilising drugs as possible factors accounting for this overall variation. There were 
an insufficient variety and number of procedures to permit examination of the 
influences of drug and dosage regimens as covariates in the model and this was also the 
case for many other factors that were considered a priori as possible determinants of 
variation in the parameters measured (notably animal age, bodyweight, positioning of 
animal, anaesthetic maintenance protocol, ventilation method and extent of 
anaesthetist experience).  
There was very strong evidence for species differences in virtually all the homeostatic 
parameters measured (Table 2.2). The post hoc analysis (Table 2.3) displays the variety 
of inter-species differences that were seen across the analyses of physiological 
parameters, blood gas analyses and serum biochemical analyses. 
There are many interesting inter-species variations that warrant closer analysis. 
Regarding the physiological variables, relative hypotension and higher heart rates were 
recorded in baboons (Table 2.3, Figures 2.1a and 2.1b), while cheetahs were relatively 
markedly hypertensive, also recording relatively higher heart rates (Table 2.3, Figures 
2.1a and 2.1b) concomitant with strong evidence for having relatively lower lactate 
levels (Table 2.3). Combining physiological and blood gas measures, both these species 
also demonstrated relatively elevated end-tidal carbon dioxide and pCO2 levels, despite 
recording relatively elevated respiratory rates (Table 2.3, Figures 2.1c, 2.2b and 2.1d). 
Levels of pCO2 were somewhat stratified by species, with rhino pCO2 levels often being 
exceeded by many smaller species (Figure 2.2b). Likewise, lions also displayed relatively 
lower end-tidal carbon dioxide and pCO2 levels (Table 2.3, Figures 2.1c and 2.2b).  
Regarding electrolyte and metabolite measures, baboons and cheetahs displayed 
markedly lower and higher blood potassium levels respectively (Table 2.3, Figure 2.3b). 
In cheetahs, relative elevations in blood glucose levels were apparent (Table 2.3), while 
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lion glucose levels lay significantly below the group mean (Table 2.3). Species could 
largely be grouped according to azotaemia marker levels and while physiologically 
intuitive to an extent, felids nevertheless demonstrated profoundly elevated creatinine 
levels in relative terms (Table 2.3, see also data supplied in Appendix A1). In terms of 
markers of cellular injury, lion CK levels stood out as being relatively low, while cheetah, 
nyala and baboon levels were relatively high (Table 2.3, Figure 2.5). Surprisingly, no CK 
elevation was apparent over time during the rhino anaesthesia (Figure 2.5). 
As an overall reflection of how all animals fared as anaesthesia progressed, very strong 
(p<0.001) to strong (p<0.01) evidence for time effects were also evident for many of the 
homeostatic parameters measured in this study (Table 2.2). Of the physiological 
parameters, there was very strong evidence (p<0.001) of an effect of time on body 
temperature (Table 2.2), with animals appearing to tend towards mild hypothermia as 
anaesthesia progressed (Figure 2.1e).  Likewise, there was also strong evidence for 
changes over time involving physiological measures of respiratory performance, 
(including end tidal CO2 and RR, Figures 2.1c and 2.1d).  In contrast, there was 
insufficient evidence (p>0.1) for time effects on those physiological parameters which 
broadly reflect cardiovascular performance (MAP, HR, Figures 2.1a and 2.1b).  
Of the blood gas and acid-base analytes measured or calculated, there was extremely 
strong evidence (p<0.0001) for an effect of time from immobilisation on pC02 levels and 
thus for the respiratory component of acid base-status (Figure 2.2b). The same was the 
case for the metabolic component of acid base status (BE; Figure 2.2c). An overall trend 
of reducing base deficit (BD) or, alternatively, increasing BE over time was apparent in 
most species, including all felids (Figure 2.2c). Integrated measures combining the 
performance of metabolic and respiratory processes in determining acid-base status 
(Bicarbonate, pH; Table 2.2, Figures 2.2d and 2.2a) also showed strong evidence of an 
effect of time from immobilisation.  
Of the electrolyte analytes measured that represent important ionic determinants of pH 
and BE (Stewart 1983), chloride levels showed strong evidence of time effects (Table 2.2 
and Figure 2.3a), while sodium and anion gap did not. Nor did lactate, a metabolite with 
the potential to influence anion gap and therefore BE.  
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Table 2.2: The results of a GLM assessing changes in physiological parameters of zoo 
mammals under anaesthesia (a) Evidence for species effect (b) Evidence for effect of time 
since immobilisation. p <0.001 indicates very strong evidence for effect; p<0.01 strong 
evidence; p<0.05 moderate evidence, p<0.1 weak evidence; p>0.1 insufficient evidence. 
 
 
 a) Species Effect b) Time Effect 
Parameter   df F p-value df F p-value 
Physiological Parameters 
Body Temperature (Degrees Celsius) 8 5.863 <.001 1 28.058 <.001 
Mean Arterial Pressure (mm Hg) 8 6.426 <.001 1 .107 .744 
Heart  Rate (Beats/Min) 8 12.823 <.001 1 .620 .434 
End Tidal CO2 (mm Hg) 8 26.993 <.001 1 8.847 .004 
Respiratory  Rate (Breaths/Min)  8 5.775 <.001 1 6.334 .014 
Blood Gas (EPOC)  Parameters 
pH 4 68.213 <.001 1 16.946 <.001 
pCo2 (mmHg) 4 66.204 <.001 1 38.658 <.001 
cTCO2 (mmol/L) 4 79.179 <.001 1 17.962 <.001 
cHCo3- (mmol/L) 4 87.340 <.001 1 17.593 <.001 
BE (ecf) (mmol/L) 4 99.982 <.001 1 7.820 .008 
Na+ (mmol/L) 4 23.843 <.001 1 .971 .330 
K+ (mmol/L) 4 7.272 <.001 1 1.519 .225 
Ca++ (mmol/L) 4 8.596 <.001 1 2.055 .159 
Cl- (mmol/L) 4 97.433 <.001 1 9.063 .005 
Lactate (mmol/L) 4 6.799 <.001 1 .162 .689 
AG K (mmol/L) 4 7.040 <.001 1 .494 .486 
pO2 (mm Hg) 4 2.978 .030 1 .082 .776 
cSO2 (%) 4 2.545 .054 1 .100 .754 
Hct (%) 4 6.301 <.001 1 5.231 .028 
cHgb (g/dL) 4 6.537 <.001 1 6.189 .017 
Glucose (mmol/L) 4 3.624 .013 1 .146 .705 
Creatinine EPOC (micromol/L) 4 30.093 <.001 1 .234 .631 
Laboratory Clinical Pathology Parameters 
BUN (Urea) (mmol/L) 6 36.950 <.001 1 1.282 .263 
SDMA (microgrammes/dL) 6 18.050 <.001 1 .009 .926 
Creatinine wet chemistry (micromol/L) 6 54.106 <.001 1 .604 .441 
Total Protein (g/L) 6 8.731 <.001 1 24.453 <.001 
Albumin (g/L) 6 13.099 <.001 1 33.206 <.001 
Globulin (g/L) 6 10.396 <.001 1 6.793 .012 
Albumin/Globulin ratio  6 13.080 <.001 1 1.241 .271 
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CK (IU/L @ 37C) 6 24.425 <.001 1 16.241 <.001 
Phosphate (P04-) (mmol/L) 6 12.768 <.001 1 1.755 .192 
 
 
Figure 2.1a: Physiological variables: Scatter plot showing effect of species and time from 
immobilisation on Mean Arterial Pressure (in mm Hg) of zoo mammals under 
anaesthesia.  
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Figure 2.1b: Physiological variables: Scatter plot showing effect of species and time from 
immobilisation on Heart Rate (in beats per minute) of zoo mammals under anaesthesia. 
 
Figure 2.1c: Physiological variables: Scatter plot showing effect of species and time from 
immobilisation on End Tidal Carbon Dioxide (measured in mm Hg) of zoo mammals under 
anaesthesia. 
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Figure 2.1d: Physiological variables: Scatter plot showing effect of species and time from 
immobilisation on Respiratory Rate (in breaths per minute) of zoo mammals under 
anaesthesia. 
 
Figure 2.1e: Physiological variables: Scatter plots showing effect of species and time 
from immobilisation on Body Temperature (in degrees Celsius) of zoo mammals under 
anaesthesia. 
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Figure 2.2a: Blood gas variables: Scatter plots showing the effect of species and time 
from immobilisation on pH of zoo mammals under anaesthesia. 
 
Figure 2.2b: Blood gas variables: Scatter plots showing the effect of species and time 
from immobilisation on pCO2 (measured in mm Hg) of zoo mammals under anaesthesia. 
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Figure 2.2c: Blood gas variables: Scatter plots showing the effect of species and time 
from immobilisation on Extracellular Base Excess (measured in Mmol/L) of zoo 
mammals under anaesthesia. 
 
 
Figure 2.2d: Blood gas variables: Scatter plots showing the effect of species and time 
from immobilisation on Bicarbonate (measured in Mmol/L) of zoo mammals under 
anaesthesia. 
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Figure 2.3a: Electrolyte Parameters: Scatter plots showing the effect of species and 
time from immobilisation on Chloride (measured in Mmol/L) of zoo mammals under 
anaesthesia. 
 
 
Figure 2.3b: Electrolyte Parameters: Scatter plots showing the effect of species and 
time from immobilisation on Potassium (measured in Mmol/L) of zoo mammals under 
anaesthesia. 
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Figure 2.4a: Clinical pathology parameters related to oxygen carrying capacity and 
serum protein levels: Scatter plots showing the effect of species and time from 
immobilisation on Haematocrit (in percentage) of zoo mammals under anaesthesia. 
 
 
 
Figure 2.4b: Clinical pathology parameters related to oxygen carrying capacity and 
serum protein levels: Scatter plots showing the effect of species and time from 
immobilisation on Serum Albumin (measured in g/L) of zoo mammals under anaesthesia. 
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Figure 2.5: Clinical pathology parameters related to cellular damage: Scatter plot 
showing the effect of species and time from immobilisation on logarithm of Creatine 
Kinase (measured in IU/L at 37 degrees Celsius) of zoo mammals under anaesthesia. 
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Regarding laboratory clinical pathology parameters, there was insufficient evidence for 
an effect of time from immobilisation on any of the markers of extents of azotaemia 
(BUN, SDMA and creatinine). Apparent inter-assay variation between EPOC and 
laboratory creatinine measurements was noteworthy (data sheet supplied in Appendix 
A1).  
As measures of plasma protein and capacities for blood oxygen carriage, there was very 
strong evidence for time effects involving albumin, globulin and HCT, all of which 
generally demonstrated reductions over the duration of anaesthesia (Table 2.2, Figures 
2.4b and 2.4a). Interestingly, the rhino and zebra cases provided exceptions to these 
generally reducing trends over time.  Of the electrolyte and clinical pathology measures 
with the potential to become elevated under circumstances of gross cellular injury 
(Vanholder et al 2000, Breed et al 2019), CK levels showed strong evidence of the effects 
of time since immobilisation, although relative variations in CK levels were generally 
small (Figure 2.5). As the primary intracellular cation which may accumulate in the 
extracellular fluid in response to acidosis-induced cellular injury (Breed et al 2019) 
and/or reduced excretion (Schaer 1995), there was insufficient evidence for any effects 
of time since immobilisation on the plasma concentrations of potassium. 
Pertinent to overall evaluation of patient support were the frequency (19%) of MAP 
recordings of 65mmHg or less which is consistent with clinically significant hypotension 
(occurring relatively early during anaesthesia in primates; Figure 2.1a). Likewise, of 
potential concern was the frequency (26%) of pCO2 recordings exceeding 55mm Hg, 
consistent with clinically significant hypercapnia (occurring early into anaesthesia in 
primates and later in felids; Figure 2.2b). Alveolar-venous CO2 gradients exceeded 
15mmHg in 23% of cases, consistent with possible instances of inappropriate alveolar 
dead space (Hardman and Aitkenhead 1999, McSwain et al 2010, Mosing et al 2018). 
Certain outlier values are noteworthy for their clinical significance for the individual 
animals. These included cases of hyperkalaemia (>5.5 mmol/l, two of which were 
>=7mmol/l) in three felids (cheetah, two tigers), profound acidaemia (pH< 7.11) in two 
carnivores (cheetah, sun bear), relative elevation in plasma concentration of CK (19,000 
IU/L, nyala), concerning hypoglycaemia (<2mmol/l, chimpanzee) and marked 
hypoxaemia (venous pO2, 24mm Hg, nyala).  
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Table 2.3: Species differences in physiological measures and analytes for zoo mammals 
under anaesthesia as assessed by post-hoc analysis of a GLM. Empty areas represent 
species and parameters for which insufficient data was available to permit comparison. 
‘0’ denotes insufficient statistical evidence (p>0.1) for the species and parameter 
differing from the grouped species mean. ‘>’ and ‘<’ indicate there is statistical strength 
of evidence for which the species mean for the parameter is respectively greater or less 
than the grouped species mean. p <0.001 (red arrows) indicates very strong evidence; 
p<0.01 (green arrows) indicates strong evidence; p<0.05 (blue arrows) indicates 
moderate evidence.   
 
Species Baboon Cheetah Chimpanzee Lion Nyala Rhino Sun Bear Tiger 
Physiological Parameters 
Temperature 0 > < > < 0 < > 
 Respiratory  Rate  > > 0 0 0 0 0 0 
Heart Rate > > 0 < > < > < 
Mean Arterial Pressure < > < 0 0 0 0 0 
End tidal CO2  > > < < 0 0 < < 
EPOC Blood Gas/ Electrolyte Parameters 
pH > <   0 >       
pCo2 mmHg > >   < <       
pO2 mm hg 0 0   0 >       
cHCo3- mmol/L > >   < >       
BE (ecf) mmol/L > 0   < >       
cSO2 % 0 <   0 0       
Na+ mmol/L < >   > <       
K+ mmol/L < >   0 <       
Ca++ mmol/L < 0   > <       
Cl- mmol/L < >   > <       
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Table 2.3 (Continued): Species differences in physiological measures and analytes for zoo 
mammals under anaesthesia as assessed by post-hoc analysis of a GLM. Denotations are 
as per the legend for the first part of Table 2.3 (above). 
Species Baboon Cheetah Chimpanzee Lion Nyala Rhino 
Sun 
Bear 
Tiger 
EPOC Blood Gas/ Electrolyte Parameters (Continued) 
A Gap K mmol/L < >   0 0       
Hct % > >   0 <       
cHgb g/dL > >   0 <       
Glu mmol/L 0 >   < 0       
Lac mmol/L  < <   0 >       
EPOC Crea micromol/L < >   > <       
Laboratory Clinical Pathology Parameters 
SDMA  microgrammes/dL < > 0 > <   0   
CK IU/L @ 37C < 0 0 < >   <   
TP g/L < > > > >   <   
ALB g/L > > 0 < 0   <   
Glob g/L < 0 > > >   <   
A/G ratio > 0 0 < <   0   
BUN mmol/L < > 0 > <   >   
Crea micromol/L < > < > <   >   
PO4 mmol/L < > < < >   >   
 
2.4 Discussion:  
 
To the best of our knowledge, this is the first report documenting broad, intensive serial 
monitoring in a range of mammalian species to characterise homeostatic alterations 
occurring in everyday zoo anaesthesia practice. The results suggest many progressive 
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changes to physiological homeostasis are occurring, often with species differences, 
warranting further research to determine the external validity of the findings for zoo 
anaesthetic practice. Patient homeostasis sometimes demonstrated significant 
compromise, based on the premise that different mammalian species likely share 
generally similar homeostatic tolerances.  
The marked species’ differences evident in virtually all of the homeostatic parameters 
measured is an expected finding, attributable largely to the uniqueness of each species’ 
physiology.  Nevertheless, within the broad species ranges that were apparent in the 
homeostatic parameters measured, many unexpected findings were manifest in the way 
that different species and/or different conspecific individuals responded to anaesthesia, 
highlighting the individuality of each anaesthetic event and likely reflecting the 
importance of many other factors besides the anaesthetic regimens adopted in 
influencing the course of homeostasis under anaesthesia. This emphasises that no single 
protocol can be defined as ideal for a particular species, and provides a reminder that 
the kind of homeostatic disturbances observed in this study may be expected even for 
protocols which have been identified by anaesthetists as reflecting current best practice.  
Mild hypothermia was evident in most of the patients, despite body temperature being 
actively managed to prevent its progression, thus mitigating serious risks of potentiating 
hypotension and cardiac arrhythmias (Ko and Krimins 2014). Otherwise, evidence of 
mild hypoventilation was the most widely manifest disturbance recorded in this study, 
with somewhat unexpected species representations in terms of ventilatory 
performance. For instance, rhinoceroses normally hypoventilate under anaesthesia, 
even with ventilation support, and ventilation-perfusion mismatches are often 
associated with the difficulties in supplying the required tidal volumes without 
simultaneously prolonging pulmonary vascular compression. Yet the pCO2 
concentrations sometimes attained during the rhino procedure in this study compared 
favourably against those in other studies following the administration of potent opioids 
(Hattingh et al 1994, Fahlman et al 2016, Buss et al 2016), even matching pCO2 levels in 
non-sedated rhinos (Citino and Bush 2007). While comprising a dataset from only a 
single anaesthetic episode, such performance suggests ventilation benefits may accrue 
from the substitution of potent opioids with a combination of butorphanol, midazolam, 
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medetomidine and ketamine in these animals under zoo conditions.  That pCO2 
concentrations were lower in the rhinoceros relative to many smaller species (baboons, 
chimpanzees, cheetahs) in this study draws attention to the often inadequate 
ventilation of the latter species under anaesthesia, although most of the pCO2 
manifestations may be considered generally mild under high inspired oxygen fractions 
if blood pH reductions are small (Mama 2019).  The relatively normal (35-45mm Hg) 
pCO2 concentrations often recorded in the lions in this study may have reflected the 
predominant use of mechanical ventilation throughout anaesthesia in this species and 
advances have permitted the safer application of this technology even in some larger 
megafauna (Horne et al 2001, Citino et al 2007). Such support deserves much more 
extensive physiological evaluation, especially for its possibly wide application in 
zoological settings. Of interest, an arterial pO2 level of 706mmHg under 100% oxygen 
was achieved for a nyala receiving mechanical ventilation while being maintained under 
propofol anaesthesia, likely attained through optimisation of ventilation-perfusion 
matching. 
Measures of cardiovascular performance showed insufficient evidence of showing time 
effects, however it is worth noting that the cardiovascular system is actively managed 
by anaesthetists which may have masked the effect of time from immobilisation. 
Important trends in cardiovascular performance were nevertheless evident. Given the 
insensitivity of MAP as a measure of mild to moderate hypo-perfusion (Boag and Hughes 
2005) and the possible difficulties associated with re-establishing microcirculatory 
perfusion under such circumstances, the extent and occasionally sustained nature of 
MAP recordings below 65mmg Hg observed in this study was concerning, particularly as 
concurrent heart rates (as a means to augment cardiac output) often fell below those 
expected from extrapolations based on allometric scaling of heart rate for bodyweight 
(Sedgewick 1991). Furthermore, the instances of venous pCO2-ETCO2 gradients 
exceeding 15mm Hg may crudely reflect reduced pulmonary blood flow as a cause of 
inappropriate alveolar dead space (Hardman and Aitkenhead 1999, McSwain et al 2010, 
Mosing et al 2018). Intra-procedure ventilation varied widely and ETCO2 values may also 
have under-represented true values if endotracheal seals were not fully tight. 
Furthermore, variable venous gradients in this range are often observed in larger 
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mammals (Haskins 2015, Mama 2019). While lactate elevations were rarely even 
considered moderate (as per Kovacic 2009, defined as beyond 2mmol/l) and never 
appeared sustained, this marker may be insensitive for detecting regional hypo-
perfusion (Gillespie et al 2017). 
Although the pathophysiology of peri-anaesthetic hypotension is multifactorial, the 
depressive effects of injectable and inhalational anaesthetics on cardiovascular system 
performance are well recognised (Hall and Clarke 1991, Lees 1991, Mazzafero and 
Wagner 2001, Noel-Morgan and Muir 2018), with excessive anaesthetic depth being 
implicated as an important mechanism for haemodynamic compromise particularly in 
human geriatric anaesthesia (Wickham et al 2016). The possibility this may frequently 
be the case under zoo anaesthesia conditions warrants serious consideration and 
demands further research. Despite the aforementioned challenges associated with 
permitting valid comparisons of anaesthetic depth, parameters besides cardiovascular 
measures for further characterising depth were rarely recorded, possibly reflecting 
significant paucity of their comprehensive documentation in wider zoo anaesthesia 
practice. 
Base excess provides another useful general measure of homeostasis at the cellular 
environment level and patterns in this study suggest either that many patients 
presented with pre-anaesthetic metabolic compromise, and/or that metabolic 
challenges to patients (reflected by extents of relative metabolic acidosis) become 
particularly manifest late in the immobilisation phase or early during the initiation of 
anaesthetic maintenance. Given the marked and biphasic effects of medetomidine on 
blood pressure (Lamont et al 2001, Saleh et al 2005), its potential influence on blood 
flow should be evaluated in more detail as a possible contributory differential for the 
metabolic acidosis often recorded in this early period.  
The extensive time effect on chloride levels and the variation in chloride and anion gap 
evident during anaesthesia in some individuals indicates that aetiologies which 
respectively induce chloride and anion gap alterations (Kellum 2005, Corey 2005) are 
occurring in the patients monitored in this study and these may in turn reflect 
homeostatic alterations involving a variety of body processes and influences from 
 72 
various interventions. Further discrimination of the causative anions is thus an 
important first step in narrowing aetiological differentials (Kellum 2005), but anion gap 
may be an insensitive indicator of unmeasured ion levels in altered weak acid states 
(Lloyd 2004). Furthermore, per the reasoning of Sano et al (2005) and Damen et al 
(2016), the significant and widespread declines in HCT, albumin and globulin occurring 
during anaesthesia provide evidence for plasma dilution, through volume expansion, 
occurring as anaesthesia progressed in many patients in this study. This trend needs to 
be accommodated for when interpreting other blood analyte results and reasons for 
these changes deserve further investigation. Derivation of the strong ion gap and control 
for free water effects are required to account for the associated effects of changing 
weak acids and electrolyte concentrations as contributors to changes in base excess 
(Lloyd 2004, Anstey 2010).  
The three instances of felids demonstrating marked hyperkalaemia in this study were of 
particular concern for the health of the individuals involved and progressive potassium 
elevations in anaesthetised large felids are well documented in the literature (Gunkel 
and Lafortune 2007, Reilly et al 2014, McEntire et al 2020). In one extensive study of lion 
and tiger anaesthesia, these elevations were universal, independent of creatinine, 
always associated with progressively elevating glucose levels and more apparent with 
longer procedures in which medetomidine was used as the sedation agent (Reilly et al 
2014).   
In a more recent retrospective study of lions and tigers (with a quarter of the anaesthetic 
episodes involving those included in Reilly et al’s 2014 study) in which medetomidine or 
dexmedetomidine were part of the induction protocols, a quarter of the anaesthetic 
episodes recorded potassium elevations exceeding 5.5mmol/L and time under 
anaesthesia and early administration of atipamezole were respectively found to predict 
increasing and decreasing potassium concentrations. Furthermore, lions developed 
significantly greater potassium concentrations than tigers over equivalent anaesthetic 
times (McEntire et al 2020).  
In the present study, not all felids demonstrated glucose elevations and none of the lions 
developed potassium elevation above 5 mmol/L. Interestingly, anaesthetic 
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interventions involving the latter were occasionally prolonged to five or six hours’ 
duration. Such prolonged anaesthetic episodes also involved geriatric lions, maintained 
on propofol and for which approximately a third of the total atipamezole dose was given 
within a hundred minutes of medetomidine delivery.  In cases which did develop 
potassium elevations over time, potassium rises were independent of creatinine (and 
creatinine to sodium ratio), consistent with the findings of Reilly et al (2014). Reductions 
in pH were marked only in two (both predominantly respiratory) of the three cases 
showing marked potassium elevations (=>6.5mmol/l), while phosphate and CK levels 
were often much higher in non-effected felids, implying that tissue damage and extreme 
acidosis were not good predictors of hyperkalaemia. Falsification of ionised potassium 
readings by low pH still needs to be ruled out (Mama 2019).  Aldosterone and insulin 
assays were not undertaken in this study and while medetomidine probably plays a 
major role in the development of progressive potassium rises in large felids through its 
effect on insulin secretion as suggested by Reilly et al (2014), the results of the present 
study re-emphasize these authors’ views that other poorly determined factors are 
required to precipitate marked potassium elevations.  
The most likely reasons for markedly prolonged recoveries sometimes observed in this 
study, particularly following continuous propofol infusion in felids, could not be 
established. In the felids, they may have been related to age-related impairments in 
propofol metabolism, although prolonged recoveries have also been previously 
documented with propofol use in non-geriatric cheetahs (Buck et al 2017a). It is notable, 
though, that alterations in some of the parameters encountered in this study, such as 
marked changes in blood pressure and changes in albumin concentrations, may also 
affect propofol pharmacokinetics through altered protein binding (Mazoit and Samii 
1999) and through the potential for altered hepatic and extrahepatic flow to influence 
drug metabolism (Gelman 1987, Sahinovic et al 2018). 
Inability to perform pre-induction evaluations rendered it difficult to differentiate 
homeostatic disturbances attributable to pre-anaesthetic morbidity from those 
attributable to the effects of anaesthesia. This is a common feature of zoo animal 
anaesthesia. Patient training to permit such evaluation will be the only way to 
discriminate them, but will still leave uncertainty about how expected physiological 
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variables in the anaesthetic (and surgical) context should be adjusted to allow for an 
animal’s physiological response to such context. The observational study design and 
intermittence of monitoring imposed further interpretative limitations. Significant time 
trends and unexpected species differences for many of the parameters may partly 
reflect recruitment bias or uneven individual weighting in anaesthesia of different 
durations.  Significant homeostatic changes over time may also remain undetected with 
general linear modelling, which does not provide specific characterisation of their 
pattern.  
Particularly pertinent in this regard are the fluctuations observed in EPOC creatinine 
levels in many of the species. Although interpretation of repeated creatinine 
measurement is usually predicated on attainment of equilibrium states across body 
compartments, it is possible in human medicine to make inferences from creatinine 
fluctuations about functions such as glomerular filtration rates (Khayat et al 2019). A 
hypothesis deserving further evaluation in the zoo context is that creatinine should not 
fluctuate markedly under anaesthetic conditions where the haemodynamic status of the 
patient is stable, particularly in herbivores (V Walsh pers comm). It is uncertain what the 
biological significance of the creatinine fluctuations observed in this study were and 
given the discrepancies between the two analytical techniques used, further validation 
studies are required. Profoundly high creatinine levels (with both assays) in all the aged 
felids nevertheless suggest they presented in a state of renal insufficiency, possibly 
rendering them more sensitive to the renal and pre-renal effects which anaesthesia may 
potentially have on renal function (Mercatello 1990, Longley 2012, Greene et al 2014, 
McKinlay et al 2018).  
Generation of larger, more systematically gathered datasets using the methodology 
described may permit better assessment of how different procedural approaches 
influence patient safety. Such analytical capabilities may also be enhanced by closer 
examination of homeostatic parameters in relation to particular procedural changes 
occurring during the course of anaesthetic events. For example, further analysis of 
homeostatic changes in relation to more specific quantification of drug delivery (see, for 
example, McEntire et al 2020), particular phases of the anaesthesia protocol (see, for 
example, Napier et al 2013 and Rodriguez et al 2018), defined timeframes since 
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immobilisation (see, for example, Zeiler et al 2015) or combinations of these (see, for 
example, Siegal-Willott et al 2019) may also help to identify changes associated with the 
nature of specific interventions undertaken at different times.  
2.5 Conclusions:  
 
This study identified several physiological disturbances to homeostasis occurring during 
zoo anaesthetic procedures using established and frequently applied anaesthetic 
protocols. The external validity of the findings as a reflection of wider zoo anaesthetic 
practice remains to be determined. The clinical implications or pathological 
consequences of the homeostatic alterations identified are also uncertain, with such 
alterations including blood pressure changes, changes to ventilation, possible 
ventilation-perfusion mismatches, moderate to marked alterations in acid-base status 
and occasional but concerning hypoglycaemia, hypoxaemia and hyperkalaemia. Some 
of these would remain undetected or are unlikely to be anticipated if only routine 
physiological parameters are monitored, emphasising the value of applying strategic, 
serial point of care blood analysis even in cases which do not appear at elevated risk.  
Within species, markedly different individual responses to anaesthesia were apparent, 
sometimes despite use of relatively similar induction protocols, highlighting the 
importance of other procedure-related considerations, pre-anaesthetic states and 
different individual physiological responses to drugs in determining the course of 
anaesthesia. Protocols and other procedure-related management methods are widely 
disseminated and may quickly become established into institutional routine, yet they 
should not be considered as generic best practice for all occasions and if they are used, 
the kind of homeostatic disturbances identified in this study should be anticipated for 
better risk management. Findings from this study support a need to continuously seek 
procedure refinements and to closely tailor anaesthesia to individual patient responses.  
With a systematic approach and generation of a much broader database, the 
methodology described in this study should provide a means to promote a better 
mechanistic understanding of how and why homeostatic disturbances are occurring 
under anaesthesia, particularly when covariate parameters can be related to each other 
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in fuller context in order to provide more information about physiological functioning. 
However, the marked inter-species differences in these results suggest the comparative 
method used here would be better replaced by a tighter focus on more closely related 
species (Chapter 3). As such a dataset is built, the approach may also become better 
able to inform about the relevance of particular responses to anaesthesia and whether 
or not they are associated with particular post-anaesthetic outcomes.  
References: 
Anstey, C.M. (2010). Estimating the net effect of unmeasured ions in human 
extracellular fluid using a new mathematical model. Part I: Theoretical considerations. 
Anaesthesia and Intensive Care 38: 862-869. 
 
Breed, D, Meyer, L.C.R., Steyl, J.C.A., Goddard, A., Burroughs, R. and Kohn, T.A. (2019). 
Conserving wildlife in a changing world: Understanding capture myopathy—a malignant 
outcome of stress during capture and translocation. Conservation Physiology 7(1): 
coz027; doi:10.1093/conphys/coz027. 
Buck, R.K., Tordiffe, A.W.S. and Zeiler, G.E. (2017). Cardiopulmonary effects of 
anaesthesia maintained by propofol infusion versus isoflurane inhalation in cheetahs 
(Acinonyx jubatus). Veterinary Anaesthesia and Analgesia 44: 1363-137. 
Buck, R.K., Meyer, L.C.R, Stegmann, G.F., Kastner, S.B.R., Kummrow, M., Gerlach, C., 
Fosgate, G.T. and Zeiler, G.E. (2017). Propofol-medetomidine-ketamine total 
intravenous anaesthesia in thiafentanil-medetomidine-immobilized impala (Aepyceros 
melampus). Veterinary Anaesthesia and Analgesia 44: 138-143. 
Buss, P., Miller, M., Fuller, A., Haw, A., Wanty, R., Olea-Popelka, F. and Meyer L (2016). 
Cardiopulmonary effects of etorphine in immobilized white rhinoceros (Ceratotherium 
simum) and subsequent intravenous administration of butorphanol. 2016 Joint 
AAZV/EAZWV/IZW Conference Proceedings: pp123-124. 
Citino, S.B. and Bush, M. (2007). Reference cardiopulmonary physiologic parameters for 
standing, unrestrained white rhinoceroses (Ceratotherium simum). Journal of Zoo and 
 77 
Wildlife Medicine 38(3): 375–379. 
Clarke, K.W., Trim, C.M. and Hall, L.W. (Eds) (2014). Veterinary Anaesthesia. Eleventh 
Edition. Saunders Elsevier. 
Corey, H.E. (2005). Stewart and beyond: New models of acid-base balance. Kidney 
International 64: 777–787. 
Damen, T., Reinsfelt, B., Redfors, B. and Nygren, A. (2016). Pressure-dependent changes 
in haematocrit and plasma volume during anaesthesia, a randomised clinical trial. Acta 
Anaesthesiologica Scandinavica · January 2016 DOI: 10.1111/aas.12687. 
Dekkers, O.M., Egger, M., Altman, D.G. and Vandenbroucke, J.P. (2012). Distinguishing 
Case Series from Cohort Studies. Annals of Internal Medicine.156: 37-40. 
Fahlman, Å., Edner, A., Wenger, S., Foggin, C. and Nyman, G. (2016) Pulmonary gas 
exchange and acid–base status during immobilization of black rhinoceroses (Diceros 
bicornis) in Zimbabwe. Journal of the South African Veterinary Association 87(1), a1328. 
DOI: 10.4102/jsava.v87i1.1328  
Gelman, S. (1987). General anesthesia and hepatic circulation. Canadian Journal of 
Physiology and Pharmacology 65: 1762- 1779. DOI: 10.1139/y87-276 
Gerlach, C.A., Kummrow, M.S., Meyer, L.C., Zeiler, G.E., Stegmann, G.F., Buck, R.K., 
Fosgate, G.T. and Ka ̈stner S.B. (2017). Continuous intravenous infusion anesthesia with 
medetomidine, ketamine, and midazolam after induction with a combination of 
etorphine, medetomidine, and midazolam or with medetomidine, ketamine, and 
butorphanol in impala (Aepyceros melampus). Journal of Zoo and Wildlife Medicine 
48(1): 62–71. 
Gillespie, I., Rosenstein, P.G. and Hughes, D. (2017). Update: Clinical Use of Plasma 
Lactate. Veterinary Clinics of North America (Small Animals) 47: 325–342. 
Greene, J.P., Lefebvre, S.L., Wang, M., Yang, M., Lund, E.M. and Polzin, D.J. (2014). Risk 
factors associated with the development of chronic kidney disease in cats evaluated at 
primary care veterinary hospitals. Journal of the American Veterinary Medical 
 78 
Association 244:320–327. 
Gunkel, C. and Lafortune. M. (2007). Felids. In: West, G., Heard, D.J. and Caulkett, N. 
(eds.). Zoo Animal and Wildlife Immobilization and Anesthesia. First Edition. Ames (IA): 
Blackwell, pp 443-457. 
Hattingh, J., Knox, C.M. and Raath, J.P. (1994). Arterial blood pressure and blood gas 
composition of white rhinoceroses under etorphine anaesthesia. South African Journal 
of Wildlife Research 24 (1): 12-14. 
Hall, L.W. and Clarke, K.W. (1991). Veterinary Anaesthesia. Ninth Edition. WB Saunders 
London. 
Hardman, J.G. and Aitkenhead, A.R. (1999). Estimation of Alveolar Deadspace Fraction 
Using Arterial and End-Tidal CO2: A Factor Analysis Using a Physiological Simulation. 
Anaesthesia and Intensive Care 27: 452-458. 
Haskins, S. (2015). Monitoring Anesthetised Patients. In: Grimm, K.A., Lamont, L.A., 
Tranquilli, W.J., Greene, S.A. and Robertson S.A. (Eds). Veterinary Anesthesia and 
Analgesia: The Fifth Edition of Lumb and Jones. Wiley Blackwell, pp 86-113. 
Hernandez, S.M.  (2014). Chemical immobilization of wild animals. Chapter 18. In: 
Clarke, K.W., Trim, C.M. and Hall, L.W (Eds).  (2014). Veterinary Anaesthesia. Eleventh 
Edition. Saunders Elsevier, pp 571-584. 
Horne, W.A., Tchamba, M.N. and Loomis, M.R. (2001). A simple method of providing 
intermittent positive-pressure ventilation to etorphine- immobilized elephants 
(Loxodonta africana). Journal of Zoo and Wildlife Medicine 32:519–522. 
Hubbell, J.A.E. and Muir, W.W. (2009). Monitoring Anaesthesia. In: Equine Anesthesia: 
Monitoring and Emergency Therapy. Second Edition. Saunders, Elsevier, pp 149-170. 
Hunter, R.P. (2010). Interspecies Allometric Scaling. In: Cunningham, F., Elliott, J. and 
Lees, P. (Eds) Comparative and Veterinary Pharmacology. Handbook of Experimental 
Pharmacology Series 199, pp139-157. Retrieved April 2020 https://link-springer-
com.ezproxy.massey.ac.nz/book/10.1007%2F978-3-642-10324-7 
 79 
Kellum, J. (2005). Clinical review: Reunification of acid–base physiology. Critical Care 
2005, 9: 500-507. 
Khayat, M.I., Deeth, J.M. and Sosnov, J.A. (2019). A bedside clinical tool using creatinine 
kinetics to predict worsening renal injury and early recovery. Clinical Kidney Journal 12 
(2): 248–252. 
Ko, J.C. and Krimins, R.A. (2014). Thermoregulation. In: West, G., Heard, D. and Caulkett, 
N. (Eds). Zoo Animal and Wildlife Immobilization and Anesthesia. Second Edition. Wiley, 
Blackwell, pp65-68. 
Kovacic, J.P. (2009). Lactic Acidosis. In: Silverstein, D.C. and Hopper, K. (Eds). Small 
Animal Critical Care Medicine. Saunders. St Louis, Missouri, pp 254-257. 
Lamont, L.A., Bulmer, B.J., Grimm, K.A., Tranquili, W.J. and Sisson, D.D. (2001). 
Cardiopulmonary evaluation of the use of medetomidine hydrochloride in cats. 
American Journal of Veterinary Research 62: 1745–1749. 
Lees, P. (1991). Injectible and Inhalational anaesthetics. In: Brander, G.C., Pugh, D.M., 
Bywater, R.J. and Jenkins, W.L. (Eds). Veterinary Applied Pharmacology and 
Therapeutics. Fifth Edition. Bailliere Tindall, pp 355-391. 
Lloyd, P. (2004). Strong Ion Calculator – A Practical Bedside Application of Modern 
Quantitative Acid-Base Physiology. Critical Care and Resuscitation 6: 285-294. 
Longley, L. (2012). Aging in Large Felids. In: Miller, R.E. and Fowler M.E. (Eds). Zoo and 
Wild Animal Medicine: Current Therapy. Volume Seven.  Saunders, Elsevier and Co., pp 
465-469. 
Mama, K. (2019). Perianesthetic Monitoring: Equipment and Interpretation. In: Miller, 
R.E. Lamberski, N. and Calle, P.P. (Eds). Fowler's Zoo and Wild Animal Medicine: Current 
Therapy. Volume Nine. Elsevier, St Louis, Missouri, pp 185-192.  
Mazoit, J.X. and Samii, K. (1999). Binding of propofol to blood compartments: 
implications for propofol pharmacokinetics and pharmacodynamics. British Journal of 
Clinical Pharmacology 47: 35-42. 
 80 
McEntire, M.S., Ramsay, E.C., Price, J., and Cushing, A.C. (2020). The effects of procedure 
duration and atipamezole administration on hyperkalemia in tigers (Panthera tigris) and 
lions (Panthera leo) anesthetized with α-2 agonists. Journal of Zoo and Wildlife Medicine 
51 (3):490-496. 
McKinlay, J., Tyson, E. and Forni, L.G. (2018) Renal complications of anaesthesia. 
Anaesthesia 73 (Supplement 1): 85–94. DOI:10.1111/anae.14144 
McSwain, S.D., Hamel, D.S., Smith, P.B., Gentile, M.A., Srinivasan, S., Meliones, J.N. and 
Cheifetz, I.M. (2010). End-Tidal and Arterial Carbon Dioxide Measurements Correlate 
Across All Levels of Physiologic Dead Space. Respiratory Care 55(3): 288–293. 
Mazzaferro, E.  and Wagner, A.E. (2001). Hypotension During Anesthesia in Dogs and 
Cats: Recognition, Causes, and Treatment. Compendium of Small Animal and Exotics 23 
(8): 728-737. 
Mercatello, A. (1990). Changes in renal function induced by anesthesia. Annales 
Francaises d’ Anesthesie et de Reanimation 9(6): 507-24. 
Mosing, M., Böhm, S.H., Rasis, A., Hoosgood. G., Auer, U., Tusman, G., Bettschart-
Wolfensberger, R. and Schramel, J.P. (2018). Physiologic Factors Influencing the Arterial-
To-End-Tidal CO2 Difference and the Alveolar Dead Space Fraction in Spontaneously 
Breathing Anesthetised Horses. Frontiers in Veterinary Science 5:58 Retrieved in April 
2020 from https://doi.org/10.3389/fvets.2018.00058  
 
Musizza, B. and Ribaric, S. (2010). Monitoring the Depth of Anaesthesia. Sensors 2010, 
10, 10896-10935; doi:10.3390/s101210896. Accessed 19 November 2019. 
Napier, J.E., Kutinsky, I.B., Armstrong, D.L., Orton, D., Hicks, C.L., Waldoch, J. and Devlin, 
W.H. (2013). Evaluating Echocardiogram and Indirect Blood Pressure Results in Male 
Western Lowland Gorillas (Gorilla gorilla gorilla) During Three Phases of an Anesthetic 
Protocol. Journal of Zoo and Wildlife Medicine 44 (4): 875-881.   
Noel-Morgan, J. and Muir, W.W. (2018). Anesthesia-Associated Relative Hypovolemia: 
Mechanisms, Monitoring, and Treatment Considerations. Frontiers in Veterinary Science 
 81 
5: (Article 5) 1-13. www.frontiersin.org. DOI: 10.3389/fvets.2018.00053 
Noori, S. and Seri, I. (2008). Etiology, Pathophysiology and Phases of Neonatal Shock. In: 
Kleinman, C. and Seri, I. (Eds). Haemodynamics and Cardiology: Neonatology Questions 
and Controversies. Saunders Elsevier, Philadelphia, pp 3-18. 
Ozeki, K. and Caulkett, N. (2014). Monitoring. In: West, G., Heard, D. and Caulkett, N. 
(Eds). Zoo Animal and Wildlife Immobilisation and Anesthesia. Second Edition. Wiley 
Blackwell. 
Reilly, S., Seddighi, M.R., Steeil, J.C., Sura, P., Whittemore, J.C., Gompf, R.E., Elliott, S.B. 
and Ramsay, E.C. (2014). Selected Clinical, Biochemical, And Electrolyte Alterations in 
Anesthetized Captive Tigers (Panthera tigris) And Lions (Panthera leo). Journal of Zoo 
and Wildlife Medicine 45(2): 328–334. 
Rodriguez, K.T., Gompf, R.E., Smith, C.K., Price, J.M. and Cushing, A.C. (2018). 
Echocardiographic Parameters in Eight Adult Tigers (Panthera tigris) During Two Phases 
of an Anesthetic Protocol. Journal of Zoo and Wildlife Medicine 49 (4): 875-880. 
Sahinovic, M., Struys, M.M.R.F. and Absalom, A.R. (2018). Clinical pharmacokinetics and 
pharmacodynamics of propofol. Clinical Pharmacokinetics 57: 1539-1558. 
Saleh, N., Aoki, N., Shimada, T., Akiyoshi H., Hassanin, A. and Ohashi, F. (2005). Renal 
effects of medetomidine in isoflurane-anaesthetised dogs with special reference to its 
diuretic action. Journal of Veterinary Medical Science 67(5):461-465. DOI: 
10.1292/jvms.67.461 
Sano, Y., Sakamoto, A., Oi, Y. and Ogawa, R. (2005). Anaesthesia and circulating blood 
volume. European Journal of Anaesthesiology 22: 258–262. 
 
Schaer, M. (1995). Hyperkalaemia and Hypernatraemia. In: Ettinger, S.J. and Feldman, 
E.C. (Eds). Textbook of Veterinary Internal Medicine: Diseases of the Dog and Cat. 
Volume 1, Chapter 10. WB Saunders, Philadelphia, pp 46-49. 
 
Sedgewick, C.J. (1991). Allometrically scaling the data-base for vital sign assessment 
 82 
used in general anaesthesia of zoo species. Proceedings of the American Association of 
Zoo Veterinarians Annual Meeting, September 28-October 3: 360-369. 
Siegal-Willott, J.L., Bauer, K.L., Hayek, L.C., Luensman, N.M., Cross, T.N., Sajecki, J.L. and 
McRuer, D.S. (2019). Comparison of isoflurane gas versus a guaifenesin, ketamine, and 
medetomidine constant-rate infusion for maintenance anesthesia in American black 
bears (Ursus americanus). Journal of Zoo and Wildlife Medicine 50(3): 570–578. 
 
Stewart, P.A. (1983) Modern quantitative acid-base chemistry. Canadian Journal of 
Physiology and Pharmacology 61: 1444-61. 
Vandenbroucke, J.P., von Elm, E., Altman, D.G., Gøtzsche, P.C., Mulrow, C.D., Pocock, 
S.J., Poole, P., Schlesselman, J.J. and Egger, M. (2007). Strengthening the Reporting of 
Observational Studies in Epidemiology (STROBE): Explanation and Elaboration. Annals 
of Internal Medicine 147: W-163–W-194. 
Vanholder, R., Sever, M.S., Erek, E., Lameire, N. (2000). Rhabdomyolysis. Journal of the 
American Society of Nephrology 11: 1553–1561. 
Whelan, G. and Flecknell, P.A. (1992). The assessment of depth of anaesthesia in animals 
and man. Laboratory Animals 26: 153-162. 
 
Wickham, A., Highton, D. and Martin, D. (2016). Care of elderly patients: a prospective 
audit of the prevalence of hypotension and the use of BIS intraoperatively in 25 hospitals 
in London. Perioperative Medicine 5:12-19. 
Zeiler, G.E., Stegmann, G.F., Fosgate, G., Buck, R.K., Ka s̈tner, S.B.R, Kummrow, M., 
Gerlach, C. and Meyer, L.C.R. (2015). Etorphine–ketamine–medetomidine total 
intravenous anesthesia in wild impala (Aepyceros melampus) of 120-minute duration. 
Journal of Zoo and Wildlife Medicine 46(4): 755–766. 
Zeiler, G.E. and Meyer, L.C.R. (2017a). Comparison of thiafentanil-medetomidine to 
etorphine-medetomidine immobilisation of impalas (Aepyceros melampus). Journal of 
the South African Veterinary Association 88(0), a1520. Retrieved April 2020 https://doi. 
 83 
org/10.4102/jsava. v88i0.1520 
Zeiler, G.E., and Meyer, L.C.R. (2017b). Blood acid-base status in impala (Aepyceros 
melampus) immobilised and maintained under total intravenous anaesthesia using two 
different drug protocols. BMC Veterinary Research 13:246-255.  
  
 84 
Chapter Three: Metabolic acid-base changes in large felids under anaesthesia: An 
observational study assessing the role of unmeasured anions: 
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3.1 Introduction: 
 
Important objectives of anaesthetic monitoring are to assess whether blood flow is likely 
to be preserved to vital organs and whether oxygen delivery is likely to meet tissue 
demands (Ozeki and Caulkett 2014). In zoo anaesthesia practice, various haemodynamic 
parameters are used in conjunction with one another to make assessments about tissue 
perfusion (Ozeki and Caulkett 2014). Unfortunately, such assessment is not easy 
(Lonjaret et al 2014, Ackland et al 2019), especially since blood pressure may not always 
provide an accurate gauge of cardiac output and therefore of blood flow (Edner 2005, 
Wagner 2005, Lawson and Hutton 2012). Mucous membrane colour, refill time and refill 
vigour retain some utility as general gauges of perfusion under immobilisation and 
anaesthesia, but they may not necessarily reflect critical organ blood flow (Haskins 
2015). 
 
Some organs may be more liable to hypoxia than others as they are afforded lower 
circulatory priority in low flow states (Bonanno 2011, Post and Vincent 2018). Renal 
medullary thick ascending tubular cells are particularly sensitive to hypovolaemia-
induced ischaemia (Kellen et al 1994, Goren and Matot 2015, Layton 2016, Meersch et 
al 2017, Salmasi et al 2017). In domestic felids, anaesthesia has been identified as a risk 
factor for chronic kidney disease (Greene et al 2014). Similar risks may apply to non-
domestic Felidae, particularly with the potential cardiopulmonary impact of high 
dosages of immobilising drugs (Forsyth et al 1999) and the depths at which anaesthesia 
may be maintained in Pantherae for the safety of human operators. There are 
challenges with assessing blood pressure in conscious states in these dangerous wild 
animals, which leads to uncertainty about how this parameter scales to bodyweight in 
mammals (Poulsen et al 2018), while scaling of perfusion pressure still needs to be 
examined (White and Seymour 2013). Overall, these factors compound uncertainty 
about the ranges and combinations of blood pressure and heart rates likely to sustain 
renal perfusion in large felids under anaesthesia. 
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Techniques which allow haemodynamic and pulmonary monitoring to detect 
compromises to cellular respiration may aid in protecting organs afforded lower 
circulatory priority.  Serial blood lactate measurement is used to monitor 
haemodynamic resuscitative efforts, although lactate elevation may not occur until 
hypo-perfusion becomes moderate to severe (Haldane 2015) and it may be an 
insensitive marker for regional hypo-perfusion (Gillespie et al 2017).  In high-risk human 
anaesthesia, sophisticated means for monitoring peripheral haemodynamics, 
microcirculation and tissue oxidation have been developed (Kipnis et al 2012, Kipnis and 
Vallet 2016).   For zoo animal anaesthesia, where time and safe access to the patient are 
limited, more practical means of alerting anaesthetists to deteriorating states of cellular 
respiration will be required.  
 
To this end, the body’s pH homeostasis is defended as vigorously as that of oxygen 
transport and perfusion pressure (Rubash 2001) and while there is much to be learned 
about the identity and significance of unmeasured anions (UA) in different disease 
processes (Lemann et al 2003, Vanholder et al 2003, Forni et al 2006, Bruegger et al 
2007, Annecke et al 2012), changes to blood flow may result in the accumulation of 
anionic metabolites favouring hydronium ion generation which are produced during 
compromised states of cellular respiration. In hypoxic states, many UA have been found 
to be intermediary products in energy substrate metabolism, products of incomplete 
oxidation (Kellum 2000, Bruegger et al 2007) or the products of endothelial glycocalyx 
shedding (Annecke et al 2012), the former two often being quantitatively (and in 
valence) far more significant than lactate in such circumstances (Forni et al 2006). 
Theoretically, UA increases may reflect tissue hypo-perfusion, highlighting suboptimal 
blood flow in patients under anaesthesia. In clinical zoo anaesthesia where point of care 
electrolyte measurement is easily deployed, UA increases may be reflected by 
exacerbations in metabolic acidosis and increases in the anion gap and/or by 
exacerbations in base deficit that cannot be explained by changes in strong ion 
difference (SID) (Story et al 2002). 
 
While the metabolic component of acid-base status reflects the cellular performance of 
many organs (Reddi 2018), reduced blood flow and oxygen provision to organs such as 
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the liver and kidneys may alter their effectiveness to participate in its homeostasis. 
Unmeasured ion elevation has been documented in states of renal and hepatic 
dysfunction in critically ill patients (Moviat et al 2008, Abramowitz et al 2012, Zingg et 
al 2018). Besides a role in elimination of many fixed acids (Vanholder et al 2003), the 
hepato-renal system works in unison to mitigate acidosis by permitting increases in SID 
(Vanholder et al 2003, Hamm et al 2015). Decreased renal perfusion and urine output 
limit urine acidification mechanisms and cause metabolic acidosis (Seifter and Chang 
2017). Altered renal performance, including for pre-renal reasons, may also be reflected 
in UA accumulation (Wesson et al 2011) and possibly also in SID reduction.  
 
Approaches to better understanding the possible causes of peri-operative metabolic 
acidosis have been applied to human anaesthesia (for example, see Lawton et al 2019) 
but are somewhat foundational in the zoo anaesthesia context. This study describes 
serial changes to acid-base status occurring in captive large felids under anaesthesia, 
focussing on the metabolic component, the involvement of UA and whether UA values 
are associated with mean arterial blood pressures in the anaesthetic period preceding 
blood sampling events.  
The chapter includes some base data (first procedures on each animal) that has been 
included in the previous comparative anaesthesia chapter (Chapter Two). 
 
3.2 Materials and Methods:  
 
3.2.1 Study Design, Inclusion Criteria and Patient Recruitment:  
 
Serial acid-base status of large felids during anaesthetic procedures was monitored at 
two New Zealand zoos between November 2017 and June 2019. Patient recruitment 
was opportunistic, governed by zoo veterinary staff decisions on which animals required 
anaesthetic interventions. The extent and timing of monitoring varied depending on 
safety considerations and accessibility to the animals at the time. Monitoring 
commenced as soon as safely feasible following intramuscular delivery of immobilising 
drugs, continuing until final medetomidine reversal. 
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3.2.2 Blood Sampling, Analytes Measured and Physiological Monitoring: 
 
 
Peripheral venous samples (n=83) were drawn into 3mL non-heparinised syringes via 
20G needles or intravenous catheters, discarding the first 1-2mLs of blood. Samples 
filled 600 microlitre lithium heparin/ PST gel BD microtainers®, which were then 
carefully agitated. The remainder was placed into silicon coated serum BD microtainers® 
(BD Diagnostics, Franklin Lakes, NJ, USA). Venous heparinised samples were analysed as 
soon as feasible with the same EPOC device (EPOC®, Siemens Healthineers, Erlangen, 
Germany) using EPOC® cartridges (EPOC® BGEM, Epocal Inc, Ottowa, ON, Canada) to 
directly determine or calculate (prefix ‘c’) acid-base parameters pH, pCO2, cHCO3, 
cBE(ecf) (hereinafter base deficit or BD), cAG(K), Na, Cl, K, Ca and lactate. The silicon-
coated microtainer samples were chilled to 2°C, left to clot for 30 min then centrifuged 
at ca.1000G for 10 min. Pipetted serum was frozen to -81°C and later analysed in two 
batches by wet biochemistry at a commercial laboratory (IDEXX – New Zealand 
Veterinary Pathology, Palmerston North, New Zealand) for phosphate (PO4) and 
albumin (Alb) determination. Time from sample collection to analysis varied from one 
to eighteen months.  Arterial samples (n=17) were taken from pre-catheterised dorsal 
pedal arteries, discarding the first 2mLs of blood.  Samples were analysed immediately 
from capped, unpressurised 3mL non-heparinised syringes with the EPOC device, with 
the remaining sample managed as per venous blood.  
 
A Surgivet® Advisor® Monitor (Smiths Medical, Dublin, OH 43017, USA) or Tafonius® 
Large Animal Monitor (Vetronics®, Abberkerswell, UK) were used (n=8, n=3 respectively) 
to estimate mean arterial pressure (MAP) non-invasively, at intervals as close as feasible 
to 5 minutes, using recommended blood pressure cuffs with a width measuring 30-40% 
of appendage circumference (Haskins 2015). When accessed, invasive methods to 
continually monitor MAP corrected to atrial level were preferentially used.  MAP 
readings over a period of 30 minutes prior to each blood sampling were then averaged 
(hereinafter termed ‘tMAP’). 
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3.2.3: Acid Base Interpretations:  
 
Per criteria proposed by Hopper and Epstein (2012) for domestic felids, metabolic 
acidosis was defined as a base deficit exceeding -7mmol/L. A quantitative acid-base 
approach (Stewart 1983) was used to differentiate strong ion and non-volatile buffer ion 
(A-) contributions to extracellular base deficit (BD). Charge differences after summation 
of strong ions and non-volatile buffer ions were considered to represent “unmeasured” 
ions. Referred to as the strong ion gap (SIG), this measure contributes to the non-
respiratory component of body fluid pH, together with A- and apparent strong ion 
difference (SIDa).   
The calculated SIDa included lactate and calcium per methods of Figge et al (1992), but 
excluded magnesium (see Box 1).  Quantification of the anionic effects of albumin and 
phosphate (summated as A-) and bicarbonate (altogether summated as effective strong 
ion difference, or SIDe) were based on human derivations (Figge et al 1992).  Justification 
for this was based on similarity between domestic felid-specific and human total plasma 
concentrations and dissociation constants of non-volatile buffers (McCullough and 
Constable 2003). The SIG was calculated as SIDa –SIDe (per Kellum et al 1995), such that 
positive values indicate UA ‘excesses’.  Derivations are summarised in Box 1.  
 Box 1: Summary of Stewart Acid-Base Derivations. 
 
 
 
 
 
 
3.2.4 Statistical Analysis: 
 
All statistical analysis was carried out using SPSS v25 (IBM, Armonk, NY, USA). A general 
linear model (GLM) was carried out to assess for differences between species in the 
dependent parameters SIDa, SIG and A-. Time from immobilisation, BD and tMAP were 
SIDa = (Na+ + K+ + Ca2+) - (Cl- + Lac-) 
A- = [Albumin] × (0.123 × pH - 0.631) + [Phosphate] × (0.309 × pH - 0.469). 
SIDe = 1000 × 2.46 × 10exp-11 × (pCO2/10exp-pH) + A- 
SIG = SIDa –SIDe. 
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included as covariates, with patient identity as a random factor. Where strong effects of 
a predictor variable were considered to obscure effects of other contributory 
parameters on BD as a covariate, forward stepwise automatic linear modelling was 
undertaken to identify those parameters which were the best predictors of BD. 
3.3 Results:  
 
Eleven large felid anaesthetic procedures (6 x African lion Panthera leo subsp. 
melanochaita, 3 x African cheetah Acinonyx jubatus subsp. jubatus, 2 x Sumatran tiger 
Panthera tigris subsp. sumatrae) were monitored.  Anaesthetic duration from initial 
immobilisation varied (140 to 415 minutes), as did immobilisation, anaesthetic induction 
and maintenance regimens used (data sheet supplied in Appendix A2). Animals ranged 
from two to nineteen years of age, with many exceeding fifteen years and classifiable as 
geriatric (Table 3.1).  
Table 3.1: Age breakdown by species for the felids included in the study. 
Number of individuals of each species 
by age 
Age in Years 
Species 0-5 6-10 11-15 16-20 
Lion  Panthera leo subsp. melanochaita 0 0 1 5 
Tiger Panthera tigris subsp. sumatrae 0 2 0 0 
Cheetah Acinonyx jubatus subsp. 
jubatus 
2 1 0 0 
 
Increments and timing of medetomidine antagonism as well as more specific 
anaesthetic interventions to normalise blood pressure and support lung ventilation also 
varied between procedures.  All individuals received intravenous fluids throughout the 
procedures (most often lactated ringers at between 5-10 ml/kg/hr) but despite this 
support, eleven relatively hypotensive events of MAP of 60mm Hg or less were 
recorded, involving five different individuals (Figure 3.1) and ranging in cumulative 
duration from to 5 to 30 minutes per procedure. In most of these cases, vasopressors 
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were administered to restore MAP (dopamine at 2-5Ug/kg/min, or noradrenaline at 
0.02-0.05Ug/kg/min). In two cheetahs, prolonged, relative hypertension was apparent, 
involving MAP greater than 150mm Hg for circa 60 minutes’ cumulative duration. All 
lions and tigers were mechanically ventilated, while ventilation in all cheetahs was 
principally spontaneous, with occasional manual assistance (data sheet supplied in 
Appendix A2). In one cheetah, marked hypercarbia was apparent (data sheet supplied in 
Appendix A2). 
All patients survived the procedures and none developed clinically overt post-
anaesthetic complications, although post-anaesthetic recoveries were reported in the 
Species360® Zoo Information Management System (ZIMS) as being notably protracted 
in the geriatric lions in which propofol was used as the primary anaesthetic maintenance 
agent. 
On average, 5.5 EPOC measurements were taken per procedure (range: 3-12, SD: 2.61). 
SIDa and SIG could be calculated for 95% (59/62) and 83% (52/62) of EPOC 
measurements respectively, with an average of 5.5 SIDa measurements (range: 2-12; 
SD: 2.73) and 4.9 SIG measurements (range: 2-11; SD: 2.6) per procedure. Very strong 
evidence (p<0.001) was apparent for a species effect on SIDa, SIG and A- (Table 3.2). In 
all felids combined, there was moderate evidence (p<0.05) for an effect of SIG on BD, 
but not for SIDa or A-, and strong evidence (p<0.01) for effects of time and tMAP on A- 
(Table 3.2). However, the best predictors of BD were found to vary between species. For 
lions, these included SIG and to a lesser extent SIDa (Figure 3.2), while for tigers and 
cheetahs respectively, SIDa and time from immobilisation were better predictors 
(Figures 3.3 and 3.4). No single parameter provided extremely strong prediction of BD 
either between or within species. There was an absence of evidence for an effect of 
tMAP on SIG (Table 3.2).  
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Figure 3.1: Measured blood pressure changes over time during anaesthesia for each of the felids in the study. Horizontal red line demarcates 
relative hypotension of MAP 60 mm Hg. Horizontal black line demarcates relative hypertension of MAP 150 mm Hg. 
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Table 3.2: The results of a GLM assessing the effects of different factors on the 
parameters SIDa, SIG and A- of zoo felids under anaesthesia. Interpretation of p-values 
in terms of evidence for effect: p <0.001 indicates very strong evidence; p<0.01 strong 
evidence; p<0.05 moderate evidence, p<0.1 weak evidence; p>0.1 insufficient evidence. 
 
Independent Variable and Covariates Dependent Variable DF F - 
value 
p-
value 
Time from Immobilisation SIDa 1 .711 .404 
A- 1 9.455 .004 
SIG 1 .981 .328 
tMAP  SIDa 1 1.395 .245 
A- 1 10.382 .003 
SIG 1 1.815 .186 
Base Deficit 
(mmol/L) 
SIDa 1 .376 .544 
A- 1 .013 .911 
SIG 1 5.076 .030 
Species SIDa 2 11.674 <0.001 
A- 2 46.884 <0.001 
SIG 2 17.391 <0.001 
 
The metabolic acid-base component (BD) generally contributed less acidity over time 
during the monitored period of anaesthesia (Figure3.5), but no meaningful patterns 
over time were observed for SIG and SIDa (Figures 3.6 and 3.7). BD occasionally 
exceeded -10.5 mmol/L (Figure 3.5) and many of these instances of metabolic acidosis 
were apparent prior to the administration of intravenous fluids, at a time when MAP of 
most of the individuals concerned were relatively high (Figure 3.1). SIG levels exceeded 
5mmol/L in five individuals, two of which displayed these relatively high SIG levels during 
the early monitoring period, while in the other three cases, such levels developed as 
anaesthesia progressed (Figure 3.6). There was a wide apparent variation in SIDa, both 
within and between procedures (Figure 3.7).  
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Figure 3.2: Results of Automatic Linear Modelling identifying factors that are the best 
predictors of Extracellular Base Deficit for lions under anaesthesia in the study, to 
accommodate for the obscuring effects of species as a predictor of this parameter. 
 
Figure 3.3: Results of Automatic Linear Modelling identifying factors that are the best 
predictors of Extracellular Base Deficit for tigers under anaesthesia in the study, to 
accommodate for the obscuring effects of species as a predictor of this parameter. 
 95 
 
Figure 3.4 Results of Automatic Linear Modelling identifying factors that are the best 
predictors of Extracellular Base Deficit for cheetahs under anaesthesia in the study, to 
accommodate for the obscuring effects of species as a predictor of this parameter. 
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Figure 3.5: Extracellular Base Deficit (BD) changes over time during anaesthesia for each of the felids in the study. 
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Figure 3.6: Strong Ion Gap (SIG) changes over time during anaesthesia for each of the felids in the study. 
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Figure 3.7: Graph showing Apparent Strong Ion Difference (SIDa) changes over time during anaesthesia for each of the felids in the study. 
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3.4 Discussion: 
 
This study aimed to characterise changes to metabolic acid-base status and particularly 
the UA contribution to such changes in captive large felids under anaesthesia. Its 
purpose was to assess whether metabolic acidosis and the UA contribution towards this 
condition are apparent enough to warrant further investigation of their causes. One 
application of such further research would be to assess whether serial UA measurement 
could augment haemodynamic monitoring as a means of identifying circumstances 
associated with clinically significant deteriorations in tissue blood flow under 
anaesthesia. Early identification of these changes allows the greatest chance of 
intervention during anaesthesia to limit or prevent tissue damage. 
Metabolic acidosis was recorded frequently, per Hopper and Epstein’s (2012) proposed 
definition of the state in domestic felids. BD in some of the study animals occasionally 
exceeded respective species mean and median venous whole blood values reported in 
the Species360® Global ZIMS database (accessed March 2020) for chemically restrained 
lions (ZIMS mean -8.7, median -9) and tigers (ZIMS mean -10, median -10), but not for 
cheetahs (ZIMS mean -6.7, median -7). Without recent pre-anaesthetic blood work, the 
effect of pre-anaesthetic health and physiological status on metabolic acid-base status 
during anaesthesia was unknown and training patients for conscious phlebotomy is 
strongly encouraged to assist in establishing pre-anaesthetic baselines for comparison.  
The key finding of the study was that even within the group of large felids examined, 
there were marked species differences in acid-base status under anaesthesia, and 
further analysis showed that the drivers of the changes also varied between species. 
This finding is important to clinical zoo mammal anaesthesia because it seems likely that 
inter-species extrapolations of acid-base physiology will be flawed. While this does not 
diminish the value of applying acid-base monitoring to improve the safety of zoo animal 
anaesthesia, it does indicate that there is a strong need for readily accessible species-
specific reference ranges. 
We erroneously expected species within the family Felidae to share very similar acid-
base physiology and respond similarly to the same challenges facing acid-base 
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homeostasis posed by anaesthesia. Very strong evidence for differences between 
species in all the contributors to BD may, in part, have reflected physiological differences 
between the species and thus different intrinsic responses to similar anaesthetic 
challenges. If so, differing species ecology and phylogenetic distance may underlie such 
differences, which are likely to be more pronounced between Panthera and Acinonyx 
genera than within the Panthera genus.  
Some care is needed in evaluating this conclusion. The distribution of data pertaining to 
both tigers and cheetahs were discontinuous and not normally distributed, which is 
probably attributable to the much more limited representations of these species in the 
study.  Unlike lions, data from these species conformed poorly to assumptions 
underpinning the validity of automatic linear modelling. Species differences may equally 
have reflected recruitment biases (in factors such as animal age and pre-anaesthetic 
clinical status) and differences in approach to the anaesthetic management of each 
species (including species bias in the qualification and experience of attending 
anaesthetists). Therefore, while there was strong evidence for our inferences from this 
study about species differences in acid-base physiology and responses to given 
anaesthetic challenges, further work should be carried out to compensate for the low 
power of our analysis.  
Given the moderate strength of SIG as a predictor of BD in lions and the proportionately 
far greater representation of lions in the study, evidence for an effect of SIG on BD and 
absence of evidence of an effect of SIDa in the GLM may reflect such representational 
differences and obscuring species effects.  It is also possible that the predictive strength 
of SIG for BD in lions may have reflected geriatric age bias in the lions recruited to the 
study. That neither SIG nor SIDa ever provided overwhelming strength in predicting BD 
imply that these parameters varied in direction of change and in proportionate 
contribution to metabolic acid-base status, especially since overall SID (and therefore 
BD) is largely a function of these two parameters (Kellum 2005a, Kellum 2005b).  
Evidence suggesting UA accumulations did occur and that mixed metabolic states were 
apparent is supported by a few findings and observations in this study. Besides evidence 
for an overall effect of SIG on BD, these included the occasional inability of SIDa changes 
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to explain the direction of BD changes over time (see Figures 3.5 to 3.7), the instances 
in which metabolic acidosis were explained by relative increases in SIG and the number 
of cases displaying relatively marked elevation in SIG in spite of relative metabolic 
alkalosis. Interestingly, absolute SIG values or sudden SIG fluctuations exceeding 
5mmol/L in this study are comparable in magnitude with those documented in hypoxic 
canine patients using similar assumptions and methods for calculating SIG (Bruegger et 
al 2007). Similarly, such magnitudes compare with absolute SIG values commonly 
documented in critically ill human patients (Story 2008). However, since SIG in states of 
health may vary between species and since ranges of pre-intervention anion gap (and/or 
SIG) values are rarely known for individual patients (Kraut and Madias 2007), it is difficult 
to interpret the significance of absolute values of anion gap or SIG for each individual 
(Wheeler and Kovacic 2017).  
What may have been responsible for determining the SIDa in each of the felids was also 
difficult to ascertain from this study.  As with SIG, acid-base determinations do not 
provide any mechanistic information about the processes determining the quantities of 
measured ions contributing to SIDa (Wooten 1999, Wooten 2003, Wooten 2004, Figge 
et al 2018). Furthermore, to better represent acid-base changes, more complex acid-
base models than the plasma-based model used in this study may be required to control 
for fluid and electrolyte shifts occurring between body fluid compartments (Wolf and de 
Land 2011) and to ensure that extracellular base excess and SIDa are more invariant to 
carbon dioxide (Anstey 2010, Morgan 2011). Trans-erythrocytic chloride shifts in 
response to changing erythrocytic bicarbonate concentrations are important 
determinants of SIDa (de Morais and Leisewitz 2012, Johnson and de Morais 2012, de 
Caro Carella and de Morais 2017) and it is also likely that a combination of other causes 
of corrected chloride changes (including the possibility that SIDa is not independent of 
SIG) and free water changes also influenced SIDa at different times and to varying 
extents in different individuals. It is unknown to what extent, if any, differential rates of 
excretion of measured strong ions contributed to SIDa changes. While there was strong 
evidence for BD and time effects on A-, it is unlikely that A- was an important 
determinant of changes in BD, given the minor effects of weak acids on the dissociation 
of water (Stewart 1983, Kellum 2005a, Kellum 2005b) and given that weak acids varied 
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little in molar terms in comparison with SIDa and SIG variations (data sheet supplied in 
Appendix A2).  
A number of explanations may be offered for absence of evidence for an effect of tMAP 
on SIG but without specific assessments of tissue blood flow, these remain speculative. 
Besides hypoxic states and/or uraemic waste accumulations, there are also many other 
causes of elevations in anion gap (Kraut and Madias 2007, Venkatesh and Morgan 2008, 
Artero 2017) and no attempt was made to inform of actual anion identity in this study.  
If other factors (including endogenous processes and/or the administration of 
exogenous substances) were important determinants of SIG, then SIG itself may have 
lacked specificity for the detection of hypoxic and/or uraemic states if they were 
occurring. Alternatively, SIG may not have borne any relation to perfusion-related 
capacities for maintaining acid-base homeostasis, tMAP may have provided a poor proxy 
for tissue blood flow, or no such compromises to blood flow were manifest in the study 
animals. 
Limitations imposed by the observational nature of the study design may also have 
masked a possible association between SIG and tMAP. Wide SIG variations between 
individuals at initial EPOC monitoring, reflecting states of homeostasis prior to 
immobilisation and during early anaesthetic periods, will subsequently have influenced 
absolute SIG values during the ensuing monitoring period. If states of perfusion and 
renal function were playing a role in determining SIG over periods preceding particular 
measurements, it is possible that their effects on SIG may have endured or became 
manifest later in time. As such, association between tMAP and SIG may have been 
obscured by asynchrony between periods of major tMAP fluctuation and subsequent 
UA kinetics. A hypothesis deserving of testing in future single-species studies is that if 
both SIG and tMAP do bear relation to tissue perfusion, corresponding directions of 
tMAP fluctuations and SIG fluctuations would be expected to differ according to the 
particular blood pressure spectrum across which tMAP fluctuations are taking place, 
since alterations in tissue perfusion should be expected to become most manifest 
towards extremes of blood pressure.  
If reduced blood flow does play a role in explaining rising SIG levels, the sensitivity of SIG 
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changes for identifying such altered states of blood flow may be hypothesised to 
improve in geriatric felids. Chronic renal disease is a significant cause of morbidity in 
aged captive felids (Wack 2008) and older animals are more likely than their younger 
counterparts to present with pre-anaesthetic hypertension and other pathologies 
associated with degenerative renal disease (Longley 2012). Already volume contracted 
patients may be much more susceptible to the vasodilatory effects of anaesthetics 
(Lawson and Hutton 2012, Barak et al 2015), rendering them more sensitive to 
hypotensive influences. It is also plausible that for geriatric patients, reduced renal 
abilities to excrete fixed acids (and possibly also to elicit increases in SIDa) may also arise 
for given reductions in blood flow, compared with younger animals which are more 
likely to possess less renal degenerative changes and more functioning nephrons.  
While SIG was a better predictor of BD in lions (most of which were geriatric) and 
although geriatric animals appear to have displayed greater fluctuations and elevations 
in SIG than their younger counterparts (Figure 3.6), this cannot be taken as evidence in 
support of the proposed hypothesis, particularly given the low case number and 
significant representational bias in the species and age of animals recruited to the study. 
Interestingly, though, an eight-year old cheetah was the ‘younger’ exception displaying 
relatively marked SIG values and as a species, cheetah display demonstrably shorter 
longevity in captivity than lions and tigers (Species360® Global ZIMS data, accessed April 
2020).   Furthermore, in captive cheetah, Mitchell et al (2018) identified age and renal 
medullary fibrosis as primary factors influencing the pathogenesis of chronic renal 
disease, while Bolton and Munson (1999) found the severity of glomerulosclerosis to 
increase with age, occurring mainly in captive cheetahs exceeding seven years of age. 
Given their already high prevalence of renal disease (Munson 1993, Munson et al 1999), 
captive cheetah may benefit from and provide an informative focus for future studies 
investigating the determinants of SIG in large felids under anaesthesia.   
While the goal of the study was to identify changes occurring under clinical anaesthesia 
management, it is not known whether (and if so, to what extent) the various efforts to 
restore blood pressure to more normotensive states may subsequently have influenced 
the progression of acid-base homeostasis. It is possible that such progression may have 
been very different had such interventions not occurred and without an experimental 
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study design, the influence of the restorative interventions themselves cannot be 
controlled for in assessing the relationship between blood pressure changes and acid-
base homeostasis. 
It should be borne in mind that the possibility of analyte measurement error may have 
generated varying degrees of imprecision in classifying contributory ions, leading to 
possible erroneous interpretation of the metabolic acid–base disorder (Gunnerson 
2005). Bias and imprecisions associated with each extra analyte mean confidence 
intervals around SIG determination may be quite wide (Morgan 2004) and in this study, 
there was no opportunity to establish measurement-based variance in contributory 
parameters. Furthermore, SIG determination may also have been influenced by use of 
lithium-coated containers (Morgan 2004) and immediate point of care testing from non-
heparinised syringes would be strongly recommended for future studies of this nature.  
Drugs commonly used for immobilisation, induction and maintenance of anaesthesia of 
large felids are acknowledged for eliciting profound, dose and phase-dependent effects 
on various haemodynamic parameters (Scheinin et al 1989, Grimm et al 2001, Sinclair 
2003, Saleh et al 2005).  Anticipating how they interact to effect blood flow to lower 
priority organs such as the kidneys is not straightforward and finding a sensitive means 
to monitor and identify concerning changes in blood flow will help to associate these 
changes with anaesthetic events and identify better ways to manage anaesthesia of 
these animals. The possible impact of different anaesthetic regimens on renal blood flow 
has been studied specifically in domestic felids (Mitchell et al 1998) and large felids 
(Stagegaard et al 2017) and although the ultrasound-based approaches that were used 
are particularly valuable to research into the effects of anaesthetic interventions on 
renal perfusion, they probably hold little practical value as a routine means of 
monitoring in clinical zoo anaesthesia.  
If domestic Felidae serve as a valid comparison, BD recorded in the Species360® ZIMS 
database support findings from this study to suggest that metabolic acidosis commonly 
occurs in chemically restrained or anaesthetised Pantherae. The prevalence of 
metabolic acidosis in conscious, captive large felids is unknown but results of this study 
suggest that its clinical significance under anaesthesia is deserving of further enquiry 
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and that further work to reveal the identity of normally unmeasured anions is warranted 
to help establish possible causes. More research is required to assess the value of serial 
SIG monitoring for the purpose proposed, with much transferable knowledge likely 
obtainable from anaesthesic studies involving species amenable to more robust study 
design and comprehensive data collection.  Greater traction may, nevertheless, be 
gained from the application of other practical perfusion assessment techniques such as 
strategic oxygen extraction and arterio-venous carbon dioxide gradient determinations 
(Zhang and Vincent 1993, Kipnis et al 2012, Kipnis and Vallet 2016), to aid in matching 
anaesthetic events to perfusion endpoints.  Such reference bases should then provide 
further means to assess quality of anaesthetic delivery and to refine anaesthetic 
techniques for improved patient safety. 
3.5 Conclusions: 
 
This study revealed marked species differences in the acid-base status of large felids 
under anaesthesia, with drivers of changes varying between species. This implies that 
inter-species extrapolations of acid-base physiology may be flawed, highlighting the 
need for readily accessible species-specific reference ranges to realise the value of acid-
base monitoring as a means of improving the safety of zoo animal anaesthesia.  
 Metabolic acidosis was found to be common in the Panthera genus, if proposed 
definitions of the condition for domestic Felidae are also valid for Pantherae. Increased 
metabolic acidity could occasionally be attributable to relative increases in SIG, 
suggesting occasional UA accumulation, an inference supported by evidence for an 
effect of SIG on BD. There was an absence of evidence for any association between 
tMAP, as a crude proxy for blood flow, and SIG. However, many design limitations 
related to the study’s observational nature, the limited number of animals recruited to 
the study and the marked species differences apparent in metabolic acid-base status 
limited the ability to make inferences about factors associated both with absolute SIG 
values and SIG fluctuations.  
Contributors to SIG and determinants of anaesthesia-induced morbidity/mortality will 
both need to be better understood on a species-specific basis.  Only with knowledge 
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relating determinants of SIG to such endpoints will it be possible to evaluate if 
unmeasured anion monitoring offers utility as a means to assess risks of patients 
developing anaesthesia-induced pathology. 
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Chapter Four:  General Discussion: 
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1.1 Background: 
 
Anaesthesia is not without risk. For dangerous zoo animals, additional risks to patients 
are associated with the precautions required to assure human safety. Evaluating the 
safety of anaesthetic approaches is not straightforward, given limitations associated 
with the measures used to assess physiological homeostasis, the range of potential 
parameters involved and the difficulties associated with relating disturbances to 
morbidity endpoints, particularly where subclinical injury is involved. Without recourse 
to experimental studies and meta-analyses to contribute to an evidence base, there are 
also particular challenges associated with attributing alterations in physiological 
parameters to particular interventions in zoo anaesthesia. Nevertheless, in zoo animal 
anaesthesia, much knowledge will necessarily have to be derived from observational 
studies in order to identify procedure-related refinements which enhance patient 
safety.  
Safety-related evaluations have often been based on intermittent monitoring of a 
restricted range of physiological parameters, with choice usually predicated upon those 
most immediately pertinent to patient survival. This leaves uncertainty about the wider 
range of disturbances to homeostasis that patients may be experiencing. The broader 
the range of parameters which are serially monitored and related to each other, the 
more detailed will be the representation of physiological events occurring during 
anaesthesia and the better the prospect of being able to explain and mitigate the 
changes observed.   
Consideration of the risk factors associated with alterations to physiological 
homeostasis is an equally important part of this explanatory process and besides the 
choice of immobilisation regimen, risk mitigation requires a better understanding of the 
factors most determinant of risk as anaesthesia is delivered. Few studies in the zoo 
medical literature have assessed patient support in zoo anaesthetic practice, 
highlighting the need to address how well anaesthesia is both monitored and delivered, 
and the safety implications of major procedure-related decisions made during the 
course of its delivery.  
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4.2 Reminder of Aims and Objectives: 
 
The aims of the research presented in this thesis were: 
- to identify homeostatic disturbances occurring in larger species of mammals 
under anaesthesia in zoo practice, in order to advance understanding about the safety 
of anaesthetic practices for zoo patients. 
- to gain further insight into how and why such disturbances occur.  
The practical application of this research is that a better understanding of the causes 
and mechanisms associated with the physiological disturbances identified should allow 
more effective measures to mitigate them, through refinements in both monitoring and 
procedural protocols. 
These research aims were addressed by pursuing the following objectives:  
1. To apply readily accessible techniques to serially monitor and describe the 
prevalence and extent of physiological disturbances occurring in large mammals 
during zoo anaesthesia practice; 
2. To initiate examination of risk factors associated with these disturbances; 
3. To describe and characterise serial alterations in metabolic acid-base and 
unmeasured ion status occurring in large felids during anaesthesia; 
4. To assess whether unmeasured anion values are associated with mean arterial 
blood pressures in the anaesthetic period preceding blood sampling events; 
4.3 Summary of Major Findings: 
 
One of the key findings from the first part of this study was the strong evidence for the 
effects of time since immobilisation on a range of measures of physiological homeostasis 
that were monitored (Chapter Two). There were also marked individual or species 
differences evident in many of these parameters, representing important differences in 
species physiology that limits cross-species extrapolations when monitoring anaesthesia 
of this diverse group of animals.  In some instances, involving closely related species, 
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strong evidence for time and species effects on parameters were apparent in spite of 
relatively minor variations in the immobilisation protocols used, as was the case within 
the Panthera species in the study. 
 
In the second part of the study, which focussed on contributors to metabolic acid-base 
changes in anaesthetised large felids (Chapter Three), a quarter of all blood samples 
showed a base deficit exceeding -7 mmol/L, with all such recordings involving the 
Panthera species (lions and tigers). If the definition proposed for this condition in 
domestic felids serves as a valid comparison to the Panthera species, this would suggest 
that metabolic acidosis is common in anaesthetised Panthera. Moderate evidence was 
established for an effect of strong ion gap (SIG) on base deficit (BD), while there was no 
evidence for an effect of mean arterial pressure (tMAP) on SIG. The key finding of this 
study was that even within the small group of large felids examined, there were marked 
species differences in acid-base status under anaesthesia, and further analysis showed 
that the drivers of the changes also varied between species. Unmeasured anion (UA) 
accumulations appeared to be occurring: SIG values above 5 mmol/L were recorded, 
sometimes in spite of concurrent base deficits being relatively alkalotic, and fluctuations 
of 5mmol/L or more occasionally occurred between successive EPOC measurements. 
Cautionary caveats should, nevertheless, be framed around inferences drawn from 
these study findings, given marked species differences and the possibility that 
representational bias and measurement-related errors may have influenced them.  
 
While more an observation than a finding, the paucity of monitoring undertaken and 
documented even for routine physiological measures was notable for the zoo mammal 
anaesthetic procedures included in the study, relative to the monitoring undertaken 
during anaesthesia in many domestic animal settings. Such paucity was represented by 
the often protracted times taken to initiate the monitoring of many measures, the 
intermittence and briefness of their subsequent monitoring, or the fact that certain 
measures may not have been either monitored or recorded at all. Limitations to the 
extent of monitoring were attributable to the logistical constraints associated with the 
anaesthesia of dangerous zoo animals, together with mindfulness about procedure 
duration.  
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4.4 Implications of The Study Findings and Recommendations for Future Research: 
 
Evidence for species and time effects on many of the measured parameters of 
homeostasis likely reflect a mix of influences, arising from individual and species 
differences in physiology, variations in pre-anaesthetic health status and differences in 
the way individuals were managed over each anaesthetic episode. These time effects 
and unexpected species effects were nevertheless evident following the use of carefully 
considered choices of immobilisation and induction protocols and sometimes profound 
disturbances to homeostasis were associated with their use. Such anaesthesia protocols 
have been applied widely and refined by multi-institutional experience and as such, 
strong empirical support has often been garnered for their purported safe use. This 
raises important questions about further scope for refinement of these regimens, the 
extents to which effects may primarily be attributable to the subsequent anaesthetic 
management of different individuals, and extents to which the homeostatic 
disturbances observed may be preventable. 
 
With the exception of a repeat procedure on a baboon, which was euthanased for 
becoming and remaining comatose (and which was excluded from the overall analysis 
due to inclusion restrictions to initial procedures), no overtly apparent complications 
arose as a result of anaesthesia other than some protracted recoveries.  Otherwise, it 
was not possible to ascertain the pathological significance, if any, of the alterations to 
homeostasis documented in this study. The dearth of reference intervals (as defined by 
Friedrichs et al 2012) also precluded examination of how much the parameters 
measured may have differed from healthy populations of comparable individuals. 
Nevertheless, if different mammals share similar tolerances to disturbances to 
homeostasis of similar magnitude, there are reasonable grounds to suggest that if 
progressive, some disturbances would have the potential to induce pathology and 
occasionally pose a risk to life.  These disturbances included sustained relative 
hypotension below 60mm Hg, sustained relative hypertension above 150mm Hg, 
sustained relative hypercarbia above 65mm Hg and episodic but marked acidaemia, 
hypoglycaemia, hypoxaemia and hyperkalaemia.  Identification of extreme oesophageal 
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lumen acidity (of pH 2) in a chimpanzee (Pan troglodytes) and difficulties with clearing 
regurgitated ingesta at the laryngeal entrance of a Hamadryas baboon (Papio 
hamadryas) at intubation provide illustration that despite the wide range of parameters 
that were measured, some potential disturbances to homeostasis and anaesthetic 
complications were not formally investigated or may not necessarily have been 
detected.  
 
Amongst the most prevalent of the homeostatic alterations were instances of sustained 
relative hypercarbia, which were often associated with relative elevations in end tidal 
carbon dioxide and therefore likely attributable primarily to hypoventilation in such 
cases. While recognising the worth and the sometimes obligatory requirement to 
mechanically support ventilation, the haemodynamic impact of positive pressure 
ventilation may be potentially significant, further reducing cardiac output if 
hypovolaemic conditions are precipitated by anaesthesia and not duly recognised (Poor 
2018). Further research comparing different approaches to mechanical ventilation in 
large mammal species is strongly warranted in a zoo context, particularly in terms of 
optimising the trade-off between the benefits of these techniques and the risks of 
unwanted consequences associated with their application. 
 
Instances of mean arterial blood pressures falling below 65 mmHg were also not 
uncommon (and were sometimes sustained) among the disturbances documented. The 
best way to characterise hypotension is still debated even in human medicine (Salmasi 
et al 2017), but important guidelines have nevertheless been established from studies 
of cardiac and renal injury associated with it in humans and some domestic animals. 
While such guidelines may be more applicable to critical patients undergoing higher risk 
procedures (Meersch et al 2017), sustained hypotension of less than 55mm Hg is 
nevertheless considered by Clarke and Trim (2014) to be life threatening, although the 
veterinary context is not specified. Elevated risk of acute kidney injury has been 
associated in retrospective human studies with MAP less than 60mm Hg for more than 
20 minutes and MAP less than 55mm Hg for more than 10 minutes (Meersch et al 2017). 
Salmasi et al (2017) even concluded that in human operative cases, associations exist 
between myocardial and renal injuries and sustained MAP falling under 65mm Hg, 
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without any important interaction with preoperative blood pressure. It is unknown what 
minimum acceptable MAP ranges may apply to different species of large zoo mammals 
under anaesthesia and given the critical importance of age as a risk factor for the 
development of perioperative hypotension in human anaesthesia (Cheung et al 2015), 
widely different guidelines may apply to aged or geriatric individuals.  
 
Irrespective of the appropriate guidelines associated with their classification, the 
prevalence of relative hypotension and hypoventilation evident in this study suggests 
the need for much more critical scrutiny of the circumstances leading to these states. 
Although the sometimes intermittent nature and limited breadth of monitoring records 
were particularly apparent for many of the combined measures usually used to refine 
estimation of anaesthetic planes, such states probably resulted from the inclination to 
maintain anaesthesia towards deeper planes, the prolonged effects of medetomidine, 
or a combination of these factors.  
 
Better mitigation of the risks associated with the development of these states therefore 
likely rests in large part with the ability to be confident with the accuracy of depth of 
anaesthesia estimation. The ability to provide more standardised measures of depth 
would also assist with comparing different approaches to anaesthetic management.  
Realisation of these objectives is challenging because of the different physiological and 
autonomic responses of different species to the same drugs, the different depths at 
which these responses may be manifest in different species (Clarke, Trim and Hall 2014) 
and because of the unique way that different drugs alter cardinal signs both in a 
particular species and among conspecific individuals (Taylor and Clark 2007, Hubbell and 
Muir 2009).  
 
To address these issues in the zoo anaesthesia context, measures which relate plasma 
concentrations of anaesthetic drugs to pharmacodynamic effects will have important 
research value. Certain measures of electro-encephalographic activity may, with much 
further research, offer some clinical potential (Hatt and Jurado 2012), but they are 
currently unlikely to serve any immediate practical value.  However, better assessment 
of anaesthetic depth in zoo mammals will depend on more frequently measuring and 
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recording of the various somatic and autonomic measures of anaesthetic depth and 
relating these to injectable drug dosing history and end tidal anaesthetic concentrations.  
 
In this respect, heart rate and blood pressure monitoring are usually considered to 
provide an insensitive and unreliable indicator of anaesthetic depth. In human 
anaesthesia, for example, haemodynamic measures have been found to provide a poor 
indicator of the hypnotic-anaesthetic status of the patient (Struys et al 2002). In the 
veterinary context, cardiopulmonary effects are determined by the combination of pre-
anaesthetic and anaesthetic agents used and their dose rates, making heart rates and 
blood pressure unreliable guides to depth of anaesthesia (Popilskis et al 2008, Trim et al 
2014). Haskins (2015) also cautions that autonomic parameters may not change until 
after the anaesthesia level suddenly becomes too light and in piglets, for example, 
changes in heart rate and blood pressure were not considered as a good measure of 
depth of anaesthesia when evaluated immediately after application of a noxious 
stimulus (Jaber et al 2015).  Similarly, in horses, heart rate and arterial blood pressure 
are considered by Trim (1998) to provide an unreliable guide to the depth of 
anaesthesia.  
 
For the anaesthesia of dangerous zoo animals, with inclination to maintain patients at 
relatively greater anaesthetic depths for reasons of human safety (Hatt and Jurado 
2012), the onus of monitoring may lean more towards assessing for impending 
responsiveness rather than on mitigating risks of emerging awareness.  At these greater 
anaesthetic depths, the accurate, real-time and trend information provided by invasive 
arterial blood pressure monitoring may offer more usefulness as a means to monitor, 
respond to, and re-evaluate changes in anaesthetic depth. This is particularly the case 
when such measures are interpreted in the clinical context of the haemodynamic status 
of the patient and when they are related to likely levels of nociception or other forms of 
stimulation, such as patient repositioning. Typically, the lighter the anaesthetic plane, 
the higher the sympathetic activity (Ozeki and Caulkett 2014) and with the inclination to 
make large changes to anaesthetic drug delivery in response to perceived lightening of 
anaesthetic planes in these dangerous animals, such real-time, trend information may 
also reduce tendencies towards over-reactive responses by the anaesthetist, 
 123 
contributing to overall management of anaesthesia at less physiologically challenging 
depths. Since physical signs such as movement and protective reflex responses also tend 
to become more depressed and less reliable during prolonged anaesthetic procedures 
(Hubbell and Muir 2009), the time taken to establish invasive blood pressure monitoring 
should become justifiable from an anaesthetic depth monitoring point of view when 
such circumstances are anticipated.  
 
During emergence from general anaesthesia in humans, responsiveness to noxious 
stimuli precedes awareness (Ghoneim 2000) and return of brainstem function and 
associated reflexes which involve breathing, heart rate, blood pressure and return of 
muscle tone respectively follow an approximate caudal-cranial progression from the 
medulla through the pons to the midbrain (Reshef et al 2019). Similar sequential events 
should apply to zoological species and provided that these various brainstem-mediated 
reflexes are all carefully monitored in integrated fashion, subtle lightening of 
anaesthetic depth may be achievable and animals should not suddenly awaken from 
general anaesthesia to the point of posing immediate risk to personnel. 
 
Another important emphasis of future research will be to identify and explore dose-
sparing options for reducing required quantities of anaesthetics such as isoflurane and 
propofol, which have varying inhibitory effects on cardiorespiratory performance. 
Continuous rate infusions of phenyl-piperidine opioid derivatives such as remifentanil 
have been shown to have strong MAC-sparing effects in humans (Lang et al 1996), while 
the nonspecific plasma and tissue esterase metabolism, anti-nociceptive and non-
cumulative effects of remifentanil make it a potentially useful adjunct to anaesthesia 
involving painful procedures in felids (Ferreira et al 2015). Nevertheless, its use in large 
felids would need to be carefully considered, given the potential for opioids to induce 
CNS stimulation in this taxon (Lamont and Grimm 2014).    
 
Besides possible difficulties associated with re-establishing blood flow following 
microcirculatory collapse (Moore et al 2015), the dominant contribution made by 
venous vasodilation to the anaesthesia-driven condition of relative hypovolaemia is 
another important reason for the pre-emption and avoidance of hypotension. In human 
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anaesthesia, venous vasodilation may be relatively unresponsive to the use of 
vasopressors (Noel-Morgan and Muir 2018) and this may be equally relevant to zoo 
animal anaesthesia.  As important, therefore, as the need to find ways to pre-empt 
hypotension are the initiatives directed towards its early recognition and treatment.  
Given the safety and other practical constraints associated with assuring early initiation 
and continuity of monitoring, its observed paucity and often protracted nature in this 
study is likely to reflect extents of monitoring in wider zoo anaesthesia practice. 
Anecdotally, primates in this study displayed early tendencies towards hypotension, 
with relatively slow responses evident with the initiation of vasopressor support. 
Wherever possible, more timely initiation of monitoring would be strongly advised. 
 
Sustained mean arterial pressures at the higher end of the blood pressure spectrum 
were also documented in this study (sometimes exceeding 170mm Hg), but the 
relevance of this finding as a possible influence on tissue perfusion is uncertain. More 
hypertensive blood pressures may not necessarily translate into normal perfusion when 
alpha-two agonists are responsible for the higher blood pressure. Although the effects 
of medetomidine on renal arterial blood flow in dogs have been shown to be much less 
pronounced than in other abdominal organs (Miño et al 2008), variations in its effects 
on renal blood flow and glomerular filtration rate have been found in different studies 
(Kushiro-Banker et al 2013). These variations may reflect the different drug regimens 
used, with the dosage and route of administration of medetomidine influencing its 
biphasic effects on blood pressure (Saleh et al 2005). Furthermore, glomerular blood 
flow may not equate with distal renal parenchymal flow, particularly as the effects of 
alpha-2 agonist vasoconstriction in the kidneys are mediated primarily through efferent 
arterioles (Kushiro-Banker et al 2013). As such, it is possible that increases in glomerular 
blood flow and glomerular filtration rates in states of hypertension may be associated 
with concomitant reductions in renal medullary blood flow. 
 
This study highlighted a need to investigate practical means of improving the detection 
of hypo-perfusion in the zoo anaesthesia context. In this regard, assuming measurement 
artefact is ruled out, explanations are still required for the apparent accumulations of 
unmeasured anions documented for many of the felids in this study, particularly those 
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cases which developed this accumulation subsequent to the first monitoring period.  
While apparent high levels recorded at first monitoring may still reflect physiological 
states prior to immobilisation and while measures of homeostasis should always be 
interpreted to allow for the appropriate physiological response to the anaesthetic and 
surgical context (Hall and Desborough 1996, Khokhlova et al 2017), those accumulations 
developing subsequently have more likelihood of being directly attributable to the 
immobilisation and anaesthetic events themselves.  
 
Although this study found no evidence of an association between tMAP and SIG, much 
further work will be required to evaluate whether or not particular relationships exist 
between the direction of fluctuation of SIG levels and those of MAP fluctuations, 
depending on the particular blood pressure spectrum across which MAP fluctuations are 
taking place. Much more accurate representations of perfusion states than those 
provided by blood pressure may be required to evaluate whether or not any association 
exists between changes in SIG levels and corresponding states of blood flow. In the zoo 
context, it is recommended that future safety-oriented research focuses on the strategic 
measurement of parameters such as arterio-venous carbon dioxide gradients (as 
proposed in Chapter Three), as these may provide clinically more practical and superior 
means to gauge the adequacy of perfusion than the sole or combined monitoring of 
various haemodynamic measures and unmeasured anion levels. 
Until these more accurate representations of underlying perfusion states are combined 
with research to unravel the identity of unmeasured ions and characterise the 
underlying biochemical mechanisms associated with them, it will not be possible to 
draw firm conclusions about the biological significance of the apparent unmeasured 
anion accumulations in this study. In the interim, there is a need to rule out possible 
underlying perfusion-related causes in circumstances where the direction of apparent 
strong ion difference changes do not explain major base deficit exacerbations. 
Confounding influences (species, time and age effects) precluded evaluation of the 
predictive value of the anion gap and the sodium: chloride ratio as clinically accessible 
and practical means to identify more marked elevations in SIG at given base deficits. Our 
results show that further evaluation of these parameters in zoo animals will need to be 
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carried out on individual species under more controlled conditions than this 
observational study allowed. 
Limited address was given to factors which may have been associated with apparent 
strong ion difference (SIDa) fluctuations in this study, though it is acknowledged that 
differential excretion of measured strong ions provides a principal means by which the 
kidneys and liver in particular moderate acid-base homeostasis. As such, if changes to 
SIDa do in any way reflect acute changes in the function of regulatory organs, this would 
need to be better accommodated for in future studies, particularly as there is emerging 
evidence to suggest that the kidneys may begin to alter ammonium kinetics and effect 
SIDa changes within minutes (Weiner and Verlander 2017). Fractional urinary excretion 
studies would be required to assess for acute alterations in their function (Maciel et al 
2013) and the techniques required to achieve this in real-time are very unlikely to be 
applied in zoo animals. 
 
Evidence for the effect of time under anaesthesia on many of the parameters measured 
in the grouped species analysis was difficult to interpret without corresponding 
information about the pre-anaesthetic physiological status of each animal to provide 
some indication of the overall effects of interventions. Furthermore, the stress imposed 
on an animal during interventions including from restraint, anaesthesia and surgery may 
have an effect on clinical parameters under study (Reichard 2008), particularly as 
anesthetic agents can directly alter tissue metabolism (Khokhlova et al 2017) and neuro-
endocrine stress responses to surgical interventions (Hall and Desborough 1996). Given 
these well described physiological responses to the contexts of anaesthesia and surgery, 
there is a lack of knowledge in zoo species about the magnitude of physiological 
variables that may be considered appropriate to the clinical circumstances of 
anaesthesia, rendering it more difficult to determine the point at which measured 
clinical parameters become inappropriate.  
 
It was also difficult to match changes to the chronology of interventions and possible 
underlying processes, making it problematic to assess which of the immobilisation, 
induction, maintenance and recovery components of the anaesthetic process may have 
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generated the greatest challenges to homeostasis. Parameters of physiological 
homeostasis would nevertheless be expected to remain relatively unchanged (or 
improve) over the subsequent course of anaesthesia under circumstances where 
delivery either supports homeostasis or poses little physiological challenge. As such, if 
the variety of parameters measured in this study provide timely and sensitive 
representation of the physiological conditions immediately preceding them, they should 
collectively provide some representation of the stability of anaesthesia delivered.  
 
Anecdotally, certain individuals did appear to display markedly more stable parameters 
under anaesthesia than others and comparison of the circumstances involved may 
provide insight into possible causes. A standout example of a relatively stable 
anaesthesia involved a thirteen year-old Malayan sun-bear (Helarctos malayanus), for 
which relatively normotensive blood pressure ranges were maintained without any 
need for vasopressor support, in spite of the long duration the animal had been placed 
under anaesthesia (data sheet supplied in Appendix A1). Relative normocarbia (or slight 
hypocarbia) was consistently achieved and relatively less base deficit variation and much 
more minor changes in creatinine were also apparent, compared with other animals in 
the study (data sheet supplied in Appendix A1). It should, however, be noted that in one 
instance, blood pH varied very little in the sun-bear concerned, in spite of an episodic, 
marked increase in sodium to chloride ratio. Since pCO2 and weak acid concentrations 
remained stable at the time, this may suggest that relatively significant unmeasured ion 
accumulations may nevertheless still have been occurring (data sheet supplied in 
Appendix A2). In this patient, a ventilator was used very promptly after the initial 
approach, while response to lightening planes of anaesthesia involved strategic propofol 
use and local nerve blocks to reduce the amount of isoflurane delivered. 
 
One of the practical applications of the research in this study was towards identification 
of safer ways to manage anaesthesia. Many management questions or clinical 
conundrums require addressing, with some pressing examples being proposed in the 
second chapter.  The ability to address these questions in zoo animal anaesthesia 
departs greatly from the kind of clinical trials and meta-analyses that are able to support 
evidence based decision making in human anaesthesia. In the latter case, while major 
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areas of uncertainty are still strongly apparent, it is nevertheless still possible to specify 
clinical contexts where available evidence favours one approach over another (Fleischer 
2013).   
 
In zoo animal anaesthesia, it is rarely possible to match morbidity endpoints to specific 
anaesthetic actions. The sample size of this current study was far too small to permit 
investigation of the many risk factors that were considered a priori for their potential 
role in influencing homeostasis over the course of anaesthesia. Nevertheless, it was still 
possible to review the small dataset and begin the process of comparative assessment 
which may yield important retrospective information about risk factors most deserving 
of further enquiry. In contrast to the relatively stable sun-bear procedure that was 
referred to previously, certain procedures stood out for the diversity of changes to 
measures of physiological homeostasis. These cases displayed varying constellations of 
elevated pCO2, elevated alveolar to arterial (or venous) carbon dioxide gradients, 
prolonged hypotension, elevations in blood lactate, anion gap, potassium and 
creatinine, and declines in blood pH and base excess (data sheet supplied in Appendix 
A1).  
 
Although many factors other than the quality of anaesthetic delivery may have been 
responsible for these inter-procedural differences, such factors are less likely to be as 
convincing at explaining why particular groups of disturbances were more or less 
apparent (or absent altogether) in different procedures involving the same individuals. 
More systematic collection of information about homeostasis and application of the 
investigatory methods to a large scale database may retrospectively permit 
improvements in anaesthetic quality and outcome. As such a database is built, it may 
also become possible to compare and relate anaesthetic progression in large zoo 
mammals with progression in domestic animals which share similar size-related 
anaesthetic challenges. In this regard, equine anaesthesia may serve as a useful 
comparative model for many zoo animals, as there is more scope to anaesthetise horses 
well in comparison with zoo animals which are of wild and more often of dangerous 
disposition. Furthermore, relationships between the progression of homeostatic 
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parameters and outcome in horses are better understood, permitting risk categories for 
specific outcomes to be identified that may have relevance for species held in zoos.  
 
4.5 Conclusions: 
 
While the particular protocols which were chosen by anaesthetists in this study may 
represent current best practices that have been refined through multi-institutional 
experience, the findings of the study emphasise the need to appreciate the very unique 
response each individual is likely to have to any particular immobilisation and 
anaesthetic induction protocol. There is a need to be careful with preconceptions about 
the expected progression of anaesthesia for any given protocol and patient risk 
category. The question then follows of how much variability is attributable to the patient 
and how much relates to the manner in which anaesthesia is delivered. This study 
illustrates that even with the protocols widely considered to represent current best 
practice, some clinically important physiological disturbances were occurring in zoo 
animal anaesthesia that were considered to have successful post-anaesthetic outcomes. 
None of the disturbances documented in the data chapters were associated with 
mortality or any overt morbidity and thus no conclusions can be drawn from the data 
presented in them about zoo anaesthesia safety. Nevertheless, if we accept that our 
goal should be to refine and improve zoo animal anaesthesia practice towards 
minimising risk of patient harm, then these disturbances should not be accepted as 
routine and much benefit is likely to be derived from better understanding of the 
reasons for their occurrence. 
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Appendix A1: 
 
Data sheet showing physiological, blood gas (EPOC) and laboratory clinical 
pathology parameters for all procedures covered under Massey University MUAEC 
Permit 17/50 and special permit for non-human hominids granted by the Director 
General of the New Zealand Ministry of Primary Industries. Only first procedures are 
included in the analysis (Chapter Two). 
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lion 1 1 18.5 136 MeK 94 Iso 38 20 58 75 32 V 7.265 40 45 18.2 -9 74 151 4.8 1.32 124 18 15 30 10.2 2.1 0.63 309 24 166 80 29 51 18.9 339 1.91 
lion 1 1 18.5 136 MeK 187 Iso 37.7 20 60 64 35 V 7.195 52.5 37 20.3 -8 57 151 4.6 1.32 122 22 13 30 10.2 3.9 0.79 282 24 151 76 27 49 18.5 345 1.96 
lion 1 1 18.5 136 MeK 217 Iso  20   32 V 7.209 54.3 53 21.7 -6 79            26 179 69 24 45 18.4 350 2.15 
rhino 1 3 18.0 1915 DMiBK 40 TIVA 34.7 12    V 7.299 60.5 129.1 29.7 3.3 98.5 135 4 1.34 95 31.6 14 31 10.6 7.7 0.78 106    24     
rhino 1 3 18.0 1915 DMiBK 56 TIVA 34.4 10 28 88  V 7.324 53.2 142.2 27.7 1.7 98.9 134 3.8 1.37 95 29.3 15 30 10.2 8.8 0.8 107  167  24   140 1.73 
rhino 1 3 18.0 1915 DMiBK 81 TIVA 34 10 28   V 7.314 62.7 138.6 31.9 5.7 98.8 134 3.7 1.38 92 33.8 14 30 10.3 10.4 0.75 108  175  23   149  
rhino 1 3 18.0 1915 DMiBK 112 TIVA 34.2 12 28   V 7.328 62.5 96 32.8 6.8 96.6 135 3.8 1.34 94 34.7 12 31 10.5 10.6 0.89 108    25     
rhino 1 3 18.0 1915 DMiBK 127 TIVA 34.1 12 28   V 7.326 61.8 85.5 32.3 6.3 95.2 135 3.7 1.32 88 34.2 18 31 10.4 11.1 0.97 114    26   137  
rhino 1 3 18.0 1915 DMiBK 139 TIVA 34.1 12 28   V 7.353 59.2 89.4 32.9 7.4 96.1 135 3.8 1.24 93 34.7 13 31 10.5 9.6 0.95 112  173    5.1   
lion 4 1 13.8 192 MeK 54 Iso 36.5    24 V 7.214 41.1 64.3 16.6 -11.2 87.4 153 4.2 1.32 127 17.9 14 53 17.9 4.9 2.04 185  108 79 31 48 12.8 189 1.58 
lion 4 1 13.8 192 MeK 79 Iso 37.2 16 49 94 30 V 7.316 36.2 212.7 18.5 -7.7 99.7 153 4.3 1.28 124 19.6 15 45 15.4 9.4 0.8 181  100 74 30 44 13 183 1.82 
lion 4 1 13.8 192 MeK 110 Iso 37.4 12 46 93 27 A 7.302 43.7 583.7 21.6 -4.7 100 152 4.5 1.33 121 23 14 38 12.8 12.6 0.77 202  116 69 27 42 13 187 1.85 
lion 4 1 13.8 192 MeK 134 Iso 36.4 13 46 79 29 A 7.301 41.4 550 20.4 -6 100 150 4.7 1.21 119 21.7 15 39 13.4 16.8 0.85 219  115 66 27 39 12.7 185 1.87 
lion 4 1 13.8 192 MeK 174 Iso 36.5 13 46 81 33 A 7.272 40 548 18.4 -8.4 100 148 5.3 1.26 120 19.7 15 39 13.4 20.9 1.06 191         
baboon 
1 1 15.9 39 MeK 30 Iso 37.8 16 84 63 60 V 7.362 55.2 51.1 31.3 5.9 83.5 143 3.5 1.24 102 33 13 53 17.9 11.4 1.83 77  213  32   96  
baboon 
1 1 15.9 39 MeK 72 Iso 36.7 21 65 50 57 V 7.339 61.8 34.8 33.3 7.5 61 143 3.4 1.23 102 35.2 11 49 16.7 12.1 1.08 83         
baboon 
1 1 15.9 39 MeK 102 Iso 36.2 22 62 66 66 V 7.303 70.5 93 34.9 8.6 95.9 143 3.6 1.22 100 37.1 12 52 17.7 12.8 1.18 91    39     
baboon 
1 1 15.9 39 MeK 130 Iso 36 18 65 63 60 V 7.332 70 58.1 37.1 11.2 86.4 143 4 1.2 102 39.2 8 50 17.1 12.1 1.07 93 10 145 59 24 35 6 65 1.55 
baboon 
1 1 15.9 39 MeK 156 Iso 36.1 18 65 58 61 V 7.339 65.7 62.7 35.3 9.5 89.1 143 4.6 1.23 102 37.3 10 52 17.7 10.5 1.2 87    29  7.4 74 1.94 
baboon 
1 1 15.9 39 MeK 179 Iso  26    V 7.329 66.9 43.1 35.2 9.2 73.1 143 4.7 1.22 103 37.2 9 49 16.5 10.5 1.03 103         
lion3 1 19.0 117 MeK 46 Iso 36.8 24 60 137 34 V 7.294 32.3 51.5 15.7 
-
10.8 82.7 154 4.1 1.39 123 16.7 19 46 15.8 6.8 1.11 272 20 118 84 29 55 12.7 277 1.66 
lion3 1 19.0 117 MeK 86 Iso 36 12 59 92 25 V 7.317 34.9 60.6 17.9 -8.2 89 152 3.9 1.38 125 19 13 41 14 7 1.19 249 19 135 84 28 56 13.2 261 1.66 
lion3 1 19.0 117 MeK 110 Iso 36.1 12 47 70 21 V 7.294 38.2 55.2 18.6 -7.9 85.1 153 3.9 1.37 125 19.8 13 36 12.3 6.9 1.51 243 17 167 76 25 51 12.7 262 1.62 
lion3 1 19.0 117 MeK 150 Iso 34.9 8 52 54 27 V 7.277 40.7 87.9 19 -7.8 95.4 154 4.1 1.35 125 20.2 14 31 10.7 6.9 1.23 328 20 270 72 24 48 12.9 270 1.71 
lion3 1 19.0 117 MeK 202 Iso 36.2 12 52 61 27 V 7.295 40.5 73 19.7 -6.8 92.7 153 4.2 1.35 123 21 15 34 11.6 6.5 1.43 288 19 516 68 23 45 11.7 261 1.67 
lion3 1 19.0 117 MeK 241 Iso      V 7.307 39.3 67.5 19.7 -6.6 91.3 153 4.3 1.43 124 20.9 14 29 9.8 6.8 1.2 238  599  21   273 1.71 
chimp 1 1 39.6 86 MeKMi 17 Iso  20    V 7.395 59.4 55.3 36.3 11.4 87.1 143 3.5 1.06 101 38.1 9 51 17.5 9 1.59 126  275  34    1.54 
chimp 1 1 39.6 86 MeKMi 67 Iso 36.6 6 52 37 30 V                          
chimp 1 1 39.6 86 MeKMi 79 Iso 36.4 6 54 59 33 A                          
chimp 1 1 39.6 86 MeKMi 89 Iso 36.2 6 58 77 36 A 7.47 48.8 499.8 35.5 11.9 100 148 2.6 1.09 104 37 11 43 14.8 7.2 1.28 108 12 246 78 30 48 9.4 118 1.42 
chimp 1 1 39.6 86 MeKMi 99 Iso 35.9 7 60 95 37 V 7.407 58.9 51.8 37.1 12.4 85.2 146 2.9 1.11 103 38.9 9 48 16.2 6.3 1.73 131 13 334  30  11.1 111 1.64 
chimp 1 1 39.6 86 MeKMi 118 Iso 35.6 8 55 45 36 A 7.465 49.7 503.8 35.8 12 100 148 2.9 1.16 103 37.3 12 47 15.8 3 1.33 132 15 432  31  12 114 1.72 
chimp 1 1 39.6 86 MeKMi 141 Iso 35.4 6 59 78 33 A 7.467 48.4 529.6 35 11.3 100 150 2.7 1.13  36.5  43 14.8 1.8 1.29 111 12 322 70 28 42 8.2 105 1.15 
chimp 1 1 39.6 86 MeKMi 152 Iso 35.7 6 61 138 32 V 7.435 53 57.2 35.6 11.4 89.5 148 2.8 1.11 104 37.2 11 43 14.8 2.4 1.58 133  455  29  11.3 114 1.63 
lion 5 1 16.3 144 MeKMi 43 Iso     27 V 7.278 41.5 71.5 19.4 -7.3  151 4.3 1.1 123 20.7 13   7 2.71 305 21 299 77 32 46 10.3 307 1.52 
lion 5 1 16.3 144 MeKMi 76 Iso 40 7 56 84 30 A 7.372 31.9 457.6 18.6 -6.7 100 152 4.8 1.2 126 19.5 12 44 14.9 10.1 0.42 335         
lion 5 1 16.3 144 MeKMi 116 Iso 38.6 7 59 81 30 V 7.325 36.6 294.5 19.1 -6.9  152 4.5 1.29 121 20.2 16   9.7 2.28 273 19  66 27 39 10 312 1.47 
lion 5 1 16.3 144 MeKMi 140 Iso 37.8 7 53 107 29 V 7.273 46.9 50.2 21.7 -5.2 79.8 152 4.8 1.25 121 23.1 14 37 12.6 10.6 0.8 288 19 291 73 30 43 11.2 347 1.64 
lion 5 1 16.3 144 MeKMi 169 Iso 37.8 7 60 113 30 V 7.261 48.1 42.2 21.6 -5.4  151 4.8 1.3 119 23.1 15   11.4 0.84 319 21 287 67 28 39 9.8 310 1.47 
lion 5 1 16.3 144 MeKMi 232 Iso 37.3 7 57 86 30 A 7.33 38.5 640.2 20.3 -5.6 100 151 5.1 1.34 116 21.5 20 35 12 14.1 0.3 271  405  25  15.5 278 2.3 
lion 5 1 16.3 144 MeKMi 296 Iso 37.1 7 56 122 30 V 7.247 50.4 51.3 22 -5.3 79.4 150 5.2 1.28 118 23.5 15 41 13.9 13.7 0.58 340 21 293 77 26 51 11.7 292 1.43 
chimp 2 1 33.0 62 MeKMi 30 Iso  33 70 62 40 V 7.39 51.7 75 31.3 6.3 94.4 142 4.1 1.1 104 32.9 11 49 16.5 11 1.91 98  213  34   81 0.9 
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chimp 2 1 33.0 62 MeKMi 69 Iso  34 74 43 38 V 7.413 48.4 125.2 30.9 6.3 98.8 140 4.4 1.1 102 32.4 12 43 14.7 10.9 1.73 129         
chimp 3 1 36.0 61 MeKMi 29 Iso   71   V 7.38 52.8 102.9 31.3 6.1 97.7 143 3.3 1.05 105 32.9 10 51 17.5 11.4 1.21 84         
chimp 3 1 36.0 61 MeKMi 51 Iso 37.4 38 70 65 37 A 7.38 50.9 282 30.7 5.7 99.9 142 3.1 1.07 104 32.3 10 47 15.8 10.7 1.45 53         
cheetah 
3 1 2.0 40 MeK 38 Iso 38.6 24 76 178 35 V                  33 1582  35  19.4 277 2.89 
cheetah 
3 1 2.0 40 MeK 68 Iso 38.5 24 76 160 38 V 7.259 47.9 91 21.5 -5.6 95.5 157 3.8 1.32 126 22.9 13 50 17 10.4 1.24 212 20 1197 75 36 39 17.1 252 2.61 
cheetah 
3 1 2.0 40 MeK 100 Iso 38.2 24 74 154 40 V 7.217 58.1 99.5 23.6 -4.1 96 157 4.1 1.35 123 25.4 15 47 16 10.8 1.39 233         
cheetah 
3 1 2.0 40 MeK 140 Iso 38 24 74 110 36 V 7.252 56.9 104.1 25.1 -2.1 96.8 155 4.7 1.26 119 26.9 16 45 15.2 10.1 1.24 234 19 921 65 33 32 16 206 2.54 
cheetah 
2 1 2.0 39 MeK 32 Iso 38.7 12 84 185 35 V 7.28 43.5 59 20.4 -6.3 86.6 158 3.8 1.32 124 21.8 17 54 18.4 10.9 1.06 224 17 413 79 40 39 18.7 244 2.41 
cheetah 
2 1 2.0 39 MeK 86 Iso 36.9  80 128 45 V 7.213 59 89.3 23.8 -4.1 94.5 157 4.4 1.35 122 25.6 16 50 16.9 15.1 1.01 228  399  37  21.3 275 2.82 
cheetah 
2 1 2.0 39 MeK 113 Iso  20 80 124 45 V 7.224 54.7 132 22.6 -5.1 98.3 154 4.7 1.34 123 24.3 13 47 16 13.8 1.18  16 1695  36  18.4 266 1.96 
cheetah 
2 1 2.0 39 MeK 133 Iso  12 80   V 7.279 50.8 84.1 23.8 -2.9 94.6 152 5.2 1.27 120 25.4 13 49 16.6 14.8 1.2 211  462  37   282 2.84 
cheetah 
1 1 8.5 55 MeK 62 Iso 37.4 18 72 99 54 V 7.181 67.4 85 25.2 -3.2 92.9 164 3.8 1.35 122 27.3 21 43 14.6 11.3 0.51 250 16 722 67 35 32 16 218 1.8 
cheetah 
1 1 8.5 55 MeK 115 Iso 37.4 16 79 58 66 V 7.109 82.1 58.2 26 -3.5 77.5 162 4.8 1.35 122 28.6 19 40 13.7 13 0.3 270 21 691 75 33 42 15.6 233 2.05 
cheetah 
1 1 8.5 55 MeK 172 Iso 37.6 14 121 90 76 V 7.119 89 41.6 28.9 -0.5 57.7 149 7.7 1.15 114 31.6 14 41 13.9 30.5 0.38 325 21 667 75 31 44 15.8 256 2.09 
sun 
bear 1 1 13.3 100 MeZoTi 26 Iso 36.4 12 89 67 22 V 7.223 53.1 56.9 21.9 -5.7 82.8 145 4.3 1.38 112 23.5 15 49 16.8 7.6 1.64 206 11 94 60 27 33 12.9 198 1.83 
sun 
bear 1 1 13.3 100 MeZoTi 64 Iso 36.6 12 88 59 23 V 7.192 57.3 47.7 22 -6.2 72.4 145 4.3 1.45 112 23.7 15 46 15.6 8.7 1.72 194 11 100 54 24 30 13 198 1.99 
sun 
bear 1 1 13.3 100 MeZoTi 92 Iso 36.5 13 112 81 26 V 7.325 30.7 63.6 16 -10 90.6 147 4 1.2 113 16.9 22 41 14 7.8 1.68 172         
sun 
bear 1 1 13.3 100 MeZoTi 141 Iso 35.5 12 83 47 25 V 7.103 73.8 48.4 23.1 -6.5 67.4 143 4.8 1.22 113 25.4 12 44 14.9 8.2 1.96 224 13 160 51 22 29 13.4 237 2.49 
baboon 
2 1 12.8 38 MeKMi 16 Iso  20 80   V 7.354 52.1 56.4 29 3.5 87 143 2.9 1.2 109 30.6 8 47 15.9 12.9 2.06 60 8 298 68 38 29 4.4 73 1.15 
baboon 
2 1 12.8 38 MeKMi 75 Iso 37.6 21 71 50 50 V 7.34 59.8 53.5 32.2 6.4 84.2 144 3.1 1.18 107 34.1 8 43 14.6 12.6 0.84 67 12 351 60 34 26 4.5 72 1.73 
baboon 
2 1 12.8 38 MeKMi 88 Iso 37.3 18 71 50 52 V 7.372 54 55.3 31.4 6.1 86.8 148 3 1.14 108 33 12 42 14.3 11.1 0.5 52    31     
baboon 
2 1 12.8 38 MeKMi 103 Iso 36.4 21 58 76 49 V 7.338 61.2 162.4 32.9 7.1 99.3 146 3 1.2 109 34.8 7 45 15.4 11.9 0.53 58    34     
baboon 
2 1 12.8 38 MeKMi 117 Iso 36.5 24 61 72 50 V 7.321 60.8 41.2 31.4 5.3 70.7 147 2.9 1.14 109 33.2 10 42 14.4 10.4 0.66 59 9 293 65 29 36 5 62 1.85 
baboon 
2 1 12.8 38 MeKMi 139 Iso  22 70  50 V 7.363 52.7 137.4 30 4.6 99 145 3.3 1.14 111 31.6 7 41 14 10.6 1.03 55    32   69  
chimp 4 1 19.5 54 MeKMi 20 Iso  30 72   V 7.385 52.5 107.8 31.3 6.3 98 141 3.8 1.09 102 33 12 51 17.2 8.4 1.35 86         
chimp 4 1 19.5 54 MeKMi 50 Iso  41 71 65 42 V 7.431 47.4 191.6 31.5 7.2 99.7 142 4.1 1.08 102 33 13 47 16 9.5  81  170  33   95  
rhino 1 2 17.9 1915 DMiBK 61 TIVA 36.2 14 32 144  V 7.398 43 105.4 26.5 1.7 98 133 4 1.29 97 27.9 14 30 10.3 9.2 0.89 126         
rhino 1 2 17.9 1915 DMiBK 81 TIVA  10 32 151 36 V 7.331 51.1 53.1 27 1 84.2 132 3.9 1.26 96 28.5 13 28 9.6 10.9 0.85 128 8 125  23  4.5 158 1.2 
rhino 1 2 17.9 1915 DMiBK 95 TIVA 36 12 32 162 43 V 7.319 57.7 52.6 29.7 3.6 83 133 3.9 1.3 94 31.4 13 29 9.8 11.7 0.93 134 8 113  22   154 1.29 
rhino 1 2 17.9 1915 DMiBK 111 TIVA 35.9 12 32 133 35 V 7.356 51.3 52.3 28.7 3.2 84.5 132 3.9 1.27 94 30.3 13 29 9.8 12.5 1.09 145 10 122  22  4.5 161 1.37 
rhino 1 2 17.9 1915 DMiBK 118 TIVA  16    V 7.346 52.6 44.2 28.8 3.1 76.4 133 4 1.3 95 30.4 13 30 10.2 12.1 1.19 135 7 111  22  4.5 164 1.4 
chimp 5 1 7.7 38 MeKMi 18 Iso      V 7.381 53.5 52.4 31.7 6.6 85.2 138 4.3 1.23 101 33.4 10 56 19 10.4 1.79 80    37   77  
chimp 5 1 7.7 38 MeKMi 30 Iso 37.5 45 82   V 7.484 37.1 103.2 27.9 4.4 98.4 138 4.3 1.08 101 29 13 50 16.9 11.2 1.61 78         
chimp 5 1 7.7 38 MeKMi 48 Iso 37.5 47 83   V 7.314 59.7 85.5 30.3 4.2 95.2 137 4.7 1.19 100 32.2 11 51 17.2 13.7 2.23 102    35   90  
baboon 
3 1 7.3 25 MeK 18 Iso  16 95   V 7.372 55.1 70.3 32 6.8 92.9 143 3.1 1.2 103 33.7 11 48 16.2 11.2 1.7 75 9 218 62 40 22 4.9 74 1.22 
baboon 
3 1 7.3 25 MeK 69 Iso 37.8 17 86 55 58 A 7.379 55.1 455.1 32.5 7.4 100 142 3.5 1.15 102 34.2 11 44 15.1 11 0.38 67 11 409 62 37 25 5.9 79 1.66 
baboon 
3 1 7.3 25 MeK 111 Iso 37.6 19 101 43 57 A 7.355 56.5 532 31.5 6 100 147 3.3 1.1 107 33.3 12 41 13.9 9.1 0.3 57 10 423 58 35 23 5.7 72 1.57 
rhino 1 1 17.5 1885 DMiBK 43 TIVA 36.8 6 40 80  V 7.336 52.5 161.1 28.1 2.3 99.3 131 4.3 1.39 93 29.7 14 31 10.5 9.7 0.78 160  113  21   237 1.63 
rhino 1 1 17.5 1885 DMiBK 69 TIVA 36.7 12 32 72  V 7.334 58.9 52.7 31.3 5.5 83.5 130 4 1.3 92 33.1 11 33 11.2 11.5 0.54 153    21     
rhino 1 1 17.5 1885 DMiBK 89 TIVA 36.7 10 32 72 43 V 7.346 58.2 47.6 31.8 6.1 79.6 129 4 1.37 90 33.6 11 33 11.4 13.1 0.42 177  132  21   242 1.61 
rhino 1 1 17.5 1885 DMiBK 106 TIVA 36.6 12 36 72 46 V 7.35 51.8 94 28.6 3 96.7 130 3.9 1.33 93 30.2 12 33 11.3 12.3 1.02 159  129  22   209  
lion 4 2 14.5 206 MeK 26 Iso  10 60   V 7.352 29.8 54.5 16.6 -9 87 154 4 1.21 126 17.5 15 44 14.8 6.8 1.17 203 8 106 73 29 44 14.2 230 1.39 
lion 4 2 14.5 206 MeK 49 Iso  14 50   V 7.301 36.7 73.9 18.1 -8.3 93.2 153 4 1.26 126 19.2 13 40 13.5 7.7 1.24 213    28   289  
nyala 1 1 2.2 100 EtMe 7 Etor/Me 38.6 12 77   V 7.339 47.2 45.7 25.4 -0.4 78.2 145 3.4 1.15 112 26.9 11 36 12.2 7.3 1.98 105  19884 84 41 43 7 60 1.15 
nyala 1 1 2.2 100 EtMe 23 Etor/Me      V 7.348 48.9 220.3 26.8 1.2 99.7 146 3.6 1.15 110 28.3 13 35 11.8 9.6 1.15 91         
sun 
bear 1 2 22.0 111 MeKMi 30 TIVA  20    V 7.325 39.8 62.4 20.7 -5.3 89.8 138 4 1.27 112 21.9 9 45 15.3 7.8 1.32 165  76  30  14.1 177 2.45 
sun 
bear 1 2 22.0 111 MeKMi 68 TIVA 37.1 12 86 146 36 V 7.268 47.2 104 21.6 -5.4 97.1 138 3.8 1.33 108 23 12 43 14.7 8.8 1.48 149 29 65 82 30 52 11.7 168 2.04 
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sun 
bear 1 2 22.0 111 MeKMi 98 TIVA 37 8 85 139 38 V 7.261 46 80.6 20.7 -6.3 93.8 139 3.8 1.28 112 22.1 10 43 14.7 8.8 1.49 141         
sun 
bear 1 2 22.0 111 MeKMi 128 TIVA 37.2 8 83 162 38 V 7.246 47.6 151.7 20.7 -6.6 98.9 139 3.8 1.33 113 22.2 9 42 14.3 9.3 1.63 147 13 68 85 28 57 12.4 160 2.47 
nyala 2 1 2.8 64 MeKB 17 TIVA      V 7.366 52.1 107 29.8 4.5 97.8 140 4.4 1.14 104 31.4 11 34 11.7 4.9 1.58 90         
nyala 2 1 2.8 64 MeKB 65 TIVA 36.8 10 70 65 45 V 7.434 43.9 191.7 29.4 5.2 99.7 142 3.7 1.11 103 30.8 13 35 12 7.4 1.49 89 7 1695 82 30 52 6.2 66 1.96 
nyala 2 1 2.8 64 MeKB 66 TIVA 36.8 10 70 65 45 A 7.465 46.1 548 33.2 9.4 100 146 2.8 1.15 106 34.6 10 34 11.6 8.4 0.64 69         
nyala 2 1 2.8 64 MeKB 100 TIVA 36.2 10 70 102 40 V 7.456 44 256 31 7.1 99.9 144 3.1 1.13 104 32.3 12 36 12.1 8 1.51 73 6 1714 82 29 53 6.2 65 1.96 
nyala 2 1 2.8 64 MeKB 106 TIVA 36.1 10 70 102 40 A 7.497 44.2 706 34.2 11 100 147 2.9 1.19 103 35.6 13 38 12.8 8.2 0.65 88         
nyala 2 1 2.8 64 MeKB 143 TIVA 35.9 5 62 118 52 V 7.399 53.5 66.5 33 8.2 92.3 145 2.9 1.19  34.7  38 12.9 7.6 0.6 103         
nyala 2 1 2.8 64 MeKB 204 TIVA 35.5 10 63 118 38 V 7.468 40.7 135.3 29.5 5.8 99.2 142 3.6 1.11 107 30.7 9 38 13 6.7 0.84 108         
baboon 
3 2 8.5 29 MeKMi 22 Iso   86 92 56 V 7.314 58 84.2 29.5 3.3 95 142 4.5 1.25 103 31.2 14 39 13.4 11.1 2.93 99         
baboon 
3 2 8.5 29 MeKMi 100 Iso   85 56 31 V 7.241 37.7 235.1 16.2 -11.2 99.7 149 3.3 0.81 119 17.4 17 25 8.5 7.8 1.63 55         
baboon 
3 2 8.5 29 MeKMi 200 Iso    89 46 V 7.09 97.8 76.1 29.8 -0.1 87.2 143 6.2 1.18 104 32.8 15 50 16.9 8.9 7.05 183         
baboon 
3 2 8.5 29 MeKMi 320 Iso      V 7.253 61.5 188 27.2 0 99.4 143 5.3 1.14 109 29 12 49 16.8 2.6 2.3 231         
baboon 
3 2 8.5 29 MeKMi 369 Iso      V 7.354 52.3 179 29.1 3.6 99.5 146 6.1 1.2 108 30.7 15 36 12.3 1.7 2.15 183         
baboon 
3 2 8.5 29 MeKMi 420 Iso      V 7.3 60.7 94.1 30.2 3.8 96.2 145 5.1 1.15 108 32 12 42 14.3 3.4 1.33 208         
baboon 
3 2 8.5 29 MeKMi 448 Iso      V 7.33 54 199 29.1 3.3 99.6 147 4.4 1.11 110 30.7 12 37 12.6 3.9 0.93 176         
lion 2 1 17.0 135 MeK 70 TIVA 38.9 8 56 65 32 V 7.316 37 45.4 18.9 -7.3 77.6 148 3.8 1.28 122 20 11 43 14.7 8.5 1.38 232 12 149 72 28 44 17.2 241 1.53 
lion 2 1 17.0 135 MeK 100 TIVA 38.9 8 48 52 34 V 7.31 37.3 68.5 18.8 -7.5 91.8 148 3.7 1.3 120 19.9 13 36 12.2 8.5 1.15 294 13 168 68 26 42 16.8 233 1.51 
lion 2 1 17.0 135 MeK 135 TIVA 38 8 48 88 30 V 7.32 39.5 68.3 20.3 -5.8 91.9 148 3.7 1.33 123 21.5 8 30 10.3 8.8 0.93 210 13 228 65 25 40 16.6 242 1.63 
lion 2 1 17.0 135 MeK 175 TIVA 37.8 8 48 98 31 V 7.317 39.1 89.2 20 -6.1 96.1 148 3.8 1.32 122 21.2 10 28 9.6 8.6 0.85 205 14 313 62 24 38 16.1 241 1.62 
lion 2 1 17.0 135 MeK 220 TIVA  6 48 75 38 V 7.287 49.5 54 23.7 -3 83.3 147 4 1.34 121 25.2 6 29 10 7.8 1.2 186 14 437 65 24 41 15.4 241 1.66 
lion 2 1 17.0 135 MeK 262 TIVA    73 40 V 7.25 52.8 48 23.2 -4.1 76.1 149 4 1.37 122 24.8 8 27 9.3 7.3 0.91 239 13 538 58 22 36 14.4 230 1.6 
lion 2 1 17.0 135 MeK 322 TIVA      V 7.387 32 99.2 19.3 -5.8 97.7 149 4.6 1.22 124 20.2 10 27 9.2 7.4 0.59 231 16 1036 64 24 40 14.6 253 1.87 
nyala 3 1 1.1 65 MeKB 10 TIVA 38.6 12 58  46 V 7.34 52.1 24.2 28.1 2.3 38.5 140 4 1.21 107 29.7 9 29 10 6.4 1.76 109         
nyala 3 1 1.1 65 MeKB 50 TIVA  12 76 146 40 V 7.427 40.3 42 26.6 2.2 78.7 137 3.8 1.2 105 27.8 9 28 9.6 12.5 1.61 114 4 1382 64 29 36 5.7 85 2.44 
nyala 3 1 1.1 65 MeKB 84 TIVA  12 78 131 34 A 7.48 36.6 639.2 27.3 3.9 100 139 3.6 1.16 104 28.5 11 27 9.3 12.9 1.27 113  2199  28   95  
nyala 3 1 1.1 65 MeKB 122 TIVA  12 73 125 37 A 7.447 41.4 660.8 28.4 4.3 100 141 3.2 1.24 105 29.6 11 30 10.2 10.7 1.45 130  3100  28   89  
nyala 3 1 1.1 65 MeKB 159 TIVA  12 76  33 V 7.45 38 82.9 26.4 2.4 96.7 139 3.3 1.21 106 27.6 10 29 10 9.2 2.11 117    28     
nyala 3 1 1.1 65 MeKB 203 TIVA   77   V 7.256 66.3 23.1 30.2 3.2 31.1 139 4.9 1.18 105 32.2 9 38 12.8 9.9 3.69 147 4 4121 69 28 41 6 103 2.77 
zebra 1 1 26.0 290 EtDB 41 Etor/TIVA 38.4 12 44 179 49 V 7.448 43.7 76.3 30.2 6.2 95.6 135 4.1 1.32 98 31.6 11 30 10.1 13.8 1.74 173 9 177 59 27 32 5.5 175 1.17 
zebra 1 1 26.0 290 EtDB 60 Etor/TIVA 38.5 8 46 172 46 V 7.286 65.8 51 31.3 4.7 79.8 137 3.7 1.32 99 33.4 10 27 9.1 14 2.25 164 10 2915  26  7.1 229 1.65 
zebra 1 1 26.0 290 EtDB 96 Etor/TIVA 37.8 8 40 90 54 V 7.216 87.3 100.7 35.4 7.6 95.7 140 3.6 1.25 100 38.1 8 27 9.2 13.8 1.9 159         
zebra 1 1 26.0 290 EtDB 109 Etor/TIVA 37.8 6 39 82  V 7.248 81.8 126.9 35.7 8.5 98 141 3.6 1.23 101 38.2 8 26 8.7  1.75 167 10 221 63 27 36 5.7 172 1.67 
rhino 1 4 18.5 1915 DMiBK 41 TIVA    168  V 7.332 55.4 36 29.3 3 64 133 4.2 1.49  31  35 11.9 6.7   7 267 75 25 50 5.3 129 1.08 
rhino 1 4 18.5 1915 DMiBK 65 TIVA  12 32   V 7.343 55.7 48 30.2 5 80 130 3.9 1.44  32  30 10.2 8.1   7 244 85 24 61 6 123 1.18 
rhino 1 4 18.5 1915 DMiBK 102 TIVA 36.7 12 36   V 7.369 50.7 46 29.3 4 79 130 4 1.41  31  29 9.9 9.8   7 262 75 24 51 5.1 123 1.1 
rhino 1 4 18.5 1915 DMiBK 112 TIVA  12 36   V 7.394 46.5 169 28.4 4 99 130 4.1 1.32  30  28 9.5 9.7   6 200 74 24 50 4.9 116 1.05 
lion 6 1 17.5 135 MeKMi 45 TIVA 37 6 60   V 7.299 38.4 58 18.9 -7.6 86.9 151 3.9 1.3 126 20 10 43 14.6 6.7 1.31 242 18 124 72 29 43 17.3 263 1.31 
lion 6 1 17.5 135 MeKMi 72 TIVA 36.8 6 51 158 30 A 7.31 38.2 291.9 19.2 -7 94.9 151 4 1.39 124 20.4 12 39 13.3 12 0.69 234 17 154 68 27 41 16.5 251 1.25 
lion 6 1 17.5 135 MeKMi 105 TIVA 36.4 6 45 76 32 A 7.273 41.9 276.8 19.4 -7.4 99.8 153 3.7 1.42 125 20.7 12 36 12.4 10.8 0.62 226 18 174 66 28 38 16.3 251 1.29 
lion 6 1 17.5 135 MeKMi 137 TIVA 36.2 6 42 76 33 A 7.255 40.8 280.5 18.1 -9.1 99.8 153 3.6 1.42 120 19.3 19 35 11.8 9.8 0.81 218 16 203 63 26 37 15.7 249 1.3 
lion 6 1 17.5 135 MeKMi 171 TIVA 36 6 40 80 34 A 7.233 48.1 281.5 20.3 -7.2 99.8 152 3.5 1.44 121 21.8 14 34 11.5 9.2 0.74 226 17 240 62 25 37 15.2 246 1.29 
lion 6 1 17.5 135 MeKMi 218 TIVA 35.6 6 40 93 36 A 7.241 48.4 271.2 20.8 -6.5 99.8 152 3.7 1.45 121 22.3 14 33 11.2 8.7 0.82 280 16 283 62 25 37 14.5 246 1.32 
lion 6 1 17.5 135 MeKMi 260 TIVA 35.4 6 49 80 36 A 7.288 40.8 249.4 19.5 -7.1 99.8 152 3.7 1.4 122 20.8 14 32 11 8.4 0.69 228         
lion 6 1 17.5 135 MeKMi 284 TIVA 35.4 6 57 93 37 A 7.224 49.6 225.9 20.5 -7.2 99.7 152 3.8 1.44 123 22 12 33 11.1 8.4 0.99 223 18 399 62 24 38 14.2 244 1.39 
lion 6 1 17.5 135 MeKMi 318 TIVA 35.5 6 50 74 38 A 7.211 53.5 148.8 21.4 -6.4 98.7 151 3.8 1.45 119 23.1 14 33 11.3 8.4 1.1 227 17 480 61 24 37 13.9 245 1.46 
lion 6 1 17.5 135 MeKMi 350 TIVA 35.4 8  79 31 A 7.261 46.9 126.9 21.1 -6 98.3 151 4 1.42 120 22.5 14 33 11.1 8.3 1.07 219 18 663 57 22 35 13.6 257 1.55 
lion 6 1 17.5 135 MeKMi 385 TIVA 35.5 8  68 28 V 7.233 54.9 44.2 23.1 -4.4 70.5 151 3.9 1.37 122 24.8 10 38 12.8 7.1 1.64 228 17 659 63 25 38 13.7 252 1.53 
lion 6 1 17.5 135 MeKMi 409 TIVA  8    V 7.25 52.9 44.9 23.2 -4 72.5 149 4.1 1.37 119 24.8 11 33 11.1 7.3 1.35 252 18 660 56 22 34 13.8 258 1.53 
tiger 1 1 10.0 124 MeK 45 Iso  2 60 74 35 V 7.219 46.1 69.1 18.8 -8.9 89.5 150 4 1.37 127 20.3 8 39 13.3 11.1 0.92 173  791 72 35 37 17 150 1.64 
tiger 1 1 10.0 124 MeK 100 Iso 36.9 14 50 87 28 V 7.221 43.5 50.2 17.8 -9.9 77.6 149 4.1 1.27 127 19.2 8 36 12.1 8.6 1.73 167         
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tiger 1 1 10.0 124 MeK 130 Iso 36.6 10 48 90 29 V 7.225 44.4 71.7 18.4 -9.2 90.7 148 4.6 1.31 126 19.8 8 38 12.9 10.8 1.38 171  834 70 35 35 16.8 154 1.85 
tiger 1 1 10.0 124 MeK 157 Iso 36.4 14 52 78 40 V 7.211 49.9 76.6 20 -7.9 91.8 147 5.2 1.32 123 21.5 9 39 13.2 11.9 1.56 163         
tiger 1 1 10.0 124 MeK 172 Iso 36.4 14 52 69 40 V 7.225 49.9 90.6 20.7 -6.9 95 146 6 1.28 121 22.2 10 40 13.5 13.2 1.23 164  764 66 33 33 16.9 164 1.95 
tiger 1 1 10.0 124 MeK 194 Iso  14 56 101 41 V                          
tiger 1 1 10.0 124 MeK 220 Iso  12 56   V 7.162 62.1 55.6 22.3 -6.4 78.7 146 7 1.33 122 24.2 9 37 12.7 13.3 1.14 197  839 64 32 32 16.5 177 1.9 
tiger 2 1 8.8 93 MeKMi 25 Iso 39.5 6  92  V 7.232 39.7 70.4 16.7 
-
10.8 90.6 150 3.6 1.28 128 16.7 10 41 13.8 11.9 1.46 193  139 75 37 38 17.2 200 1.31 
tiger 2 1 8.8 93 MeKMi 82 Iso 38.2 14 47 93 31 V 7.314 32.5 178.1 16.5 -9.7 99.5 149 3.9 1.26 126 16.2 12 34 11.7 11.8 1.08 184  194 71 36 35 16.4 197 1.63 
tiger 2 1 8.8 93 MeKMi 111 Iso 38.2 16 47 103 32 V 7.293 35.7 176.1 17.3 -9.3 99.4 149 3.9 1.29 128 17.1 9 32 11 11.4 1.14 169  210 68 34 34 15.3 191 1.56 
tiger 2 1 8.8 93 MeKMi 140 Iso 37.8 15 49 79 29 V 7.244 40.3 163.7 17.4 -9.9 99.2 150 4.4 1.32 128 17.4 10 33 11.2 12 0.77 191  215 68 34 35 15.9 191 1.56 
tiger 2 1 8.8 93 MeKMi 175 Iso 37 20 52 74 30 V 7.285 37.6 140.3 17.9 -8.8 98.9 148 5.1 1.3 122 17.7 14 30 10.2 14 1.15 185  233 67 33 34 14.6 194 1.54 
tiger 2 1 8.8 93 MeKMi 226 Iso 36.8   92  V 7.32 32.4 218.3 16.7 -9.4 99.7 146 6.5 1.18 127 16.4 10 31 10.6 17.1 1.1 192         
tiger 2 2 8.8 94 MeKMi 68 Iso 39.1 12 40 140  V 7.268 34 113.1 15.5 
-
11.4 97.8 153 3.1 1.25 121 16 20 40 13.5 15.1 2.03 239         
tiger 2 2 8.8 94 MeKMi 82 Iso 39.1 12 40 129 37 A 7.318 38.4 500.1 19.7 -6.4 100 155 3.3 1.34 124 20.2 15 35 11.8 14 0.61 211  221 72 35 37 21.1 190 1.55 
tiger 2 2 8.8 94 MeKMi 118 Iso 38.2 8 45 124 37 A 7.331 38.7 465.4 20.4 -5.5 100 154 3.8 1.24 120 20.9 18 33 11.4 12.9 0.64 193  229 70 34 36 20 188 1.63 
tiger 2 2 8.8 94 MeKMi 148 Iso 37.8 8 50 114 40 A 7.298 43.9 515.1 21.5 -5 100 155 3.8 1.36 123 22 15 30 10.2 13.9 0.77 203  259 67 33 34 19.2 188 1.64 
lion 5 2 17.8 120 MeKMiB 22 Iso 37.1 10 60   V 7.215 41.3 112 16.7 -11.1 97.3 153 4.3 1.29 125 17.4 16 24 8 9.6 1.2 268         
lion 5 2 17.8 120 MeKMiB 98 Iso 36.2 15 52 78 36 V 7.227 42.3 49.2 17.6 -10 76.9 154 4.4 1.27 126 18.2 15 21 7.2 8.7 1.05 281         
lion 5 2 17.8 120 MeKMiB 131 Iso 36.1 16 55 82 35 V 7.234 44.7 47.8 18.9 -8.6 75.6 154 4.3 1.31 124 19.6 16 19 6.6 8 0.71 274         
lion 5 2 17.8 120 MeKMiB 169 Iso 35.8 18 50 112 38 V 7.196 49.5 68.5 19.2 -8.9 88.5 154 4.6 1.32 124 20 16 19 6.5 8.3 0.64 290         
lion 5 2 17.8 120 MeKMiB 245 Iso 35.7  50 100 32 V 7.294 38.4 51.5 18.6 -7.9 82.3 154 4.8 1.24 125 19.1 16 19 6.5 7.4 0.57 290         
tiger 2 3 8.9 95 MeKMi 58 Iso 38.4  50 135 32 V 7.21 35.8 106.9 14.4 
-
13.5 96.6 154 3.7 1.24 126 15 18 41 13.8 9.4 1.01 257         
tiger 2 3 8.9 95 MeKMi 85 Iso 37.9 13 39 153 33 V 7.22 41.9 67.6 17.2 
-
10.4 89.1 154 3.7 1.29 125 17.9 16 38 12.9 9.6 1.05 227         
tiger 2 3 8.9 95 MeKMi 110 Iso 37 10 52 98 31 V 7.28 33 182.5 15.6 
-
11.2 99.5 154 4.5 1.29 124 16 20 36 12.3 11 0.73 219         
sun 
bear 2 1 13.0 92 MeKMiB 13 Iso 37.3 16  116  V 7.276 40.5 169.1 18.9 -7.9 99.3 139 4.6 1.2 109 19.2 16 49 16.7 7.9 2.15 120  542 76 36 41 8.1 125 1.52 
sun 
bear 2 1 13.0 92 MeKMiB 89 Iso 36.9 6 49 101 27 V 7.327 34.9 172.1 18.3 -7.7 99.5 143 4.2 1.26 114 18.5 16 41 13.8 7 1.49 115  755 73 34 39 8 129 1.69 
sun 
bear 2 1 13.0 92 MeKMiB 160 Iso 35.6 6 47 95 32 V 7.327 34 221.2 17.8 -8.2 99.7 145 4.4 1.22 119 18 13 38 12.9 5.3 1.06 116  358 66 31 35 7.5 123 1.7 
sun 
bear 2 1 13.0 92 MeKMiB 248 Iso 35.9 6 66 109 32 V 7.357 33 191.8 18.5 -6.9 99.6 146 4.6 1.19 116 18.8 17 32 11 5.6 1.64 114  630 63 29 34 7 120 1.95 
sun 
bear 2 1 13.0 92 MeKMiB 289 Iso  9 77 102 32 V 7.339 37.8 200.6 20.3 -5.5 99.7 145 4.6 1.22 114 20.6 16 32 11 5.9 1.66 122  443 62 29 33 6.8 122 1.95 
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Appendix A2: 
Data sheet for blood gas (EPOC), laboratory clinical pathology parameters, 
calculated Strong ion parameters and calculated Mean Arterial Pressure (tMAP) 
parameters for all individual felid procedures covered under Massey University 
MUAEC Permit 17/50. Only first procedures are included in the analysis (Chapter 
Three). 
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lion 4 1 13.8 54 V 7.214 41.1 64.3 16.6 
-
11.2 87.4 153 4.2 1.32 127 17.9 14 53 17.9 4.9 2.04 185  108 79 31 48 0.66 12.8 189 1.58 29.48 10.73 27.28 2.20  
lion 4 1 13.8 79 V 7.316 36.2 212.7 18.5 -7.7 99.7 153 4.3 1.28 124 19.6 15 45 15.4 9.4 0.8 181  100 74 30 44 0.67 13 183 1.82 33.78 11.33 29.76 4.02  
lion 4 1 13.8 110 A 7.302 43.7 583.7 21.6 -4.7 100 152 4.5 1.33 121 23 14 38 12.8 12.6 0.77 202  116 69 27 42 0.64 13 187 1.85 36.06 10.52 32.07 3.99 85 
lion 4 1 13.8 134 A 7.301 41.4 550 20.4 -6 100 150 4.7 1.21 119 21.7 15 39 13.4 16.8 0.85 219  115 66 27 39 0.68 12.7 185 1.87 36.06 10.55 30.92 5.14 77 
lion 4 1 13.8 174 A 7.272 40 548 18.4 -8.4 100 148 5.3 1.26 120 19.7 15 39 13.4 20.9 1.06 191          33.5    70 
lion 3 1 19.0 46 V 7.294 32.3 51.5 15.7 
-
10.8 82.7 154 4.1 1.39 123 16.7 19 46 15.8 6.8 1.11 272 20 118 84 29 55 0.53 12.7 277 1.66 35.38 10.68 26.32 9.06 122 
lion 3 1 19.0 86 V 7.317 34.9 60.6 17.9 -8.2 89 152 3.9 1.38 125 19 13 41 14 7 1.19 249 19 135 84 28 56 0.5 13.2 261 1.66 31.09 10.51 28.32 2.77 96 
lion 3 1 19.0 110 V 7.294 38.2 55.2 18.6 -7.9 85.1 153 3.9 1.37 125 19.8 13 36 12.3 6.9 1.51 243 17 167 76 25 51 0.49 12.7 262 1.62 31.76 9.55 28.04 3.72 80 
lion 3 1 19.0 150 V 7.277 40.7 87.9 19 -7.8 95.4 154 4.1 1.35 125 20.2 14 31 10.7 6.9 1.23 328 20 270 72 24 48 0.5 12.9 270 1.71 33.22 9.38 28.33 4.89 55 
lion 3 1 19.0 202 V 7.295 40.5 73 19.7 -6.8 92.7 153 4.2 1.35 123 21 15 34 11.6 6.5 1.43 288 19 516 68 23 45 0.51 11.7 261 1.67 34.12 9.11 28.76 5.36 67 
lion 3 1 19.0 241 V 7.307 39.3 67.5 19.7 -6.6 91.3 153 4.3 1.43 124 20.9 14 29 9.8 6.8 1.2 238  599  21    273 1.71 33.53 8.68 28.29 5.24 91 
lion 5 1 16.3 43 V 7.278 41.5 71.5 19.4 -7.3  151 4.3 1.1 123 20.7    7 2.71 305 21 299 77 32 46 0.69 10.3 307 1.52 30.69 11.16 30.52 0.17  
lion 5 1 16.3 76 A 7.372 31.9 457.6 18.6 -6.7 100 152 4.8 1.2 126 19.5 12 44 14.9 10.1 0.42 335          31.58     
lion 5 1 16.3 116 V 7.325 36.6 294.5 19.1 -6.9  152 4.5 1.29 121 20.2 16   9.7 2.28 273 19  66 27 39 0.69 10 312 1.47 34.51 9.93 28.96 5.55 116 
lion 5 1 16.3 140 V 7.273 46.9 50.2 21.7 -5.2 79.8 152 4.8 1.25 121 23.1 14 37 12.6 10.6 0.8 288 19 291 73 30 43 0.7 11.2 347 1.64 36.25 10.82 32.46 3.79 88 
lion 5 1 16.3 169 V 7.261 48.1 42.2 21.6 -5.4  151 4.8 1.3 119 23.1 15   11.4 0.84 319 21 287 67 28 39 0.72 9.8 310 1.47 37.26 9.95 31.53 5.73 114 
lion 5 1 16.3 232 A 7.33 38.5 640.2 20.3 -5.6 100 151 5.1 1.34 116 21.5 20 35 12 14.1 0.3 271  405  25   15.5 278 2.3 41.14 10.90 31.14 10.00 88 
lion 5 1 16.3 296 V 7.247 50.4 51.3 22 -5.3 79.4 150 5.2 1.28 118 23.5 15 41 13.9 13.7 0.58 340 21 293 77 26 51 0.51 11.7 292 1.43 37.9 9.30 31.20 6.70 97 
cheetah 3 1 2.0 38 V                  33   35   19.4 277 2.89     161 
cheetah 3 1 2.0 68 V 7.259 47.9 91 21.5 -5.6 95.5 157 3.8 1.32 126 22.9 13 50 17 10.4 1.24 212 20 1197 75 36 39 0.92 17.1 252 2.61 34.88 14.06 35.45 -0.57 172 
cheetah 3 1 2.0 100 V 7.217 58.1 99.5 23.6 -4.1 96 157 4.1 1.35 123 25.4 15 47 16 10.8 1.39 233          38.06    154 
cheetah 3 1 2.0 140 V 7.252 56.9 104.1 25.1 -2.1 96.8 155 4.7 1.26 119 26.9 16 45 15.2 10.1 1.24 234 19 921 65 33 32 1.03 16 206 2.54 40.72 13.11 38.12 2.60 118 
cheetah 2 1 2.0 32 V 7.28 43.5 59 20.4 -6.3 86.6 158 3.8 1.32 124 21.8 17 54 18.4 10.9 1.06 224 17 413 79 40 39 1.03 18.7 244 2.41 38.06 14.87 35.26 2.80 194 
cheetah 2 1 2.0 86 V 7.213 59 89.3 23.8 -4.1 94.5 157 4.4 1.35 122 25.6 16 50 16.9 15.1 1.01 228  399  37   21.3 275 2.82 39.74 14.44 38.14 1.60 163 
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cheetah 2 1 2.0 113 V 7.224 54.7 132 22.6 -5.1 98.3 154 4.7 1.34 123 24.3 13 47 16 13.8 1.18  6 1695  36   18.4 266 1.96 35.86 12.73 35.27 0.59 126 
cheetah 2 1 2.0 133 V 7.279 50.8 84.1 23.8 -2.9 94.6 152 5.2 1.27 120 25.4 13 49 16.6 14.8 1.2 211  462  37    282 2.84 37.27 14.84 38.59 -1.32  
cheetah 1 1 8.5 62 V 7.181 67.4 85 25.2 -3.2 92.9 164 3.8 1.35 122 27.3 21 43 14.6 11.3 0.51 250 16 722 67 35 32 1.09 16 218 1.8 46.64 11.98 37.13 9.51 116 
cheetah 1 1 8.5 115 V 7.109 82.1 58.2 26 -3.5 77.5 162 4.8 1.35 122 28.6 19 40 13.7 13 0.3 270 21 691 75 33 42 0.79 15.6 233 2.05 45.85 11.57 37.53 8.32 62 
cheetah 1 1 8.5 172 V 7.119 89 41.6 28.9 -0.5 57.7 149 7.7 1.15 114 31.6 14 41 13.9 30.5 0.38 325 21 667 75 31 44 0.7 15.8 256 2.09 43.47 11.20 40.00 3.47 85 
lion 4 2 14.5 26 V 7.352 29.8 54.5 16.6 -9 87 154 4 1.21 126 17.5 15 44 14.8 6.8 1.17 203 8 106 73 29 44 0.66 14.2 230 1.39 32.04 10.43 26.92 5.12  
lion 4 2 14.5 49 V 7.301 36.7 73.9 18.1 -8.3 93.2 153 4 1.26 126 19.2 13 40 13.5 7.7 1.24 213    28    289  31.02     
lion 2 1 17.0 70 V 7.316 37 45.4 18.9 -7.3 77.6 148 3.8 1.28 122 20 11 43 14.7 8.5 1.38 232 12 149 72 28 44 0.64 17.2 241 1.53 29.7 10.27 29.11 0.59 65 
lion 2 1 17.0 100 V 7.31 37.3 68.5 18.8 -7.5 91.8 148 3.7 1.3 120 19.9 13 36 12.2 8.5 1.15 294 13 168 68 26 42 0.61 16.8 233 1.51 31.85 9.67 28.41 3.44 52 
lion 2 1 17.0 135 V 7.32 39.5 68.3 20.3 -5.8 91.9 148 3.7 1.33 123 21.5 8 30 10.3 8.8 0.93 210 13 228 65 25 40 0.63 16.6 242 1.63 29.1 9.66 29.96 -0.86 88 
lion 2 1 17.0 175 V 7.317 39.1 89.2 20 -6.1 96.1 148 3.8 1.32 122 21.2 10 28 9.6 8.6 0.85 205 14 313 62 24 38 0.64 16.1 241 1.62 30.27 9.36 29.32 0.95 93 
lion 2 1 17.0 220 V 7.287 49.5 54 23.7 -3 83.3 147 4 1.34 121 25.2 6 29 10 7.8 1.2 186 14 437 65 24 41 0.59 15.4 241 1.66 30.14 9.33 32.91 -2.77 83 
lion 2 1 17.0 262 V 7.25 52.8 48 23.2 -4.1 76.1 149 4 1.37 122 24.8 8 27 9.3 7.3 0.91 239 13 538 58 22 36 0.61 14.4 230 1.6 31.46 8.57 31.67 -0.21 68 
lion 2 1 17.0 322 V 7.387 32 99.2 19.3 -5.8 97.7 149 4.6 1.22 124 20.2 10 27 9.2 7.4 0.59 231 16 1036 64 24 40 0.6 14.6 253 1.87 30.23 10.05 29.24 0.99  
lion 6 1 17.5 45 V 7.299 38.4 58 18.9 -7.6 86.9 151 3.9 1.3 126 20 10 43 14.6 6.7 1.31 242 18 124 72 29 43 0.68 17.3 263 1.31 28.89 10.08 28.88 0.01  
lion 6 1 17.5 72 A 7.31 38.2 291.9 19.2 -7 94.9 151 4 1.39 124 20.4 12 39 13.3 12 0.69 234 17 154 68 27 41 0.65 16.5 251 1.25 31.7 9.48 28.66 3.04 158 
lion 6 1 17.5 105 A 7.273 41.9 276.8 19.4 -7.4 99.8 153 3.7 1.42 125 20.7 12 36 12.4 10.8 0.62 226 18 174 66 28 38 0.72 16.3 251 1.29 32.5 9.67 29.00 3.50 112 
lion 6 1 17.5 137 A 7.255 40.8 280.5 18.1 -9.1 99.8 153 3.6 1.42 120 19.3 19 35 11.8 9.8 0.81 218 16 203 63 26 37 0.69 15.7 249 1.3 37.21 9.10 27.16 10.05 73 
lion 6 1 17.5 171 A 7.233 48.1 281.5 20.3 -7.2 99.8 152 3.5 1.44 121 21.8 14 34 11.5 9.2 0.74 226 17 240 62 25 37 0.67 15.2 246 1.29 35.2 8.74 28.98 6.22 79 
lion 6 1 17.5 218 A 7.241 48.4 271.2 20.8 -6.5 99.8 152 3.7 1.45 121 22.3 14 33 11.2 8.7 0.82 280 16 283 62 25 37 0.66 14.5 246 1.32 35.33 8.83 29.56 5.77 90 
lion 6 1 17.5 260 A 7.288 40.8 249.4 19.5 -7.1 99.8 152 3.7 1.4 122 20.8 14 32 11 8.4 0.69 228          34.41    87 
lion 6 1 17.5 284 A 7.224 49.6 225.9 20.5 -7.2 99.7 152 3.8 1.44 123 22 12 33 11.1 8.4 0.99 223 18 399 62 24 38 0.64 14.2 244 1.39 33.25 8.63 29.07 4.18 83 
lion 6 1 17.5 318 A 7.211 53.5 148.8 21.4 -6.4 98.7 151 3.8 1.45 119 23.1 14 33 11.3 8.4 1.1 227 17 480 61 24 37 0.65 13.9 245 1.46 36.15 8.71 30.11 6.04 87 
lion 6 1 17.5 350 A 7.261 46.9 126.9 21.1 -6 98.3 151 4 1.42 120 22.5 14 33 11.1 8.3 1.07 219 18 663 57 22 35 0.64 13.6 257 1.55 35.35 8.52 29.56 5.79 81 
lion 6 1 17.5 385 V 7.233 54.9 44.2 23.1 -4.4 70.5 151 3.9 1.37 122 24.8 10 38 12.8 7.1 1.64 228 17 659 63 25 38 0.64 13.7 252 1.53 32.63 9.17 32.26 0.37 75 
lion 6 1 17.5 409 V 7.25 52.9 44.9 23.2 -4 72.5 149 4.1 1.37 119 24.8 11 33 11.1 7.3 1.35 252 18 660 56 22 34 0.65 13.8 258 1.53 34.12 8.45 31.59 2.53  
tiger 1 1 10.0 45 V 7.219 46.1 69.1 18.8 -8.9 89.5 150 4 1.37 127 20.3 8 39 13.3 11.1 0.92 173  791 72 35 37 0.97 17 150 1.64 27.45 11.88 30.66 -3.21 74 
tiger 1 1 10.0 100 V 7.221 43.5 50.2 17.8 -9.9 77.6 149 4.1 1.27 127 19.2 8 36 12.1 8.6 1.73 167          25.64    105 
tiger 1 1 10.0 130 V 7.225 44.4 71.7 18.4 -9.2 90.7 148 4.6 1.31 126 19.8 8 38 12.9 10.8 1.38 171  834 70 35 35 1 16.8 154 1.85 26.53 12.28 30.62 -4.09 86 
tiger 1 1 10.0 157 V 7.211 49.9 76.6 20 -7.9 91.8 147 5.2 1.32 123 21.5 9 39 13.2 11.9 1.56 163          28.96    84 
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tiger 1 1 10.0 172 V 7.225 49.9 90.6 20.7 -6.9 95 146 6 1.28 121 22.2 10 40 13.5 13.2 1.23 164  764 66 33 33 0.98 16.9 164 1.95 31.05 11.94 32.55 -1.50 74 
tiger 1 1 10.0 194 V                               77 
tiger 1 1 10.0 220 V 7.162 62.1 55.6 22.3 -6.4 78.7 146 7 1.33 122 24.2 9 37 12.7 13.3 1.14 197  839 64 32 32 0.98 16.5 177 1.9 31.19 11.31 33.49 -2.30 101 
lion 1 1 18.5 94 V 7.265 40 45 18.2 -9 74 151 4.8 1.32 124 18 15 30 10.2 2.1 0.63 309 24 166 80 29 51 0.56 18.9 339 1.91 32.49 11.01 29.12 3.37  
lion 1 1 18.5 187 V 7.195 52.5 37 20.3 -8 57 151 4.6 1.32 122 22 13 30 10.2 3.9 0.79 282 24 151 76 27 49 0.55 18.5 345 1.96 34.13 10.30 30.53 3.60 68 
lion 1 1 18.5 217 V 7.209 54.3 53 21.7 -6 79            26 179 69 24 45 0.55 18.4 350 2.15      
tiger 2 1 8.8 25 V 7.232 39.7 70.4 16.7 
-
10.8 90.6 150 3.6 1.28 128 16.7 10 41 13.8 11.9 1.46 193  139 75 37 38 0.98 17.2 200 1.31 25.42 11.88 28.54 -3.12  
tiger 2 1 8.8 82 V 7.314 32.5 178.1 16.5 -9.7 99.5 149 3.9 1.26 126 16.2 12 34 11.7 11.8 1.08 184  194 71 36 35 1.02 16.4 197 1.63 27.08 12.59 29.06 -1.98 101 
tiger 2 1 8.8 111 V 7.293 35.7 176.1 17.3 -9.3 99.4 149 3.9 1.29 128 17.1 9 32 11 11.4 1.14 169  210 68 34 34 0.98 15.3 191 1.56 25.05 11.83 29.07 -4.02 100 
tiger 2 1 8.8 140 V 7.244 40.3 163.7 17.4 -9.9 99.2 150 4.4 1.32 128 17.4 10 33 11.2 12 0.77 191  215 68 34 35 0.97 15.9 191 1.56 26.95 11.60 28.99 -2.04 96 
tiger 2 1 8.8 175 V 7.285 37.6 140.3 17.9 -8.8 98.9 148 5.1 1.3 122 17.7 14 30 10.2 14 1.15 185  233 67 33 34 0.98 14.6 194 1.54 31.25 11.49 29.32 1.93 86 
tiger 2 1 8.8 226 V 7.32 32.4 218.3 16.7 -9.4 99.7 146 6.5 1.18 127 16.4 10 31 10.6 17.1 1.1 192          25.58     
tiger 2 2 8.8 68 V 7.268 34 113.1 15.5 
-
11.4 97.8 153 3.1 1.25 121 16 20 40 13.5 15.1 2.03 239          34.32 13.27 28.78 5.54 140 
tiger 2 2 8.8 82 A 7.318 38.4 500.1 19.7 -6.4 100 155 3.3 1.34 124 20.2 15 35 11.8 14 0.61 211  221 72 35 37 0.96 21.1 190 1.55 35.03 12.20 31.84 3.19 139 
tiger 2 2 8.8 118 A 7.331 38.7 465.4 20.4 -5.5 100 154 3.8 1.24 120 20.9 18 33 11.4 12.9 0.64 193  229 70 34 36 0.97 20 188 1.63 38.4 12.13 32.53 5.87 130 
tiger 2 2 8.8 148 A 7.298 43.9 515.1 21.5 -5 100 155 3.8 1.36 123 22 15 30 10.2 13.9 0.77 203  259 67 33 34 0.97 19.2 188 1.64 36.39 11.73 33.18 3.21 120 
lion 5 2 17.8 22 V 7.215 41.3 112 16.7 
-
11.1 97.3 153 4.3 1.29 125 17.4 16 24 8 9.6 1.2 268          32.39     
lion 5 2 17.8 98 V 7.227 42.3 49.2 17.6 -10 76.9 154 4.4 1.27 126 18.2 15 21 7.2 8.7 1.05 281          32.62    72 
lion 5 2 17.8 131 V 7.234 44.7 47.8 18.9 -8.6 75.6 154 4.3 1.31 124 19.6 16 19 6.6 8 0.71 274          34.9    81 
lion 5 2 17.8 169 V 7.196 49.5 68.5 19.2 -8.9 88.5 154 4.6 1.32 124 20 16 19 6.5 8.3 0.64 290          35.28    104 
lion 5 2 17.8 245 V 7.294 38.4 51.5 18.6 -7.9 82.3 154 4.8 1.24 125 19.1 16 19 6.5 7.4 0.57 290          34.47    93 
tiger 2 3 8.9 58 V 7.21 35.8 106.9 14.4 
-
13.5 96.6 154 3.7 1.24 126 15 18 41 13.8 9.4 1.01 257          31.93    135 
tiger 2 3 8.9 85 V 7.22 41.9 67.6 17.2 
-
10.4 89.1 154 3.7 1.29 125 17.9 16 38 12.9 9.6 1.05 227          32.94    154 
tiger 2 3 8.9 110 V 7.28 33 182.5 15.6 
-
11.2 99.5 154 4.5 1.29 124 16 20 36 12.3 11 0.73 219          35.06    138 
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